[
    {
        "pmid": "40788195",
        "title": "Zoonotic Tuberculosis and Dairy Products: Comprehensive Meta-Analysis of Prevalence and Public Health Implications.",
        "abstract": "Tuberculosis TB remains global health concern unpasteurized milk serving major source zoonotic Mycobacterium bovis transmission endemic lowresource regions metaanalysis investigates prevalence human TB case linked contaminated dairy products assesses factor influencing transmission dynamic identifies actionable strategy reduce risks systematic metaanalysis TB case contaminated dairy consumption conducted using PubMed Web Science Scopus 20002024 Eligible study reported human TB prevalence Data extracted systematically statistical analysis MedCalc assessed heterogeneity Cochrans Q Isup2sup Random fixedeffects model applied subgroup sensitivity publication bias analysis performed metaanalysis reviewed 25 study 2000 2024 encompassing 10508 samples assess zoonotic TB linked dairy consumption Detection rate ranged widely 077 49 molecular method like polymerase chain reaction PCR showing higher sensitivity up 49 culture technique 2135 Prevalence greater TBendemic area Ethiopia Mexico Tanzania raw dairy sample outperformed blood diagnostics positivity Notably highest detection rate observed confirmed M bovis case history raw milk consumption underscoring zoonotic risk unregulated dairy contexts Significant heterogeneity Isup2sup  9892 arose diagnostic geographic population differences Pooled detection rate 608 fixedeffects 2290 randomeffects influenced unpasteurized milk poor livestock testing Publication bias notable Eggers p  00009 suggesting overrepresentation positive small studies highlighting challenge standardizing zoonotic TB detection Zoonotic TB dairy product major concern endemic area due unpasteurized milk poor veterinary infrastructure Enhanced pasteurization standardized diagnostics better surveillance key reducing risks alongside global food safety standard public health campaign protect vulnerable groups",
        "mesh_terms": [
            "Animals",
            "Humans",
            "Prevalence",
            "Zoonoses",
            "Tuberculosis",
            "Dairy Products",
            "Mycobacterium bovis",
            "Public Health"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40788195/"
    },
    {
        "pmid": "40758943",
        "title": "Nutritional status of adolescents undergoing tuberculosis treatment in urban Bangladesh: prevalence and determinants of malnutrition.",
        "abstract": "Tuberculosis global public health challenge disproportionately affecting adolescent lowand middleincome countries Malnutrition worsens immune function delay recovery increase risk treatment failure Tuberculosis patients objective study assess nutritional status adolescent undergoing TB treatment urban Bangladesh identify determinant malnutrition crosssectional study conducted November 1 2023 May 31 2024 among 339 adolescent receiving Tuberculosis treatment five hospital Dhaka Bangladesh Nutritional status primarily assessed PatientGenerated Subjective Global Assessment PGSGA Anthropometric data collected calculate BMIforage heightforage zscores verify nutritional status prevalence severe malnutrition 142  another 416  found moderately malnourished PGSGA zscores also showed 142  severe malnutrition 212  moderate malnutrition mean BMI 1789 593  participant underweight 637  experiencing degree stunting Eating difficulties particularly appetite loss reported 454  adolescents 528  received nutritionrelated information 18  received comprehensive nutritional care Logistic regression identified significant predictor malnutrition including female gender AOR051 p001 presence major comorbidities AOR367 p001 eating difficulty AOR341 p001 Type Tuberculosis AOR257 p001 less four meal AOR269 p001 PGSGA anthropometric indicator revealed significant nutritional deficits Integrated nutritional support management comorbidities prioritized alongside Tuberculosis care improve treatment outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40758943/"
    },
    {
        "pmid": "40757675",
        "title": "Tuberculosis-Induced Immune-Mediated Necrotizing Myopathy: A Challenging Case Scenario in a Non-Endemic Country.",
        "abstract": "bBackground Clinical Significanceb Tuberculosis TB pose significant global health challenge although lowmiddle income country carry heaviest burden diagnosis treatment challenging country clinical picture complex vary person person autoimmune complication hinder TB diagnosis treatment bCase Presentationb report case 38yearold man Bangladesh recently arrived Italy Balkan route presented TB cervical lymph node longstanding chronic myalgias wide range TBtriggered autoimmune entity found literature case first describe immunemediated necrotizing myopathy IMNM triggered active TB bConclusionsb IMNM previously associated infection like SARSCoV2 Dengue successful diagnosis management TBinduced IMNM achieved collaborative multidisciplinary approach involving rheumatologists immunologists infectious disease specialists showcasing innovative treatment strategy adding new insight complexity TB IMNM",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40757675/"
    },
    {
        "pmid": "40725984",
        "title": "The APLAR Recommendations for the Management of Psoriatic Arthritis.",
        "abstract": "auspex AsiaPacific League Associations Rheumatology APLAR aimed develop broad evidence consensusbased guideline aid health professional managing patient psoriatic arthritis PsA region working group 35 member comprising rheumatologists dermatologists patient research partner 18 APLAR country convened working group conducted systematic literature review derive quality evidence via GRADE method supporting efficacy safety class therapeutic agent management active PsA comorbidities screening specific infection concern region Recommendation statement principle management best use therapeutic drug developed Consensus within working group achieved external voting panel five 18 APLAR countries convened confirm agreement recommendation statements main literature review included 178 article clinical trial PsA Additional article evidence managing comorbidities uveitis inflammatory bowel disease screening chronic hepatitis B latent tuberculosis reviewed working group discussed reached consensus eight management principle 16 recommendation statement managing PsA Endorsement external voting panel n  90 response rate 80 achieved first recommendation management PsA patient APLAR region developed based best available evidence regionspecific consideration discussion among rheumatologists dermatologists patients strong agreement external expert panel",
        "mesh_terms": [
            "Humans",
            "Antirheumatic Agents",
            "Arthritis, Psoriatic",
            "Comorbidity",
            "Consensus",
            "Evidence-Based Medicine",
            "Rheumatology",
            "Treatment Outcome",
            "Systematic Reviews as Topic"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40725984/"
    },
    {
        "pmid": "40725000",
        "title": "In Silico Evaluation of Quinolone-Triazole and Conazole-Triazole Hybrids as Promising Antimicrobial and Anticancer Agents.",
        "abstract": "Cancer remains one leading cause death globally highlighting urgent need novel anticancer therapy higher efficacy reduced toxicity Similarly rise multidrugresistant pathogen emerging infectious disease underscore critical demand new antimicrobial agent target resistant infection unique mechanisms study used computational approach investigate twenty quinolonetriazole conazoletriazole hybrid derivative antimicrobial anticancer agent b1bb20b nine reference drugs studying interaction 6 bacterial DNA gyrase 10 cancerinducing target protein iE faecalisi iM tuberculosisi iS aureusi iE colii iM smegmatisi iP aeruginosai EGFR MPO VEGFR CDK6 MMP1 Bcl2 LSD1 HDAC6 Aromatase ALOX15 comparing established drug ampicillin cefatrizine fluconazole gemcitabine itraconazole ribavirin rufinamide streptomycin tazobactam compound b15b b16b emerged noteworthy antimicrobial anticancer agents respectively molecular dynamic simulations compound b15b b16b strongest binding 106 kcal molsup1sup 120 kcal molsup1sup crucial 5CDQ 2Z3Y proteins respectively exceeded druglikeness criteria displayed extraordinary stability within enzymes pocket varied temperature 300320 K addition used density functional theory DFT calculate dipole moment molecular orbital characteristic analyze thermodynamic stability putative antimicrobial anticancer derivatives finding reveals welldefined possibly therapeutic relationship supported theoretical future vitro vivo studies Compounds b15b b16b thus emerged intriguing contender fight infectious disease cancer",
        "mesh_terms": [
            "Triazoles",
            "Antineoplastic Agents",
            "Molecular Dynamics Simulation",
            "Quinolones",
            "Molecular Docking Simulation",
            "Humans",
            "Anti-Infective Agents",
            "Microbial Sensitivity Tests",
            "Computer Simulation",
            "DNA Gyrase"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40725000/"
    },
    {
        "pmid": "40719651",
        "title": "Sero-Prevalence and Molecular Detection of Mycobacterium bovis in Cattle at Sylhet Division of Bangladesh.",
        "abstract": "Mycobacterium bovis cause bovine tuberculosis bTB contagious notifiable chronic bacterial disease cause economic losses bTB remains significant zoonotic threat particularly resourcelimited setting reliable prevalence data still lacking study aimed determine serological prevalence molecular detection bTB different commercial individual dairy farm Sylhet Sunamganj district Bangladesh crosssectional study conducted total 250 blood 250 milk samples collected across selected dairy farms Serological testing performed using indirect ELISA molecular detection M bovis carried PCR Associations infection status potential risk factor evaluated using chisquare test logistic regression models overall prevalence M bovis 106 Molecular detection PCR revealed higher prevalence milk 148 compared blood 64 samples Serological testing showed prevalence Sylhet district lower 53 Sunamganj district 120 highest prevalence observed diarrhoeic animal 1949 followed female cattle 1358 Holstein Friesian cow 140 Cattle aged 13 year showed notable prevalence 1751 presence M bovis dairy cattle herd confirmed molecular serological methods highlighting endemic nature bTB study area finding underscore importance routine surveillance combining diagnostic approach implementing effective control measure reduce burden bTB dairy production systems",
        "mesh_terms": [
            "Animals",
            "Cattle",
            "Bangladesh",
            "Mycobacterium bovis",
            "Tuberculosis, Bovine",
            "Cross-Sectional Studies",
            "Prevalence",
            "Female",
            "Seroepidemiologic Studies",
            "Milk",
            "Male",
            "Polymerase Chain Reaction"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40719651/"
    },
    {
        "pmid": "40718224",
        "title": "Ultrasound-Guided Synovial Biopsy in Undifferentiated Monoarthritis: A Case Series From Bangladesh.",
        "abstract": "Ultrasoundguided synovial biopsy USGSB minimally invasive technique useful diagnosing joint tuberculosis particularly conventional method fail However role diagnosing tubercular arthritis Bangladesh remains underexplored study present case series five patient monoarthritis  three ankle involvement two knee joint tuberculosis  evaluated using USGSB aspiration procedure performed using highresolution musculoskeletal ultrasound 146 MHz probe Mindray Shenzhen China Synovial tissue sample analyzed via histopathology GeneXpert Cepheid Sunnyvale California US testing synovial fluid examined via cytology acidfast bacillus AFB staining GeneXpert Tuberculosis confirmed histologically three cases GeneXpert positive two AFB staining positive one finding support USGSB safe effective minimally invasive diagnostic option tubercular arthritis particularly resourcelimited setting like Bangladesh",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40718224/"
    },
    {
        "pmid": "40704325",
        "title": "Epidemiology and Clinical Characteristics of Musculoskeletal Extrapulmonary Tuberculosis in Lagos, Nigeria.",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40704325/"
    },
    {
        "pmid": "40697678",
        "title": "OMNIgene.SPUTUM for transporting sputum in ambient temperature for tuberculosis testing: Bangladesh experience.",
        "abstract": "Performance OMNIgeneSPUTUM OMS transporting sputum evaluated exploratory study conducted JanuaryDecember 2019 four near one distant healthcarefacilities Dhaka Smearpositive pulmonary TB patients sputum collected divided OMS untreated OMS treated portions transported testing laboratory Dhaka sameday nearsites courier distantsite smearmicroscopy culture Xpert MTBRIF Xpert testing Subset OMS treated sample tested Xpert without centrifugation Test result portion compared between Total 444 participant enrolled nearsites198 distantsite 246 test result comparable portion nearsites distantsite smearmicroscopys positivity reduced 41  OMS treated Xpert showed 100  concordance portions culture higher OMS treated OMS untreated 923  v 894  p  0288 Primary contamination rate OMS treated lower OMS untreated 20  v 98  p  005 sites median IQR timetoculture positivity 35 28 42 day portions Xpert positivity 99  concordant OMS treated regardless centrifugation OMS safe sputum transportation OMS mixed sputum tested Xpert culture study validate finding assess costeffectiveness",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40697678/"
    },
    {
        "pmid": "40689730",
        "title": "Exploring healthcare facilities' readiness for standard precautions in infection prevention and control: a cross-country comparative analysis of six low- and middle-income countries using national cross-sectional surveys.",
        "abstract": "Despite significant morbidity mortality caused healthcareassociated infection worldwide especially low middleincome country LMICs lack understanding readiness apply standard precaution infection prevention control IPC healthcare facility across different LMICs analysed nationally representative health system data Service Provision Assessment survey six selected LMICs  Afghanistan Democratic Republic Congo Haiti Nepal Senegal Bangladesh recorded seven tracer item standard precaution binary elements calculated readiness index based World Health Organizations Service Availability Readiness Assessment manual utilised surveyweighted multivariable generalised estimating equation identify factor associated readiness index Among 6054 healthcare facilities 55 95 confidence interval CI  531 565 necessary standard precaution available ranging 481 Democratic Republic Congo 65 Nepal Readiness varied service area tuberculosis service area least prepared 38 general outpatient service area prepared 66 Facilities Nepal urban region showed higher readiness mean x̄ difference 16 95 CI  136 179 3 95 CI  18 49 compared Democratic Republic Congo rural areas respectively revealed significant deficiency standard precaution within healthcare facility across six LMICs notably rural areas finding underscore urgent need targeted intervention improve IPC strategies particularly domain like tuberculosis care",
        "mesh_terms": [
            "Humans",
            "Cross-Sectional Studies",
            "Developing Countries",
            "Infection Control",
            "Health Facilities",
            "Nepal",
            "Democratic Republic of the Congo",
            "Haiti",
            "Bangladesh",
            "Cross Infection",
            "Afghanistan"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40689730/"
    },
    {
        "pmid": "40688748",
        "title": "A systematic review of the pivotal role of environmental toxicant exposure on infectious diseases in low- and middle-income countries.",
        "abstract": "objective review identify environmental toxicant linked infectious disease low middleincome country LMICs synthesizing available evidence aim summarize key findings identify research gap provide policy recommendation based association specific toxicant disease outcomes Systematic review conducted comprehensive search PubMed Scopus Web Science core collection CENTRAL the Cochrane Library identify study bacterial viral parasitic pathogenic activity search yielded 11468 studies 55 met inclusion criterion screening following standard methods consistent association found particulate matter PM25 PM10 exposure increased respiratory infection risk PM25 particularly linked increased incidence mortality disease like COVID19 tuberculosis Heavy metals including lead cadmium mercury worsen chronic infection HIVAIDS hepatitis increasing body burden inflammation review highlight air pollutants substantial impact infectious disease spread severity noting research gap pollutant including persistent organic pollutant POPs polycyclic aromatic hydrocarbon PAHs Bias assessment indicates around half study show low risk bias however potential bias noted confounding variable blinding outcome assessment systematic review emphasizes need research biological mechanism underlying association impact pollutants Findings advocate reducing environmental pollution exposure LMICs mitigate infectious disease risk",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40688748/"
    },
    {
        "pmid": "40683203",
        "title": "Integrative immune analysis in patients with leprosy reveals host factors associated with mycobacterial control.",
        "abstract": "Leprosy debilitating chronic infectious disease ranking second tuberculosis order severe human mycobacterial diseases timely treatment initiated infection causative agent Mycobacterium leprae result severe nerve damage leading lifelong disabilities Host immunity largely dictate spectral disease presentation ranging multi paucibacillary Studying host response M leprae is however complicated inability culture mycobacterium vitro Immune correlate protection person risk leprosy are therefore essentially unknown identify host factor related mycobacterial control functional mycobacterial growth inhibition assay combined extensive immunophenotyping spectral flow cytometry performed patient leprosy contacts integrative approach merged sampling peripheral blood mononuclear cell low resource area immuneanalysis using cutting edge technology contrast current dogma intrinsic difference mycobacterial control vitro patient high low bacillary load observed Immunophenotyping consecutive level revealed significant link induction chemokines mycobacterial antigen expression CXCR3 CCR4 adaptive immune cell contact controlling M leprae infection result offer detailed insight protective immunity M leprae define host factor associated bacterial control fuelling improved diagnosis treatment leprosy QM GastmannWichers Foundation Leprosy Research Initiative  Turing Foundation ILEP 7071902 R2STOP Leprosy Mission Great Britain",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40683203/"
    },
    {
        "pmid": "40672534",
        "title": "Skull bone lytic lesions: A rare form of multifocal skeletal tuberculosis.",
        "abstract": "Tuberculosis TB complex disease mimic numerous disease involving different organ systems making diagnosing TB challenging Multifocal tubercular osteomyelitis rare form skeletal TB represents minority skeletal TB cases patient 24yearold immunocompetent male complained lowgrade fever rise evening scalp aches rightsided chest pain noninflammatory back pain rest pain six months lost six kilogram period illness anemic mildly tender swelling right parietal region scalp Diffuse tenderness present dorsal spine right side chest evidence gibbus Multifocal skeletal tuberculosis diagnosed based presence lytic lesion skull ribs vertebrae along high erythrocyte sedimentation rate high tracer uptake bone scan biopsy report showing granulomatous lesion vertebra six month antiTB therapy scheduled followup visit patient showed significant improvement pain general wellbeing improvement skull lytic lesion xray Multifocal tubercular osteomyelitis rare immunocompetent male without pulmonary involvement Early recognition subsequent treatment could prevent severe complication bone destruction cases",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40672534/"
    },
    {
        "pmid": "40670587",
        "title": "A comprehensive machine learning for high throughput Tuberculosis sequence analysis, functional annotation, and visualization.",
        "abstract": "human guidance computer use machine learning ML artificial intelligence AI learn data detect trends make predictions Software adapt improve new information Imaging scan leverage pattern recognition predict outcomes diagnose disorders suggest treatments Tuberculosis TB remains common bacterial disease affecting humans World Health Organisation reported 2022 13 million people died tuberculosis death rate potentially reaching 66 proper treatment provided trained MLsupervised algorithm like XG Boost Logistic Regression Random Forest Classifier Ad aBoost Support Vector Machine help classify TB patient large RNAsequence count data algorithm provided prediction accuracy 0963 0739 0773 0866 0866 sequentially article highlight feature importance technique using ML model XGBoost highest prediction accuracy 0963 identifying significant gene TB RNA sequence count data Using key machine learning features identified 20 pathways 24 gene ontologies 20 hub genes 22 drugs Next applied advanced computational techniques including pathway analysis GO hubprotein proteinprotein interaction PPI transcriptomic miRNA interactions drugprotein interactions help analyze 100 highly expressed genes",
        "mesh_terms": [
            "Humans",
            "Machine Learning",
            "Tuberculosis",
            "Mycobacterium tuberculosis",
            "Algorithms",
            "Computational Biology",
            "Molecular Sequence Annotation",
            "Support Vector Machine"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40670587/"
    },
    {
        "pmid": "40666766",
        "title": "Tuberculous endogenous endophthalmitis presenting acute anterior uveitis with hypopyon.",
        "abstract": "27yearold male pain redness vision loss right eye diagnosed acute anterior uveitis hypopyon treated topical corticosteroid cycloplegic eyedrops Two week later developed severe vitritis Then 1 month oral corticosteroid treatment condition improve therefore underwent par plana vitrectomy intravitreal antimicrobial injection right eye suspicion endogenous endophthalmitis Polymerase chain reaction PCR vitreous aspirate negative herpes viruses eubacterial panfungal genomes 3 months patient developed painful blind eye eviscerated Histopathology PCR ocular specimen confirmed presence iMycobacterium tuberculosisi Highresolution computed tomography chest showed calcific nodule upper lobe right lung Mantoux test positive inquiry revealed patients father pulmonary tuberculosis TB 4 year earlier Ocular TB remains great masquerader clinician TBendemic region must bear high index suspicion TB managing case endogenous endophthalmitis",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40666766/"
    },
    {
        "pmid": "40657262",
        "title": "Diagnostic accuracy of RISK6 assay in childhood pulmonary TB.",
        "abstract": "recently updated target product profile TPP TB identification peripheral level guide test development conducted prospective diagnostic accuracy study among outpatient 15 year old presumed pulmonary TB International Centre Diarrheal Disease Research Bangladesh icddrb Dhaka Hospital evaluated accuracy RISK6 assay performed costperTB case identification analysis 365 enrolled children 68 microbiologically confirmed TB 94 unconfirmed TB 203 unlikely TB RISK6 meet TPP TB diagnosis child presumptive pulmonary TB individual ≤ 12 months assay outperformed 3242 Mantoux test 742 chest Xray 1142 correctly referring individual confirmatory testing RISK6 alone combination Mantoux test costeffective strategy identifying confirming TB cost low US13200 child  12 months Although RISK6 meet TPP TB diagnosis show promise triage test especially child ≤ 12 months could serve decisionsupport tool integrated treatment algorithm recommended WHO",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40657262/"
    },
    {
        "pmid": "40646273",
        "title": "Analysis of ICU resistome dynamics in patients, staff and environment for the identification of predictive biomarkers of sepsis and early mortality.",
        "abstract": "Antimicrobial resistance AMR global crisis posing critical challenge healthcare systems particularly intensive care unit ICUs multidrugresistant organism MDROs threaten patient survival study offer unique realworld perspective AMR dynamic analyzing 96 metagenomic sample three key sources oropharyngeal rectal swab deceased ICU patient both postadmission antemortem healthcare workers hightouch ICU surfaces Findings revealed ICU environment major AMR reservoir oropharyngeal swab carrying highest AMR burden healthcare staff facilitated MDRO spread primary sources Staff microbiomes MDRO pattern closely resembled environmental samples Key AMR specie included B fragilis E coli S pneumoniae S aureus P aeruginosa persisting hightouch surfaces Tetracycline resistance prevalent common resistance comprising 361 detected AMR markers Staff microbial community exhibited higher resistance macrolides fluoroquinolones lincosamides cephamycins 10day survival threshold distinguished early EM late mortality LM groups EM patient exhibited unique AMR specie oropharynx suggesting respiratorydriven infections LM patient showed greater gutassociated resistance Higher rectal AMR count correlated prolonged survival Notably four key MDROs L monocytogenes M tuberculosis S haemolyticus S agalactiae enriched sepsis patients suggesting early risk markers Fewer new resistance emerged rectal oropharyngeal swabs likely due antibiotic selection pressure Vancomycin levofloxacin frequently coadministered exerted stronger selective pressure oropharynx possibly explaining high MRSA prevalence patient environmental samples",
        "mesh_terms": [
            "Humans",
            "Intensive Care Units",
            "Sepsis",
            "Biomarkers",
            "Male",
            "Female",
            "Middle Aged",
            "Anti-Bacterial Agents",
            "Aged",
            "Drug Resistance, Multiple, Bacterial",
            "Health Personnel",
            "Oropharynx",
            "Bacteria",
            "Microbiota",
            "Drug Resistance, Bacterial"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40646273/"
    },
    {
        "pmid": "40614507",
        "title": "Novel heterocycles as antitubercular drugs: A review.",
        "abstract": "Tuberculosis TB treatment rely novel compounds improved delivery combination therapies challenge like toxicities drug resistance HIV incompatibility lack knowledge drug process persist TB remains one prevalent infectious disease globally impacting million annually led spread multidrugresistant strain extensively drugresistant Mycobacterium tuberculosis New drug urgently needed improve treatment drugresistant TB reduce new infections eliminate death rates Fortunately novel heterocyclic ringcontaining potential antitubercular candidate drug entered clinical trial recent years drug likely successful resistant strains overview new antiTB agent diverse molecular structure highlight effort develop new drug molecule lead antiTB agents Recent development study new heterocyclic compound highlighted review emphasizing compounds antimycobacterial activity mode action toxicity structureactivity relationship SARs",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40614507/"
    },
    {
        "pmid": "40600140",
        "title": "Benchmarking pangenome dynamics and horizontal gene transfer in <i>Mycobacterium marinum</i> evolution.",
        "abstract": "Horizontal gene transfer HGT key driver microbial evolution promoting genetic diversity contributing emergence antibiotic resistance study explores pangenome dynamic HGT iMycobacterium marinumi iM marinumi close relative iMycobacterium tuberculosisi Multiple pangenome datasets analyzed quantify gene gain loss pangenome openness utilizing Panstripe Generalized Linear Model GLM framework assess gene presenceabsence across strains Additionally comparative benchmarking analysis gene ontology GO annotation conducted using eggNOG InterProScan evaluate functional annotation accuracy finding demonstrated significant difference gene gain loss rates suggesting variation annotation accuracy presence mobile genetic element MGE Single nucleotide polymorphism SNPs also identified highlighting genetic variability may impact strainspecific trait pathogenicity antibiotic resistance Pangenome iM marinumi characterized highly open substantial variability gene content reflecting ongoing genetic exchange adaptability Functional annotation benchmarking demonstrated eggNOG InterProScan provided complementary insights tool excelling distinct strength gene function identification Overall finding highlight complex interplay HGT pangenome evolution antibiotic resistance iM marinumi analytical framework presented provides robust approach future study aiming inform therapeutic intervention vaccine development",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40600140/"
    },
    {
        "pmid": "40591627",
        "title": "Mixed-methods study to assess delay among patients with tuberculosis in an urban setting of Bangladesh.",
        "abstract": "Tuberculosis TB regained position leading cause death globally single infectious disease agent 2024 Delayed diagnosis treatment hamper effective TB control investigated duration diagnostic treatment delay along associated factor among people pulmonary TB Bangladesh mixedmethod study conducted December19 March21 icddrb TB Screening Treatment Centres TBSTCs Dhaka interviewed people TB PWTB seeking care TBSTCs using structured questionnaire collect data sociodemographic clinical healthcare seeking behaviors used established framework define stage delay associated factors Qualitative interview conducted among subset participant gain insight factor associated delay enrolled 895 PWTB mean ±SD age 366 ±161 years majority participant male 699 living urban area 823 median IQR patient delay estimated 47 2972 days diagnostic delay 45 3070 day treatment delay 2 24 days predictor delay diabetes OR 20 95 CI  111 342 initially selftreated OR 21 95 CI  109 388 bacteriologically diagnosed OR 37 95 CI  131 1046 Qualitative approach supported quantitative finding revealed practice visiting formal physician worsening illness neglecting acknowledge sign symptom consistent TB lack TB related knowledge financial insolvency major reason delay finding showed improper healthseeking behavior one major driver patient delay Thus targeted programmatic intervention raise community awareness TB care service special focus informal provider help reduce delay",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Male",
            "Female",
            "Adult",
            "Delayed Diagnosis",
            "Middle Aged",
            "Patient Acceptance of Health Care",
            "Urban Population",
            "Tuberculosis, Pulmonary",
            "Tuberculosis",
            "Surveys and Questionnaires",
            "Young Adult",
            "Time-to-Treatment"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40591627/"
    },
    {
        "pmid": "40457165",
        "title": "Structure-based design of Mycobacterium tuberculosis PptT-ACP complex inhibitors using derivative design and machine learning.",
        "abstract": "Tuberculosis TB caused Mycobacterium tuberculosis MTB remains critical global health challenge particularly rise multidrugresistant MDR strains study employed comprehensive computational approach identify optimize inhibitor targeting PptTACP complex key enzyme MTB lipid biosynthesis Virtual screening FDAapproved compound identified Mk3207 promising candidate Stability analysis molecular dynamic MD simulation validated selection derivative design Three chemically tractable region suitable structural modification identified second region selected derivative design due favorable structural property binding interactions One hundred derivative designed using ADMEopt screened virtually resulting three top derivative selected alongside Mk3207 evaluation compound underwent 200 n MD simulation triplicate Compound36 exhibiting highest binding stability indicated low root mean square deviation RMSD root mean square fluctuation RMSF values followed Compound98 Compound60 Free energy landscape FEL principal component analysis PCA confirmed thermodynamic stability derivatives Predicted biological activity using machine learning Random Forest Regression indicated pIC50 value 2564 2243 2232 2626 Compound36 Compound98 Compound60 Mk3207 respectively study demonstrates potential derivative design machine learning designing potent MTB inhibitors providing strong candidate experimental validation combat drugresistant TB effectively",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40457165/"
    },
    {
        "pmid": "40447420",
        "title": "Assessing the performance of a point-of-need diagnostic algorithm in rapid detection of peripheral lymph node tuberculosis (Mobile-TB-Lab): a diagnostic evaluation study protocol.",
        "abstract": "Early accurate diagnosis tuberculosis TB central ensuring proper treatment curbing transmission disease Despite significant burden diagnosis peripheral lymph nodeLNTB prevalent form extra pulmonary tuberculosis EPTB challenging low resource settings meet existing needs MobileTBLab study set evaluate two innovative approaches including thermal imaging recombinaseaided amplification assay RAA Minoo pointofneed diagnosis LNTB synergy index test expected pave way rapid detection EPTB resourceconstrained settings MobileTBLab multicountry diagnostic evaluation study performed Bangladesh Uganda protocol total 200 suspected EPTB patient cervical lymphadenitis enrolled tertiary healthcare facility Bangladesh Uganda participant subjected laboratory investigation including microscopy realtime PCR cytology culture Xpert MTBRIF Ultra tissue sample following fineneedle aspiration FNA index tests thermal imaging performed performing FNA leftover aspirate used perform RAA Minoo device diagnostic efficiency index test determined composite reference standard based laboratory methods Besides latent class analysis performed assess diagnostic accuracy index tests Finally health economic evaluation performed determine costeffectiveness investigative methods study protocol PR23031 approved research review committee RRC ethical review committee ERC institutional review board IRB icddrb Bangladesh Uganda study protocol approved Research Ethics Committee Infectious Diseases Institute Makerere University reference number IDIREC202362 approval Uganda National Council Science Technology UNCST reference number HS3494ES study material procedure used enrolment participant approved ethical review committee study performed according declaration Helsinki International Council HarmonisationGood Clinical Practice ensure participants rights safety wellbeing finding study submitted peerreviewed journal presented relevant national international meetings",
        "mesh_terms": [
            "Humans",
            "Tuberculosis, Lymph Node",
            "Algorithms",
            "Uganda",
            "Bangladesh",
            "Mycobacterium tuberculosis",
            "Nucleic Acid Amplification Techniques",
            "Lymph Nodes",
            "Point-of-Care Systems"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40447420/"
    },
    {
        "pmid": "40442917",
        "title": "Early-Life Microbiome and Neurodevelopmental Disorders: A Systematic Review and Meta-Analysis.",
        "abstract": "systematic review intends find neurodevelopmental disorders including Attention Deficit Hyperactivity Disorder ADHD Autism Spectrum Disorder ASD influenced gut microbiota throughout early childhood study look variety type microbe child exposed to particular microbiome profile associated neurodevelopmental outcomes molecular process underlie relationships performed thorough search PubMed Scopus Global Health Library GHL ISI Web Science screening 2744 original study based predetermined eligibility criteria 19 study included Microbial groupings presence highlow related neurodevelopmental disorder among primary area data extraction methodological quality study assessed using NewcastleOttawa Quality Assessment Scale NOS investigated literature repeatedly showed strong correlation dysbiosis gut microbiota neurodevelopmental disorders Cases ASD associated high number Clostridium specie low number Bifidobacterium species hand Low number E coli high number class Clostridia phylum Firmicute genus Bifidobacterium Akkermansia well specie Listeria monocytogenes Toxoplasma gondii Streptococcus mutans Mycobacterium tuberculosis linked ADHD NOS evaluation showed variation quality methodology study high scores suggesting sound technique study lower scores indicating serious methodological flaws result highlight potential impact gut microbiome throughout early life neurodevelopmental outcomes indicating microbial imbalance may play role onset disorder like ASD ADHD However improve quality data largerscale longitudinal study would required",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40442917/"
    },
    {
        "pmid": "40411718",
        "title": "Health economic evaluations of diagnostic tests for tuberculosis: a narrative review.",
        "abstract": "Tuberculosis leading cause death infectious disease globally Nonspecific symptom limitation existing diagnostics involve challenge informed policymaking clinical practice paper review common practice reporting selection definition cost effect parameters reporting translation effect parameter utility disability weights health economic evaluation TB diagnostic tests targeted literature search PubMed Cochrane Library Web Science Google Scholar identified health economic evaluation diagnosis population screening strategy TB found 28 study comprising 11 costeffectiveness 17 costutility analyses Observed patient data used 6 studies 22 relied solely modelbased evaluations Variations prevalence accuracy utility parameter common Consolidated Health Economic Evaluation Reporting Standards terminology costing used 8 28 studies Future study state exact type TB studied manifest multiple organs remain inactive long period time since different diagnostics perform differently depending site involved may influence test accuracies Additionally potential impact sequential diagnostics test accuracy cost inaction receive attention Precise terminology transparent definition parameter methodology health economics evaluation necessary generate evidence guide policymakers support clinical decisionmaking context TB",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40411718/"
    },
    {
        "pmid": "40382666",
        "title": "Developing an integrated depression and tuberculosis care pathway using a co-design approach in a low-resource setting.",
        "abstract": "Evidence suggests use participatory approach improvement TB care however limited evidence integrated depression screening care could delivered TB services Thus study codesigned integrated care pathway depression case finding treatment TB services delivered nonmental health specialist within low resourced settings conducted total 10 codesign workshop people TB carers tuberculosis mental health healthcare provider June August 2021 Dhaka Bangladesh Peshawar Pakistan adapted Hasso Plattner Institute Design Stanford University codesign process Information gathered workshop recording contemporaneous note taking collated analysed develop integrated care pathway material impmenting carepathway codesigned developed culturally adaptable care pathway integrates depression screening tuberculosis TB care working closely people affected TB healthcare worker primary secondary tertiary care setting Bangladesh Pakistan used PHQ9 identify screen depression among people TB Bangladesh whereas PHQ2 PHQ9 used depression screening among Pakistani population trained paramedic laboratory technologist Bangladesh DOTS Facilitator Pakistan working within TB facility identified agreed deliver integrated depression screening services Stakeholders valued opportunity jointly design care pathway Iterative coordinated working stakeholder enabled researcher understand better explore refine codesign process approach assisted mobilising knowledge depression integrating screening depression within existing usual TB care pathway using lived experience people TB health workers expertise",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40382666/"
    },
    {
        "pmid": "40379274",
        "title": "Clustering and visualisation of the GABRIEL network expertise in the field of infectious diseases.",
        "abstract": "Global Approach Biology Research Infectious disease Epidemics Lowincome country GABRIEL network international scientific network 21 centre coordinated Merieux Foundation Lyon France Mapping characterising similarity difference expertise activity across four major infectious disease tuberculosis antimicrobialresistant infections acute respiratory infection emerging pathogens among centre would help provide better understanding networks capacity also highlight applied methodology enhance information sharing within research networks centre responded questionnaire core activity research themes advanced multivariate analysis performed relate item together highlight new synergy among member GABRIEL network Similarities found using clustering algorithm data visualised using alluvial plots strategy enabled find new pattern GABRIEL network implementation new project global health regardless geographical proximity historical connections Five cluster based core activities consisting 6 1 3 9 2 research units respectively identified cluster 1 4 including majority units Four cluster defined based four major infectious diseases comprising 7 3 5 6 research units respectively methodology could also applied identify proximity network expert member different network efficient research surveillance global programmes",
        "mesh_terms": [
            "Humans",
            "Cluster Analysis",
            "Communicable Diseases",
            "Global Health",
            "Developing Countries",
            "Surveys and Questionnaires",
            "France",
            "International Cooperation"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40379274/"
    },
    {
        "pmid": "40309632",
        "title": "Association of Paternal Diabetes With Hemorrhagic Stroke in Bangladeshi Women: The MAGPIE Study.",
        "abstract": "Hemorrhagic stroke HS account 10 firsttime strokes increasing incidence Asia scarcity information available sexrelated differences study investigates independent predictor HS among Bangladeshi women Multidimensional Approach Genotype Phenotype Stroke Etiology MAGPIE study Bangladeshi observational study recruited nationwide HS patient 2022 2024 utilized univariate analysis identify risk pattern data sets whereas multivariate logistic regression LR analysis identified independent predictor HS women evaluated total 1080 hemorrhagic patient female predominance 595 similar age onset male ipi  038 Although male significantly higher rate hypertension ipi  0001 diabetes ipi  0008 chronic constipation ipi  003 systolic blood pressure ipi  0001 female found significantly higher body mass index 231 ± 31 vs 214 ± 29 ipi  0001 paternal diabetes 96 vs 48 ipi  0004 compared male Further ageadjusted multivariate LR model found paternal diabetes OR 21 95 CI 1235 ipi  0007 potential independent predictor HS female compared males area receiver operating characteristic AUROC curve 067 95 CI 063070 ipi  0001 677 sensitivity 582 specificity present goodness fit model Bangladeshi woman history paternal diabetes 21fold heightened risk HS men",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40309632/"
    },
    {
        "pmid": "40303072",
        "title": "<i>In Silico</i> Driven Multi-Epitope Subunit Candidate Vaccine against Bovine Tuberculosis.",
        "abstract": "Bovine tuberculosis bTB caused iMycobacterium bovisi pose significant zoonotic economic challenge globally current prevention treatment option limited increasingly complicated emergence multidrugresistant strains study employ reverse vaccinology immunoinformatics design multiepitope subunit vaccine targeting MPB83 ArfA DnaK GrpE LpqH protein iM bovisi Tcell Bcell epitope candidate vaccine predicted evaluated antigenicity allergenicity toxicity promising epitope assembled three vaccine construct bTBV1 bTBV2 bTBV3 using appropriate adjuvants pan HLA DRbinding epitope PADRE linkers construct analyzed physicochemical properties 3D structure cytokine induction stability followed molecular docking bovine CD molecule tolllike receptor TLR9 Among candidates bTBV3 chosen one promising vaccine candidate due high aliphatic index 6760 lowest instability score 2726 strong binding affinity Molecular dynamic simulation result interaction vaccinereceptor complex eigenvalue 2318704e06 show vaccine construct bTBV3 stable iIn silicoi immune simulation findings elevated IgM level increased Th cell populations suggest designed multiepitope vaccine candidate bTBV3 elicits robust humoral cellular immune responses confirming vaccines potential efficacy Additionally codon optimization CAI 0997 GC 54687 iin silicoi cloning facilitated efficient expression iE colii study highlight potential bioinformaticsdriven approach developing effective subunit vaccine bTB providing foundation experimental validation future application combating pervasive zoonotic disease bovine tuberculosis",
        "mesh_terms": [
            "Animals",
            "Cattle",
            "Tuberculosis Vaccines",
            "Vaccines, Subunit",
            "Tuberculosis, Bovine",
            "Mycobacterium bovis",
            "Epitopes, B-Lymphocyte",
            "Epitopes, T-Lymphocyte",
            "Molecular Docking Simulation",
            "Computer Simulation",
            "Epitopes"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40303072/"
    },
    {
        "pmid": "40302763",
        "title": "Migratory Wave due to Conflicts: Risk of Increased Infection From Zoonotic Diseases.",
        "abstract": "Wars devastating effect component One Health approach humans animals ecosystems Wars resulting migratory wave massively disrupt normal animal health service surveillance Among consequences adversely impact early detection prevention control animal diseases Uncontrolled movement animal undisposed carcasses destruction wildlife habitats increased interface humans wildlife domestic animal contribute uncontrolled transmission spread zoonotic pathogen animal humans last millennium zoonotic disease Black Death triggered devastating war led death large fraction human population However also recent ongoing war carry risk uncontrollable increase zoonotic diseases significant zoonotic disease reported recent war African swine fever highly pathogenic avian influenza rabies leptospirosis brucellosis well foodborne waterborne zoonotic diseases Indeed alarming rate infection antimicrobialresistant pathogen iMycobacterium tuberculosisi go along wars seen current UkraineRussia conflict Considering human migration foodborne waterborne zoonotic disease key health threat refugee due consumption unsafe food lack safe water disruption water supply sanitation system review summarizes potential factor data associated increased risk zoonotic disease emergence transmission recent ongoing conflicts",
        "mesh_terms": [
            "Zoonoses",
            "Animals",
            "Humans",
            "Armed Conflicts",
            "Risk Factors",
            "Animals, Wild",
            "Animal Migration"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40302763/"
    },
    {
        "pmid": "40302008",
        "title": "Disseminated tuberculosis in an immunocompetent healthy young male with nonspecific symptoms: challenges toward diagnosis-a case report.",
        "abstract": "Disseminated tuberculosis characterized spread Mycobacterium tuberculosis multiple noncontiguous sites rare immunocompetent individuals Diagnosing disseminated tuberculosis challenging due varied often nonspecific symptoms report case 29yearold Bangladeshi male notable past medical history presented prolonged fever night sweats cough weight loss altered bowel habit 6 months Initial evaluation Italy France yield definitive diagnosis investigation Bangladesh including sputum smear fineneedle aspiration cytology postauricular lymph node abdominal ultrasonography magnetic resonance imaging brain confirmed disseminated tuberculosis patient responded excellently standard fourdrug antitubercular therapy regimen Disseminated tuberculosis considered patient systemic symptoms particularly region high tuberculosis burden Early accurate diagnosis despite atypical presentation initial negative findings crucial effective treatment improved outcomes",
        "mesh_terms": [
            "Humans",
            "Male",
            "Adult",
            "Antitubercular Agents",
            "Magnetic Resonance Imaging",
            "Mycobacterium tuberculosis",
            "Immunocompetence",
            "Treatment Outcome",
            "Bangladesh",
            "Tuberculosis, Miliary",
            "Fever"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40302008/"
    },
    {
        "pmid": "40253515",
        "title": "Utilizing artificial intelligence to predict and analyze socioeconomic, environmental, and healthcare factors driving tuberculosis globally.",
        "abstract": "Tuberculosis TB major global health issue contributing significantly mortality morbidity rate worldwide Socioeconomic environmental healthcare factor significantly impact TB trends Therefore aimed predict TB identify determinant disease using advanced artificial intelligence AI study employed advanced machine learning ML model XGBoost eXtreme gradient boosting combined XAI eXplainable artificial intelligence spatial analysis describe global TB incidence mortality rate across 194 country 2000 2022 Spatial autocorrelation analysis utilizing Morans revealed geographical cluster significant determinant affecting TB incidence Treatment success rate MDRTB treatment initiation identified pivotal determinant TB incidence correlation study revealed substantial positive relationship TB incidence HIVpositive patient overall TB incidence r  083 Confirmed case MDRTB significant impact TB incidence SHAP  0874 Additionally air pollution notable impact TB incidence SHAP  136 XGBoost model demonstrated best predictive performance TB incidence mortality exhibiting lowest RMSE 088 highest Rsup2sup 067 Adjusted Rsup2sup 065 study highlight potential integrating XGBoost XAI methodology holistic framework effectively tackling global tuberculosis incidence mortality rates well proficient application advanced analytical technique public health",
        "mesh_terms": [
            "Humans",
            "Tuberculosis",
            "Artificial Intelligence",
            "Incidence",
            "Socioeconomic Factors",
            "Global Health",
            "Machine Learning"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40253515/"
    },
    {
        "pmid": "40240519",
        "title": "Performance of Xpert MTB/RIF ultra for the diagnosis of tuberculous meningitis in children using cerebrospinal fluid.",
        "abstract": "Rapid reliable diagnostic test tuberculous meningitis TBM child remain limited study evaluated performance Xpert MTBRIF Ultra Ultra improved version Xpert MTBRIF Xpert detecting TBM child using cerebrospinal fluid CSF Children 014 years presumptive TBM enrolled prospectively three tertiary level hospital Dhaka Bangladesh December 2019 January 2022 CSF tested Ultra Xpert LowensteinJensen LJ culture acidfast bacillus AFB microscopy Diagnostic performance assessed clinical case definitions composite microbiological reference standard CMRS LJ culture 187 children Ultra detected TBM 234 cases significantly higher 91 detected Xpert p  0001 Compared clinical case definition probable definite TBM Ultra exhibited sensitivity 88 4450 markedly outperforming Xpert 34 1750 LJ culture 30 1550 p  0001 CMRS Ultras sensitivity 100 4444 compared Xpert 386 1744 LJ culture 341 1544 p  0001 AFB microscopy showed low sensitivity 23 144 Negative predictive value clinical case definition CMRS higher Ultra 958100 Xpert 806841 LJ culture 797831 p  0001 Compared gold standard LJ culture Ultras sensitivity 100 1515 also higher Xpert 933 1415 p  0316 specificity 831 143172 983 169172 respectively Ultra detected 26 TBM case missed tests 846 trace detected category Due high performance Ultra used widely health care setting high TB burden country like Bangladesh rapid accurate diagnosis paediatric TBM using CSF samples",
        "mesh_terms": [
            "Humans",
            "Tuberculosis, Meningeal",
            "Child",
            "Child, Preschool",
            "Infant",
            "Female",
            "Male",
            "Adolescent",
            "Mycobacterium tuberculosis",
            "Sensitivity and Specificity",
            "Bangladesh",
            "Infant, Newborn",
            "Prospective Studies",
            "Cerebrospinal Fluid"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40240519/"
    },
    {
        "pmid": "40226135",
        "title": "Impact of helminth co-infection and treatment on mycobacterial growth inhibition in UK migrants with TB infection.",
        "abstract": "TB helminth infection coendemic many part world led hypothesis immunomodulation due helminth infection could adversely affect ability control iMycobacterium tuberculosisi infection Antihelminthic treatment associated improved antimycobacterial cellular response decrease frequency regulatory Tcells therefore investigated control mycobacterial growth antimycobacterial immune response modulated helminth TB coinfected individual using mycobacterial growth inhibition assay MGIA Migrants eosinophilia suspecteddiagnosed helminth infection andor TB infection TBI recruited attending University College London Hospitals London UK followed completing antihelminthic treatment Mycobacterial growth inhibition assessed using BACTEC™ MGIT™ system 72 hour coculture peripheral blood mononuclear cell PBMC iMi ibovisi bacille CalmetteGuérin BCG iM tuberculosisi Erdman Antihelminthic treatment reduced total helminthspecific antibody helminthinfected TBIhelminth coinfected individuals Helminthinfected individual displayed lower growth inhibition MGIA without helminth infections mycobacterial growth inhibition improved antihelminthic treatment Blocking interleukin10 IL10 transforming growth factorbeta TGFβ improved mycobacterial growth inhibition blocking interferongamma IFNγ alter growth inhibition Infection helminth iSchistosoma mansonii iStrongyloidesi spp may reduce ability control mycobacterial growth",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40226135/"
    },
    {
        "pmid": "40204038",
        "title": "Allele-specific detection of isoniazid metabolism modulating variants of N-acetyltransferase 2 enzyme and their frequencies in the Bangladeshi population.",
        "abstract": "Tuberculosis one oldest disease still affect million people worldwide remains significant public health challenge Nacetyltransferase 2 NAT2 enzyme metabolizes isoniazid INH primary antibiotic tuberculosis treatment single nucleotide polymorphism SNPs NAT2 affect metabolism function isoniazid rs1801280 T341C rs1208 G803A variant NAT2 associated INH drug responses Individuals slowmetabolizing rs1801280 variant NAT2 enzyme higher risk INHinduced liver damage require lower dos longer treatment regimens time individual fastmetabolizing rs1208 variant risk treatment failure due rapid drug metabolism Genotyping NAT2 variant help clinician personalize tuberculosis treatment optimize drug doses thus minimize adverse effects study allelespecific PCR ASPCR method developed genotyping NAT2 variants result validated targeted sequencing allele frequency rs1801280 locus 060 allele 040 C rs1208 participants allele frequency 027 G allele 073 allele ASPCR method quick affordable could used routine genotyping personalize treatment tuberculosis patients leading effective safer treatments also used molecular docking study rs1801280 rs1208 variant affect interaction NAT2 enzyme drugs slight change visible flexibility amino acid residues However amino acid involved ligand binding mechanism",
        "mesh_terms": [
            "Isoniazid",
            "Arylamine N-Acetyltransferase",
            "Humans",
            "Polymorphism, Single Nucleotide",
            "Antitubercular Agents",
            "Gene Frequency",
            "Bangladesh",
            "Alleles",
            "Male",
            "Female",
            "Tuberculosis",
            "Adult",
            "Genotype",
            "Molecular Docking Simulation"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40204038/"
    },
    {
        "pmid": "40176882",
        "title": "Ruptured Tubercular Baker's Cyst: A Case Report.",
        "abstract": "bBackgroundb Although tuberculosis TB affect organ ruptured Bakers cyst due TB uncommon phenomenon bCase Summaryb young lady presented unilateral atraumatic knee calf pain swelling Pain characteristic shared mechanical inflammatory natures Constitutional feature TB evident Based history clinical examination initial investigation ruptured Bakers cyst septic knee suspected Ultrasoundguided aspiration followed synovial fluid study revealed inflammatory fluid high adenosine deaminase level without bacterial growth culture negative GRAM AFB staining Empirical therapy curative Commencement antiTB brought better clinicopathological outcome Customized rehabilitation set up bConclusionb Unilateral monoarthritis ruptured tubercular Bakers cyst rare condition Diagnosis drug management rehabilitation followup recurrence prevention challenging especially low resources took initiative collaborate these",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40176882/"
    },
    {
        "pmid": "40176855",
        "title": "The Global Fund's Bangladesh program.",
        "abstract": "Global Fund program launched 2002 focus combating HIVAIDS tuberculosis TB malaria date mobilized US 65 billion across 120 countries contributing saving 65 million lives Bangladesh Global Fund played pivotal role expanding treatment coverage enhancing case detection strengthening prevention efforts Despite notable progress significant challenge persist particularly among highrisk population people inject drugs sex workers transgender individuals group face stigma limited access healthcare hinder disease control Additionally drug resistance present growing threat control malaria TB Looking ahead continued support Global Fund critical particularly scaling diagnostic infrastructure promoting communityled interventions enhancing crossborder collaboration effort essential ensuring sustained progress achieving longterm goal eliminating HIV TB malaria Bangladesh Effective coordination among government agencies nongovernmental organizations international donor essential ensure success initiatives",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40176855/"
    },
    {
        "pmid": "40175957",
        "title": "Factors influencing vaccine hesitancy toward non-covid vaccines in South Asia: a systematic review.",
        "abstract": "Declared one ten pressing threat global health 2019 complexity around vaccine acceptance hesitancy gained great momentum following COVID19 pandemic Lack vaccine acceptance may endanger mission improving vaccine uptake globally tackle pandemics reduce morbidity mortality preventable disease prevent antibiotic resistance worldwide Countries global south including South Asian Association Regional Cooperation SAARC country especially affected danger low vaccination uptake continue show decrease coverage recent years paper examines factor contributing vaccine hesitancy south Asia extent context disease specific guided modified version SAGE 5 C model Razai et al Three database searched peerreviewed article using comprehensive search strategy Results 44 quantitative qualitative mixedmethod study included systematic review appraised quality thematically analyzed mapped onto 5 C model finding India Pakistan Bangladesh Nepal Afghanistan showed vaccine hesitancy context vaccinespecific within different setting countries main factor contributing vaccine hesitancy identified narrow confidence vaccines miscommunication lack knowledge embedded overarching constraint contexts tackle vaccine hesitancy SAARC countries intervention need cocreated community mutual trust need ensured instance increased equity knowledge distribution",
        "mesh_terms": [
            "Humans",
            "Vaccination Hesitancy",
            "COVID-19",
            "Asia",
            "COVID-19 Vaccines",
            "Asia, Southern"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40175957/"
    },
    {
        "pmid": "40139209",
        "title": "Leveraging nutritional rehabilitation and tuberculosis programmes to tackle tuberculosis and severe acute malnutrition in children.",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40139209/"
    },
    {
        "pmid": "40126817",
        "title": "Xpert MTB/XDR Assay for Detection of Resistance to Isoniazid, Fluoroquinolone, Aminoglycoside, and Ethionamide Among Patients with Pulmonary Tuberculosis in Bangladesh.",
        "abstract": "Early detection drug resistance patient tuberculosis TB crucial prompt effective treatment study evaluated performance Xpert MTBXDR assay Xpert XDR detecting resistance isoniazid INH fluoroquinolones FLQ aminoglycosides AMG ethionamide ETH patient pulmonary TB PTB Bangladesh Xpert XDR performed sputum sample 793 Xpert MTBRIF positive patient PTB enrolled April 2021 March 2023 Results compared phenotypic drug susceptibility test pDST performed LowensteinJensen LJ medium detection resistance INH FLQ AMG ETH performance assay also compared newly diagnosed rifampicin RIFsensitive versus retreated RIFresistant patient PTB 793 sample tested Xpert XDR indeterminate result INH FLQ AMG ETH observed 3 04 5 06 33 42 0 0 isolates respectively assays sensitivity specificity compared pDST 940 95 CI 905964 264281 973 95 CI 954985 495509 respectively INH 860 95 CI 782918 98114 993 95 CI 983993 669674 respectively FLQ 857 95 CI 421996 67 999 95 CI 9931000 752753 respectively AMG 250 95 CI 190317 48192 967 95 CI 949980 581601 respectively ETH Agreement Xpert XDR pDST almost perfect detecting resistance INH FLQ AMG kappa 091 089 086 respectively fair ETH kappa 028 Xpert XDR performed significantly better among retreated RIFresistant patient TB compared newly diagnosed RIFsensitive cases Given high performance Xpert XDR assay programmatically implemented nationwide rapid accurate detection resistance INH FLQ AMG patient PTB aiding clinician selecting appropriate regimen treatment drugresistant TB",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40126817/"
    },
    {
        "pmid": "40109630",
        "title": "Diagnostic challenges and management of kikuchi-fujimoto disease: a rare case report.",
        "abstract": "KikuchiFujimoto disease otherwise referred histiocytic necrotizing lymphadenitis rare selflimiting disorder characterized fever lymphadenopathy upper respiratory symptoms main target illness young Asian adult prevalent females disease probably viral triggering autoimmune responses diagnosis depends histopathological examination present case 18month history recurrent highgrade fever marked weight loss enlarged occipital lymph node 42yearold diabetic male Karachi Pakistan patients symptom subside despite hospitalized several time receiving multiple course antibiotics Physical examination revealed firm nontender occipital lymph node Laboratory study showed mild anemia leukopenia raised inflammatory markers unremarkable imaging study autoimmune tests excisional biopsy lymph node confirmed KFD necrotizing lymphadenitis showing characteristic karyorrhectic debris case epitomizes diagnostic challenge KFD mimic host condition like tuberculosis lymphoma recurrent fever presence significant weight loss failure respond usual treatment raised suspicion detailed investigation Excisional biopsy established diagnosis differentiated conditions patients rapid improvement corticosteroid therapy aligns established treatment protocol KFD thus proving efficacy KFD included differential diagnosis fever unknown origin Diagnosis management KFD avoid misdiagnosis hence improve patient outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40109630/"
    },
    {
        "pmid": "40041505",
        "title": "Development of a novel encystment medium: Enhancing diagnostic potential of <i>Acanthamoeba</i> spp.",
        "abstract": "iAcanthamoebai spp pathogenic microorganism linked severe infection human animals requiring deeper understanding encystation process effective diagnostics research study focused developing novel encystment medium induce synchronized encystation iAcanthamoebai spp efficiently rapidly study employed response surface methodology central composite design optimize encystment medium formulation key component included TrisHCl NaCl glucose MgClsub2sub optimized liquid medium spraydried produce dehydrated powder practical application encystation efficiency different iAcanthamoebai strain assessed using hemocytometry fluorescence microscopy optimized medium comprising 3152 gL TrisHCl 555 gL NaCl 8 wv glucose 50 mM MgClsub2sub pH 90 demonstrated exceptional encystation efficiency rate ranging 99 100 spraydried powdered version medium equally effective achieving 9877 encystation rate iA castellaniii American Type Culture Collection 50739 glucosefree conditions Notably optimal glucose concentration varied among iAcanthamoebai strains certain strain reaching maximum encystation 68 glucose study successfully developed innovative encystment medium promotes rapid efficient cyst production iAcanthamoebai spp medium enhances laboratory research diagnostic capabilities paving way future advancement understanding managing iAcanthamoebai infections",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40041505/"
    },
    {
        "pmid": "40028641",
        "title": "Evaluation of treatment outcomes and associated risk factors in children with TB in Bangladesh.",
        "abstract": "Children aged 014 year old make 4 total number people diagnosed TB Bangladesh Local pediatric treatment outcome associated factor poorly understood understanding inform tailored intervention close delivery gaps assess risk factor unsuccessful treatment outcome among child receiving TB treatment 119 health facility Mymensingh Division conducted systematic verbal screening 2018 2021 Unsuccessful outcomes including death treatment failure loss followup LTFU analysed using logbinomial regression examine association demographic clinical characteristics Among 1967 child reported outcomes 993 ini  1954 successful primary reason unsuccessful treatment LTFU ini  12 06 followed treatment failure ini  1 01 controlling age sex child fever reduced risk unsuccessful outcome compared without fever RR 023 95 CI 006082 child TB successfully treated LTFU leading reason unsuccessful treatment outcome cohort Children fever less likely unsuccessful treatment outcomes possibly intensely engaged care child without fever due presentation symptoms Continued research pediatric TB presentation treatment outcome essential developing targeted strategy early detection treatment support",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40028641/"
    },
    {
        "pmid": "40023550",
        "title": "Challenges in diagnosing primary tubercular chorioretinitis and ocular tuberculosis in resource-limited settings of Bangladesh.",
        "abstract": "Tuberculosis pressing global health concern affect respiratory system also various extrapulmonary sites addition pulmonary symptoms tuberculosis also manifest outside lungs ocular involvement tuberculosis often presenting primary tuberculous chorioretinitis PTCR pose significant diagnostic challenge healthcare professionals review article shed light intricate nature diagnosing tuberculous infectious disease Bangladesh highlighting specific challenge faced setting Despite commendable progress tuberculosis control Bangladesh advanced diagnosis tuberculosis particularly involves eyes present formidable obstacles especially true case primary tuberculous chorioretinitis pose grave threat vision lead lifethreatening conditions particularly resourcepoor settings article underscore necessity innovative improvised diagnostic approach address unique nature cases Furthermore article delf implication Mycobacterium tuberculosis infection eye emphasizing potential cause severe blindness mitigate bias enhance patient outcomes healthcare community must focus raising public awareness improving diagnostic techniques ensuring adherence regulatory standards multifaceted approach essential effectively combat challenge posed tuberculosis particularly case involving ocular manifestations",
        "mesh_terms": [
            "Humans",
            "Tuberculosis, Ocular",
            "Bangladesh",
            "Chorioretinitis",
            "Mycobacterium tuberculosis",
            "Resource-Limited Settings"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40023550/"
    },
    {
        "pmid": "40000077",
        "title": "mHealth intervention (mTB-Tobacco) for smoking cessation in people with drug-sensitive pulmonary tuberculosis in Bangladesh and Pakistan: protocol for an adaptive design, cluster randomised controlled trial (Quit4TB).",
        "abstract": "People tuberculosis TB continue smoke likely poor health outcome quit Established smoking cessation approach mHealth may help patient TB quit smoking paper summarises methodology proposed assess effectiveness costeffectiveness mTBTobacco an mHealth intervention helping patient TB stop smoking improved health outcomes twoarm parallel openlabel multicentre cluster randomised twostage adaptive design trial proposed first evaluate superiority mTBTobacco compared usual care noninferiority mTBtobacco compared facetoface behaviour support Study setting include TB treatment centre Bangladesh Pakistan study population includes adult patients newly diagnosed within 4 weeks pulmonary TB disease daily smokers willing quit access mobile phones primary outcome includes biochemically verified continuous smoking abstinence assessed 6 month per Russell Standard generalised linear mixedeffects model used assess impact mTBTobacco intervention continuous outcomes incorporating fixed effect intervention random effect cluster relevant covariates Costeffectiveness analysis done estimate cost per quitter cost per qualityadjusted life year gained calculate incremental costeffectiveness ratio establish value money mTBTobacco trial conducted compliance International Council Harmonisation  Good Clinical Practice guideline Declaration Helsinki study approved ethic committee University Edinburgh Medical School Research Ethics Committee EMREC UK Bangladesh Medical Research Council BMRC National Bioethics Committee PMRC Pakistan result trial disseminated peerreviewed journal presented academic conferences ISRCTN86971818 httpsdoiorg101186ISRCTN86971818 preenrolment submission date 29 August 2023 registration date 11 September 2023",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Smoking Cessation",
            "Tuberculosis, Pulmonary",
            "Pakistan",
            "Telemedicine",
            "Cost-Benefit Analysis",
            "Randomized Controlled Trials as Topic",
            "Multicenter Studies as Topic",
            "Adult",
            "Female",
            "Male"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40000077/"
    },
    {
        "pmid": "39891328",
        "title": "Reversible zoonotic transmission of TB from humans to dairy cattle.",
        "abstract": "sectitleOBJECTIVEtitleTo use molecular technique assess prevalence iM bovisi iM tuberculosisi tuberculinpositive dairy cattle identify risk factor TB animalssecsectitleMETHODStitleA crosssectional study conducted 2018 2020 across Mymensingh Sirajgonj Dhaka Districts Bangladesh single intradermal comparative cervical tuberculin test administered 1580 cattle suspected bovine TB using avian bovine purified protein derivative Milk lung tissue sample positive animal examined using polymerase chain reaction PCR detect causative agent TB Multivariable logistic regression model identified risk factors Sangers dideoxy sequencing method used phylogenetic analysis PCR ampliconssecsectitleRESULTStitleSimplex PCR identified iMycobacterium tuberculosisi complex 126 samples Multiplex PCR detected iM bovisi 63 iM tuberculosisi 31 samples Phylogenetic analysis 12 ISi6110i gene sequence 8 iM bovisi 4 iM tuberculosisi confirmed alignment human isolates BangladeshsecsectitleCONCLUSIONtitleThe study suggests potential reverse zoonotic transmission iM tuberculosisi research needed understand implication assess TB transmission human cattle Bangladesh finding highlight need comprehensive One Health approachsec",
        "mesh_terms": [
            "Animals",
            "Cattle",
            "Bangladesh",
            "Cross-Sectional Studies",
            "Humans",
            "Tuberculosis, Bovine",
            "Mycobacterium bovis",
            "Mycobacterium tuberculosis",
            "Zoonoses",
            "Risk Factors",
            "Female",
            "Prevalence",
            "Tuberculin Test",
            "Tuberculosis",
            "Phylogeny"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39891328/"
    },
    {
        "pmid": "39867714",
        "title": "Frequency of Lower Lung Field Tuberculosis in Diabetes Mellitus Patients Attending Tertiary Care Hospital in Bangladesh: A Cross-Sectional Study.",
        "abstract": "People diabetes mellitus DM thought susceptible pulmonary tuberculosis PTB Several published comparative investigation reported chest xray image PTB DM considered atypical due frequent involvement lower lung field LLF study aimed investigate frequency lower lung field tuberculosis LLFTB DM risk factor DM development TB study crosssectional study PTB diagnosed positive sputum acidfast bacillus AFBCultureGene Xpert MTBRIF DM proven taking oral hypoglycemic drug receiving insulin time hospital admission Extrapulmonary tuberculosis seropositive human immunodeficiency virus HIV excluded study chest xray posterioranterior PA view done assess frequency pattern lung involvement Logistic regression analysis performed evaluate risk factor DM development TB total 117 PTBDM participant studied study mean age frequency isolated LLFTB 5317 ± 1438 year 205 respectively prevalence LLFTB radiological pattern statistically significantly correlated smear positivity 833 vs 204 erythrocyte sedimentation rate ESR  50 mm 958 vs 161 HbA1c  7 792 vs 161 Regression analysis showed odds ratio OR 681 393 DM age  40 years development LLFTB ipi  005 frequency LLFTB among PTB DM patient around 15th development LLFTB substantially associated DM age greater 40 years",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39867714/"
    },
    {
        "pmid": "39855750",
        "title": "Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysis.",
        "abstract": "data treatment child adolescent multidrugresistant MDR rifampicinresistant RR tuberculosis especially recently available drug regimens aimed describe clinical treatment characteristic association treatment outcome susceptible population conducted systematic review individual participant data metaanalysis Databases searched Oct 1 2014 March 30 2020 eligible study must included five child adolescent 019 year age treated microbiologically confirmed clinically diagnosed MDR RR tuberculosis within defined treatment cohort reported regimen composition treatment outcomes Abstracts screened independently two author identify potentially eligible records Full text reviewed two author independently identify study meeting eligiblity criteria study meeting eligiblity criteria anonymised individual patient data requested individiual level data included analysis main outcome assessed treatment outcome defined treatment success cure treatment completed versus unfavourable outcome treatment failure death Multivariable logistic regression model used identify association clinical treatment factor treatment outcomes study registered Prospero CRD42020187230 1417 study identified database searching removing duplicate screening eligibility search identified 23 369 individual participant 42 studies mostly India South Africa Overall 16 825 72·0 successfully treated treatment completed cured 2848 died 12·2 722 3·1 treatment failure 2974 12·7 lost followup primary analyses median age 16 IQR 1318 years 17 764 87·1 participant reported HIV status 2448 13·8 living HIV 17 707 89·6 microbiologically confirmed tuberculosis adjusting significant factor associated treatment outcome use two adjusted odds ratio OR 1·41 95 CI 1·091·82 p0·008 three 2·12 1·612·79 p0·0001 WHOclassified group drug bedaquiline moxifloxacin levofloxacin linezolid compared use group drug positively associated treatment success Younger clinically diagnosed child underrepresented among treated MDR RR tuberculosis focus casefinding efforts Overall treatment outcome analysis better adult lower international target 90 individual successfully treated Treatment group drug associated better treatment outcome child adolescents highlighting need rapid access drug improved regimens Unitaid",
        "mesh_terms": [
            "Humans",
            "Adolescent",
            "Child",
            "Rifampin",
            "Tuberculosis, Multidrug-Resistant",
            "Treatment Outcome",
            "Child, Preschool",
            "Antitubercular Agents",
            "Infant",
            "Male",
            "Female",
            "Antibiotics, Antitubercular"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39855750/"
    },
    {
        "pmid": "39849939",
        "title": "Age- and sex-specific care cascades to detect gaps in the care of children with tuberculosis in Bangladesh: a cohort study.",
        "abstract": "Programmatic intervention increase detection child tuberculosis TB rarely evaluated understand age sexspecific completion rates applied modified TB screening treatment cascade framework assess indicator effective implementation age sex TB screening program child zero 14 years Bangladesh implemented intensified screening program paediatric TB detection 119 health care facility 201821 followed systematic verbal screening referral full evaluation child reported symptom contact history patient TB Further linked child treatment diagnosed followed outcomes calculated percentage children age sex progressing step care cascade compared frequency step completion sex using χsup2sup tests total screened 552 182 male 461 419 female TB 28 male 26 female screened positive P  0001 742 male 739 female underwent appropriate evaluation P  0560 103 male 115 female diagnosed TB P  0008 100 child initiated treatment 976 male 971 female achieved successful treatment outcome P  0428 percent child screening positive verbal screen clinically evaluated TB diagnosed TB generally increased age variability throughout ranges 1291 598885 65219 respectively largest gap observed sex among age child appropriately evaluated TB despite screening positive research highlight value identifying gap paediatric TB care inform innovative age sextailored intervention improve future care children",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Male",
            "Female",
            "Child",
            "Child, Preschool",
            "Tuberculosis",
            "Infant",
            "Mass Screening",
            "Adolescent",
            "Cohort Studies",
            "Infant, Newborn",
            "Sex Factors",
            "Age Factors"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39849939/"
    },
    {
        "pmid": "39766204",
        "title": "Repurposed Drugs and Plant-Derived Natural Products as Potential Host-Directed Therapeutic Candidates for Tuberculosis.",
        "abstract": "Tuberculosis TB one leading cause death due infectious disease treatable disease however conventional treatment requires lengthy treatment regimen severe side effects resulting poor compliance among TB patients Intermittent drug use noncompliance patients prescription errors among factors led emergence multidrugresistant TB mismanagement multidrugresistant TB MDRTB eventually led development extensively drugresistant tuberculosis XDRTB Thus urgent need new drug development due enormous expense time required up 20 years new drug research development new therapeutic approach TB required Hostdirected therapy HDT could attractive strategy target host defense process instead microbe thereby may prevent alarming rise MDR XDRTB paper review progress HDT treatment TB using repurposed drug investigated clinical trial completed ongoing plantderived natural product clinical preclinical trial stages Additionally review describes existing challenge development future research direction implementation HDT",
        "mesh_terms": [
            "Animals",
            "Humans",
            "Antitubercular Agents",
            "Biological Products",
            "Drug Repositioning",
            "Extensively Drug-Resistant Tuberculosis",
            "Mycobacterium tuberculosis"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39766204/"
    },
    {
        "pmid": "39703447",
        "title": "Mortality Rate and Its Contributing Factors in Post-Surgical and Medical Patients with AKI Underwent CRRT.",
        "abstract": "Acute kidney injury AKI requires continuous renal replacement therapy CRRT one important problem medical surgical patients Therefore important identify influencing factor reduce dimension problem study conducted investigate mortality rate medical surgical patient AKI requiring CRRT treatment observational study conducted cross sectional analytical study 100 patient AKI requiring CRRT treatment including medical surgical patients selected 2018 2021 Masih Daneshvari Hospital mortality rate estimated Also effective factor investigated compared dead surviving patients 85 case 85 patient died underlying demographic variable statistically significant difference dead surviving patient P005 However case primary calcium P0001 primary leukocyte P0037 bicarbonate hospitalization P0025 bicarbonate AKI P0028 magnesium hospitalization P0038 magnesium end CRRT P0019 difference statistically significant conclusion mortality observed 5 6 patient acute kidney failure need CRRT treatment related risk factor bicarbonate magnesium leukocyte calcium levels Therefore multifaceted planning needed reduce dimension improve prognosis group patients",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39703447/"
    },
    {
        "pmid": "39700671",
        "title": "Diagnostic techniques for visceral leishmaniasis: An overview of methods used in East Africa.",
        "abstract": "Leishmanias parasitic infection caused protozoan belonging genus Leishmania transmitted sand fly Phlebotomus fly old world Lutzomyia New world disease prevalent tropics subtropics Southern Europe affect 15 million 2 million people annually India Bangladesh Sudan South Sudan Brazil Ethiopia account 90 VL cases Leishmania case Asia declining case East Africa especially Somalia Sudan South Sudan Ethiopia Kenya increasing rise East African case partially attributed ongoing armed conflict especially Somalia Sudan Southern Sudan displaced people increased exposure sand fly bites Migration endemic nonendemic regions misdiagnosis famine malnutrition climate change increase HIV case contributing factors clinical diagnosis Leishmania East Africa combine patients clinical sign either serological parasitological test rK39 strip microscopy major method used Diagnosis condition remains challenging current technique limitations including inability detect parasite tissue need specialized expertise prohibitive cost testing equipment low antibody titers risk misdiagnosis due coinfections disease HIV tuberculosis malaria typhoid Various techniques including serological molecular parasitological methods employed attempt address challenges limited success article therefore review technique used Leishmania diagnosis East Africa discusses available new technique aim overcoming current challenges",
        "mesh_terms": [
            "Humans",
            "Leishmaniasis, Visceral",
            "Africa, Eastern",
            "Diagnostic Tests, Routine",
            "Leishmania",
            "Animals"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39700671/"
    },
    {
        "pmid": "39698066",
        "title": "Anthropometric Measurements in Predicting Haemorrhagic Stroke Among Bangladeshi Population: The MAGPIE Study.",
        "abstract": "Anthropometric measurement used predict cardiovascular disease vary worldwide mostly derived Caucasian ancestry sought undertake measurement little studied Bangladeshi population MAGPIE Multidimensional Approach Genotype Phenotype Stroke Etiology study Bangladeshi stroke casecontrol study recruited nationwide January 2022 June 2024 univariate analysis utilised curtail risk independent variables receiver operating characteristic ROC curve employed identify cutoff value Body Mass Index BMI Waist Circumference WC Hip Circumference HC Furthermore multivariate logistic regression LR model demonstrated risk independent predictor haemorrhagic stroke HS among sexes total 1491 age sexmatched study population 918 haemorrhagic stroke 615 female predominance n489 533 significantly older men P0003 BMI 229 ±30 v 213 ±30 P0001 WC 840 ±73 v 808 ±73 P0001 HC 906 ±71 v 855 ±77 P0001 significantly higher among woman compared men ROC curve demonstrated cutoff value BMI WC HC 206kgmsup2sup 788cm 846cm respectively men 211 kgmsup2sup 815cm 881cm respectively woman haemorrhagic stroke population Furthermore ageadjusted multivariate LR model identified HC ≥846 cm men OR 28 95 CI 161497 P 0001 WC ≥815cm woman OR 16 95 CI 101237 P0001 potential independent predictor haemorrhagic stroke Bangladeshi men hip circumference ≥846cm threefold woman waist circumference ≥811cm twofold heightened risk haemorrhagic stroke",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39698066/"
    },
    {
        "pmid": "39682662",
        "title": "From Binary to Multi-Class Classification: A Two-Step Hybrid CNN-ViT Model for Chest Disease Classification Based on X-Ray Images.",
        "abstract": "Chest disease identification Tuberculosis Pneumonia disease present diagnostic challenge due overlapping radiographic feature limited availability expert radiologists especially developing countries present study aim address challenge developing ComputerAided Diagnosis CAD system provide consistent objective analysis chest Xray images thereby reducing potential human error leveraging complementary strength convolutional neural network CNNs vision transformer ViTs propose hybrid model accurate detection Tuberculosis distinguishing Tuberculosis Pneumonia designed twostep hybrid model integrates ResNet50 CNN ViTb16 architecture us transfer learning datasets iGuangzhou Womens Childrens Medical Centeri Pneumonia case datasets iQatar Dhaka Bangladesh universitiesi Tuberculosis cases CNNs capture hierarchical structure images ViTs selfattention mechanisms excel identifying relationship features Combining approach enhances models performance binary multiclass classification tasks hybrid CNNViT model achieved binary classification accuracy 9897 Tuberculosis detection multiclass classification distinguishing Tuberculosis viral Pneumonia bacterial Pneumonia model achieved accuracy 9618 result underscore models potential improving diagnostic accuracy reliability chest disease classification based Xray images proposed hybrid CNNViT model demonstrates substantial potential advancing accuracy robustness CAD system chest disease diagnosis integrating CNN ViT architectures approach enhances diagnostic precision may help alleviate burden healthcare system resourcelimited setting improve patient outcome chest disease diagnosis",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39682662/"
    },
    {
        "pmid": "39681964",
        "title": "Finding the missed millions: innovations to bring tuberculosis diagnosis closer to key populations.",
        "abstract": "Current strategy promptly effectively equitably screen people tuberculosis TB link diagnosis care insufficient new approach required find million people around world TB missed year Interventions also need designed considering people interact health care facility appropriate suitable use community Here historical new reemerging technology utilised TB diagnosis globally discussed whilst highlighting use evaluate test important test themselves",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39681964/"
    },
    {
        "pmid": "39681961",
        "title": "Early user perspectives on using computer-aided detection software for interpreting chest X-ray images to enhance access and quality of care for persons with tuberculosis.",
        "abstract": "Despite 30 year public health emergency tuberculosis TB remains one worlds deadliest diseases death among person TB reached diagnosis treatment Thus timely screening accurate detection TB particularly using sensitive tool chest radiography crucial reducing global burden disease However lack qualified human resource represents common limiting factor many high TBburden countries Artificial intelligence AI emerged powerful complement many facet life including interpretation chest Xray images However AI may serve viable alternative human radiographer radiologists high likelihood suffering TB reap benefit technological advance without appropriate clinically effective use costconscious deployment World Health Organization recommended use AI TB screening 2021 early adopter technology using technology many ways manuscript present compilation early user experience nine high TBburden country focused practical consideration best practice related deployment threshold use case selection scaleup offer technical operational guidance use AI interpreting chest Xray image TB detection aim remains maximize benefit programs implementers ultimately TBaffected individual derive innovative technology",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39681961/"
    },
    {
        "pmid": "39658125",
        "title": "The Frequency and Incidence of QT Prolongation With Extended Use of Bedaquiline or Delamanid in a Large, Multi-Country Multidrug-Resistant/Rifampicin-Resistant Tuberculosis Cohort.",
        "abstract": "2022 World Health Organization WHO guideline multidrugresistantrifampicinresistant tuberculosis MDRRRTB recommend 6 month bedaquiline Bdq alloral 9month shorter regimen 6 month longer Bdq delamanid Dlm 1820month longer regimen However lack evidence extended treatment using Bdq Dlm limited use 6 months examine frequency incidence QT prolongation based duration Bdq andor Dlm use longer regimens analyzed prospective cohort MDRRRTB patient 16 country initiated treatment Bdq andor Dlm containing regimen 1 April 2015 30 September 2018 Data systematically collected using shared protocol outcome interest first clinically relevant prolonged QT interval grade 3 above serious adverse event SAE involving prolonged QT grade Among 2553 patients 59 received 6 month Bdq andor Dlm these 579 209 patient experienced prolonged QT event majority 955 grade 1 2 Sixtyfour 25 patient experienced outcome interest 12 05 ≥1 QT prolonging drug permanently suspended incidence rate first prolonged QT event highest first six month treatment lower subsequent 6month periods demonstrate Bdq andor Dlm use beyond 6 month safe longer MDRRRTB regimen clinically relevant QT prolongation event occurring first 6 months Electrocardiogram ECG monitoring early identification QT prolongating event possible programmatic conditions",
        "mesh_terms": [
            "Humans",
            "Diarylquinolines",
            "Antitubercular Agents",
            "Tuberculosis, Multidrug-Resistant",
            "Female",
            "Male",
            "Nitroimidazoles",
            "Long QT Syndrome",
            "Adult",
            "Incidence",
            "Prospective Studies",
            "Middle Aged",
            "Oxazoles",
            "Rifampin",
            "Young Adult",
            "Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39658125/"
    },
    {
        "pmid": "39649774",
        "title": "Hypersensitivity Pneumonia Due to Lentil Aspiration: A Rare but Painstaking Pulmonary Illness.",
        "abstract": "7monthold girl suffering progressively deteriorating pneumonia despite getting multiple course broadspectrum antibiotic well antifungal drug adequate duration find cause behind deterioration patient underwent thorough clinical relevant laboratory evaluation including chest radiology  imaging screening primary immune deficiency disorder PID cystic fibrosis tuberculosis invasive fungal pneumonia congenital heart disease covid pneumonia TORCH etc failed solve mystery Upon detailed reevaluation discovered child history forcefully fed lentilbased khichuri a ricelentil mixed dish weaning process diagnosis finally confirmed hypersensitive pneumonia due lentil aspiration high level IgG specific lentil antigen Treatment commenced prednisolone resulting significant improvement clinical radiological condition within 72 hours",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39649774/"
    },
    {
        "pmid": "39617937",
        "title": "Rapid test for Mycobacterium leprae infection: a practical tool for leprosy.",
        "abstract": "Detection infection Mycobacterium leprae allows timely prophylactic treatment thereby reducing transmission well risk permanent leprosyassociated nerve damage However since worldwideimplemented standard test M leprae infection detection infection asymptomatic individual remains major challenge control program endemic areas previous studies developed fieldtested lateral flow assay LFA quantitatively detecting human IgM M lepraespecific phenolic glycolipid antiPGLI marker active past infection rapid test utilizes luminescent backgroundfree upconverting reporter particle UCP immunochromatography ie UCPLF test platform accurate quantitation antiPGLI IgM without operator bias aim study evaluate final version quantitative UCPbased rapid test ie PGLI QURapid using serum fingerstick blood FSB test comprises lateral flow strip standard plastic biodegradable cassette provided humanized recombinant control monitor test performance calculate accurate antiPGLI IgM levels performance QURtest assessed using serum FSB patient leprosy n  214 tuberculosis n  20 buruli ulcer n  19 leishmaniasis n  14 nontuberculous mycobacterial n  35 infections well healthy Dutch individual n  710 humanized recombinant antiPGLI IgM antibodies Plot receiver operating characteristic curve created sensitivity Sn specificity Sp area curve calculated evaluate test performance Test result classified multibacillary leprosy patient 950 Sn 100 Sp using serum 915 Sn 998 Sp using FSB Qualitative test result could read 2 min flow time accurate quantitation 10 min onwards new antiPGLI IgM control support production batch predetermined seropositivity threshold monitoring PGLI QURtest various settings operational version PGLI QURapid pointofcare applicability meet target product profile criteria Thus QURtest ready public health implementations",
        "mesh_terms": [
            "Humans",
            "Mycobacterium leprae",
            "Leprosy",
            "Male",
            "Female",
            "Immunoglobulin M",
            "Adult",
            "Antibodies, Bacterial",
            "Middle Aged",
            "Sensitivity and Specificity",
            "Antigens, Bacterial",
            "Glycolipids",
            "Young Adult",
            "Aged",
            "Adolescent",
            "Chromatography, Affinity"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39617937/"
    },
    {
        "pmid": "39605779",
        "title": "A systematic review on reverse-zoonosis: Global impact and changes in transmission patterns.",
        "abstract": "Reverse zoonosis zooanthroponosis transfer pathogen human animals Although less studied zoonotic diseases phenomenon pose significant risk animal public health increasing humananimal interaction driven urbanization globalization environmental change exacerbated occurrence reverse zoonosis review evaluated global impact transmission pattern reverse zoonosis highlighting anthropogenic intrinsic factor contributing emergence study performed systematic review included 91 scientific article published 2000 2022 covering viral bacterial parasitic fungal protozoal reverse zoonoses study indicated viral infections particularly respiratory virus severe acute respiratory syndrome coronavirus2 influenza highest incidence reverse zoonosis followed bacterial infection like tuberculosis methicillinresistant iStaphylococcus aureusi United States India Hong Kong among reported region reverse zoonotic events Major risk factor identified include environmental degradation climate change antimicrobial resistance global wildlife trade review underscore need enhanced surveillance systems interdisciplinary collaboration stringent regulation wildlife trade animal husbandry practice mitigate risk associated reverse zoonosis Understanding dynamic humananimal pathogen transmission crucial developing effective also sustainable strategy protect animal population well public health emerging infectious diseases",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39605779/"
    },
    {
        "pmid": "39550369",
        "title": "Analysis of a fractional order epidemiological model for tuberculosis transmission with vaccination and reinfection.",
        "abstract": "study carried using novel mathematical model dynamic tuberculosis TB transmission considering vaccination endogenous reactivation dormant infection exogenous reinfection comprehend behavior TB influence vaccination article compute basic reproduction number  math xmlnshttpwwww3org1998MathMathMLmsubmiRmi mn0mnmsub math  well vaccination reproduction number  math xmlnshttpwwww3org1998MathMathMLmsubmiRmi mivmimsub math  using nextgeneration matrix NGM approach theoretical analysis demonstrates diseasefree equilibrium point locally asymptotically stable fractional order system UlamHyers type stable perform numerical simulation model using AdamsBashforth 3step method verify theoretical result show model output graphically performing data fitting observe formulated model produce result closely match realworld data finding indicate vaccinating limited segment population effectively eradicate disease numerical simulation also show vaccination reduce number susceptible infectious individual population Moreover graphical representation illustrate number infected individual rise due exogenous reinfection endogenous reactivation",
        "mesh_terms": [
            "Humans",
            "Tuberculosis",
            "Vaccination",
            "Reinfection",
            "Computer Simulation",
            "Epidemiological Models",
            "Basic Reproduction Number",
            "Models, Theoretical"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39550369/"
    },
    {
        "pmid": "39524774",
        "title": "Evaluation of Multiplex loop-mediated isothermal amplification assay for the detection of <i>Mycobacterium tuberculosis</i> complex from clinically suspected cases of pulmonary tuberculosis.",
        "abstract": "Tuberculosis TB second leading cause death single infectious agent worldwide Bangladesh rank 7th among 30 high TB burdened country world Accurate detection iMycobacterium tuberculosisi complex MTBC challenging developing country resource poor setting suitable perform molecular techniques purpose study compare multiplex TBLAMP assay MTBNTM qPCR culture ZN staining fluorescence microscopy order assess effectiveness LAMP assay detecting case pulmonary tuberculosis research work done March 2022 February 2023 Fulfilling inclusion criterion 130 sputum sample collected TBLAMP assay qPCR culture LJ media ZN staining fluorescence microscopy performed 130 sample qPCR detected MTBC 5692  case TBLAMP detected 5385  MTBC detected culture 4615  Fluorescence microscopy 4077  ZN staining 3692  TBLAMP detected 1693  case ZN staining 1308  case fluorescence microscopy sensitivity specificity positive negative predictive value multiplexLAMP assay 95  814  814  95  respectively considering culture goldstandard MTBC negative culture sample 1857  showed positivity LAMP assay well qPCR study detected 769  nontuberculous mycobacteria NTM qPCR NTM positive sample negative TBLAMP TBLAMP easy perform costeffective reliable assay high sensitivity specificity World Health Organization recommended TBLAMP rapid molecular test rapid detection tuberculosis replacement microscopy resource poor settingshard reach areas Bangladesh high TB burden country essential implement TBLAMP achieve End TB Strategy 2035",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39524774/"
    },
    {
        "pmid": "39512283",
        "title": "Molecular and Serological Detection of <i>Mycobacterium tuberculosis</i> in Dairy Cattle From Sylhet, Bangladesh: Implications for Zoonotic Transmission.",
        "abstract": "study aimed determine seroprevalence molecular detection iMycobacterium tuberculosisi iM tuberculosisi dairy cattle using ELISA PCR techniques total 500 sample 250 blood 250 milk collected various farm Sylhet Bangladesh seroprevalence found 56 blood samples PCR confirming 160 280 positivity blood milk samples respectively finding highlight zoonotic potential public health significance iM tuberculosisi cattle suggesting need integrated One Health surveillance",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39512283/"
    },
    {
        "pmid": "39507205",
        "title": "Tuberculosis in South Asia: A regional analysis of burden, progress, and future projections using the global burden of disease (1990-2021).",
        "abstract": "Tuberculosis TB major public health issue South Asia account large share global TB burden Despite global effort curb TB incidence mortality progress South Asia uneven necessitating focused regional analysis guide effective interventions study aim analyse trend TB burden South Asia 1990 2021 project future TB incidence rate 2031 study utilized data Global Burden Disease GBD 2021 result analyse trend agestandardized incidence ASIR prevalence ASPR mortality ASMR disabilityadjusted life year DALYs rate ASDR associated TB South Asia 1990 2021 Joinpoint regression analysis employed identify significant trends whereas ARIMA model used project future TB incidence rate 2031 study revealed significant decline ASIR ASPR ASDR ASMR related TB South Asia past three decades Prominent reduction found Bangladesh Bhutan whereas India Pakistan Nepal continue bear highest TB burdens ARIMA model projection indicate continued decline TB incidence across region although extent decline varies country less favourable trend observed Nepal Pakistan analysis also highlight tobacco use high fasting plasma glucose high body mass index significant risk factor contributing TB burden Substantial progress made reducing TB burden South Asia however sustained intensified effort needed particularly country inconsistent progress finding emphasize need targeted intervention meet End TB Strategy WETS target 2035 Continuous monitoring adaptive strategy crucial maintaining accelerating progress toward TB elimination South Asia",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39507205/"
    },
    {
        "pmid": "39499513",
        "title": "Global Disparities of Cancer and Its Projected Burden in 2050.",
        "abstract": "Cancer prevention care effort challenged COVID19 pandemic armed conflicts resulting decline global Human Development Index HDI particularly low middleincome countries challenge subsequent shift health care priority underscore need continuously monitor cancer outcome disparity statistic globally ensure delivery equitable optimal cancer prevention care uncertain times measure global burden 36 cancer 2022 sex age geographic location project future trend 2050 crosssectional study used populationbased data 2022 185 country territory obtained Global Cancer Observatory database Data extraction analysis carried April 2024 Counts rates prevalence mortality incidence ratio MIRs demographybased projection used characterize current future cancer burden populationbased study included 36 cancer type 185 country territories 2050 353 million cancer case worldwide expected 766 increase 2022 estimate 20 million Similarly 185 million cancer death projected 2050 897 increase 2022 estimate 97 million Cancer case death projected nearly triple lowHDI country 2050 compared moderate increase highHDI country 1421 v 417 cancer case 1461 v 568 cancer deaths Males higher incidence greater number death 2022 females disparity projected widen 160 2050 2022 MIR cancer 466 higher MIRs observed pancreatic cancer 894 among male 517 among aged 75 year older 643 lowHDI country 699 African region 672 crosssectional study based data 2022 cancer disparity evident across HDI geographic regions age sex widening projected 2050 finding suggest strengthening access quality health care including universal health insurance coverage key providing evidencebased cancer prevention diagnostics care",
        "mesh_terms": [
            "Humans",
            "Neoplasms",
            "Male",
            "Cross-Sectional Studies",
            "Female",
            "Global Health",
            "Middle Aged",
            "Aged",
            "Adult",
            "COVID-19",
            "Incidence",
            "Prevalence",
            "Health Status Disparities",
            "Young Adult",
            "Adolescent",
            "Aged, 80 and over",
            "SARS-CoV-2"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39499513/"
    },
    {
        "pmid": "39454232",
        "title": "Global, regional, and national burden of injuries, and burden attributable to injuries risk factors, 1990 to 2019: results from the Global Burden of Disease study 2019.",
        "abstract": "study trend current situation injury burden well attributable burden injury risk factor global regional national level based Global Burden Diseases Injuries Risk Factors Study GBD 2019 presented assess attributable burden injury risk factors data interest data source retrieved Global Health Data Exchange GHDx analyzed Causespecific death injury estimated using Cause Death Ensemble model GBD 2019 burden attributable injury risk factor incorporated population attributable fraction estimate total attributable death disabilityadjusted life years Sociodemographic Index SDI used evaluate countries developmental status Globally 7139 million 95 uncertainty interval UI 6638 7669 injury incidence 43 million UI 39 46 death caused injury 2019 inverse relationship agestandardized disabilityadjusted life year rate SDI quintiles 2019 Overall low bone mineral density leading risk factor injury death 2019 contribution 105 UI 90 116 total injury agestandardized deaths followed occupational risk 70 UI 6379 alcohol use 68 UI 52 85 Various risk responsible imposed burden injuries study highlighted small persistent share injury global burden disease injury provide beneficial data produce proper policy reach effective global injury prevention plan",
        "mesh_terms": [
            "Humans",
            "Global Burden of Disease",
            "Wounds and Injuries",
            "Risk Factors",
            "Male",
            "Female",
            "Global Health",
            "Adult",
            "Middle Aged",
            "Disability-Adjusted Life Years",
            "Adolescent",
            "Young Adult",
            "Aged",
            "Child, Preschool",
            "Infant",
            "Child",
            "Cause of Death",
            "Incidence",
            "Cost of Illness"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39454232/"
    },
    {
        "pmid": "39432502",
        "title": "Genetic insights into the connection between pulmonary TB and non-communicable diseases: An integrated analysis of shared genes and potential treatment targets.",
        "abstract": "Pulmonary Tuberculosis PTB significant global health issue due high incidence drug resistance contagious nature impact people compromised immune systems mentioned World Health Organization WHO TB responsible global fatality infectious illness side also claim noncommunicable disease NCDs kill 41 million people yearly worldwide regard several study suggest PTB NCDs linked various way people PTB likely acquire NCDs time NCDs increase susceptibility active TB infection Furthermore potential drug interaction therapeutic challenges treating individual PTB NCDs difficult study focus seven NCDs lung cancer LC diabetes mellitus DM Parkinsons disease PD silicosis SI chronic kidney disease CKD cardiovascular disease CVD rheumatoid arthritis RA rigorously present genetic relationship PTB regarding shared gene outline possible treatment plans BlueThis study aim identify drug component regulate abnormal gene expression NCDs study reveal hub genes potential biomarkers drug component associated hub gene statistical measures contribute targeted therapeutic interventions Numerous investigations including proteinprotein interaction PPI gene regulatory network GRN enrichment analysis physical interaction proteinchemical interaction carried demonstrate genetic correlation PTB NCDs study nine shared gene TNF IL10 NLRP3 IL18 IFNG HMGB1 CXCL8 IL17A NFKB1 discovered TB abovementioned NCDs five hub gene NFKB1 TNF CXCL8 NLRP3 IL10 selected based degree values study found hub gene linked 10 drug components observed aspirin CTD 00005447 mostly associated hub genes bioinformatics study may help researcher better understand cause PTB relationship NCDs eventually lead exploring effective treatment plans",
        "mesh_terms": [
            "Humans",
            "Tuberculosis, Pulmonary",
            "Noncommunicable Diseases",
            "Gene Regulatory Networks",
            "Lung Neoplasms",
            "Silicosis",
            "Protein Interaction Maps",
            "Renal Insufficiency, Chronic"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39432502/"
    },
    {
        "pmid": "39419055",
        "title": "Global health 2050: the path to halving premature death by mid-century.",
        "abstract": "Global health 2050 GH2050 new report Lancet Commission Investing Health find dramatic improvement human welfare achievable midcentury focused health investments 2050 country choose halve probability premature death PPD—the probability dying age 70—from prepandemic level 2019 call goal “50 50” 50 reduction PPD 2050 intervention achieving “50 50” also reduce morbidity disability ages Historical experience continued scientific advance indicate feasible aspiration Eight 30 populous country reduced PPD last decade rate would halve PPD 2050 including country diverse Bangladesh Iran Tanzania Turkey focused gain achieved relatively early pathway full universal health coverage UHC path achieving “50 50” run control remarkably narrow set 15 conditions currently high mortality countries eight infectious disease maternal condition highest priority Seven cluster noncommunicable disease injury important everywhere addressing prove central achieving “50 50” country lower initial level mortality Focused attention health system strengthening HSS primary care first level hospital generate capacity better tackle 15 priority condition critical step way improving capacity address condition UHC package Packaging intervention 19 module eg childhood immunization module module cardiovascular disease prevention lowcost widely available treatment address 15 priority conditions Adopting focused approach also invests key area HSS address major morbidities psychiatric illness already covered mortalityreducing interventions Value money assessed twostep process technical cost effectiveness assess best achieve modulespecific goal eg reduction child mortality reduction cardiovascular mortality political evaluation tradeoff investing expanding module coverage many country seeking reform standard budgetary mechanism failed successfully reorient system toward priority intervention improve health mechanism blanket budget transfer ministry finance ministry health fit support reorientation Commission concluded problem could addressed directing substantial increasing fraction budget transfer making available affordable specific drugs vaccines diagnostics commodity currently available control 15 priority conditions Drug availability affordability typically require four complementary components i redirecting general budget transfer line item transfer subsidies specific priority drugs ii centralized procurement government or perhaps internationally iii procurement sufficient volume ensure availability needed iv use strengthening existing supply chains public private many intersectoral policy government adopt help achieve “50 50” tobacco control far important given number death caused tobacco established improving capacity government implement tobacco policy high level tobacco taxation essential valuable short medium term public finance accompanied package effective tobacco control policies Background research conducted Commission point exceptionally high ongoing level mortality risk pandemics Country performance COVID19 varied greatly although eventual vaccine availability attenuated far eliminated variability end COVID19’s emergency phase National implementation public health fundamentals—early action isolation infected individuals quarantining exposed social financial support people isolating quarantining—accounted much success bestperforming nations Japan next pandemic fundamental help avert mortality waiting vaccine development deployment conclusion primarily aimed national governments final conclusion aimed development assistance community conclude assistance focus two broad purposes first provide direct financial technical support country least resources—to help develop health system better control diseases second finance global public goods including strengthening data systems reducing development spread antimicrobial resistance preventing responding pandemics fostering global health leadership advocacy identifying spreading best practices developing deploying new health technologies purposes focusing effort 15 priority condition would best contribute “50 50” decade ago malaria vaccine available tuberculosis vaccine low efficacy Today two partially successful malaria vaccine approved three promising tuberculosis vaccine candidate late stage trials success exemplify enormous value funding development new medicines vaccines diagnostics operational research 15 priority conditions prize “50 50” interim milestone “30 2035” a 30 reduction PPD 2035 remains prize within reach efficient route focus resource narrow set condition scale financing develop deploy new health technologies economic analysis shown value achievable mortality decline remains high indeed often substantial fraction value gain gross domestic product Today case better ever value investing health reducing mortality morbidity alleviating poverty growing economies improving human welfare",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39419055/"
    },
    {
        "pmid": "39417391",
        "title": "A systematic review and meta-analysis of bovine tuberculosis occurrence and burden in Bangladesh, 1970-2023.",
        "abstract": "aimed estimate overall apparent prevalence true prevalence spatial temporal testspecific burden bovine tuberculosis Bangladesh PubMed Web Science Scopus Google Scholar BanglaJOL searched bovine tuberculosis publication Bangladesh 1 January 1970 23 June 2023 142 article screened systematic review metaanalysis performed 22 155 articles apparent estimated bovine tuberculosis prevalence 7 apparent Bayesian pooled mean bovine tuberculosis prevalence based caudal fold test single intradermal comparative tuberculin test 783 989 respectively true pooled mean prevalence 1039 1048 respectively Targeted intervention recommended district higher prevalence effectively reduce bovine tuberculosis burden areas Current diagnostic practice employed Bangladesh may accurately reflect bovine tuberculosis burden finding highlight need better diagnostic tool supplemental testing method ensure accurate diagnosis surveillance Efforts prioritize obtaining true prevalence estimate corrected misclassification bias rather relying solely apparent prevalence Underestimating bovine tuberculosis burden could result inadequate resource allocation hinder implementation effective control measures",
        "mesh_terms": [
            "Animals",
            "Cattle",
            "Bangladesh",
            "Prevalence",
            "Tuberculin Test",
            "Tuberculosis, Bovine"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39417391/"
    },
    {
        "pmid": "39398435",
        "title": "Stool Xpert<sup>®</sup> MTB/RIF Ultra for TB diagnosis in children: experience from a national scale-up programme.",
        "abstract": "describe programmatic scaleup stool testing using Xpertsup®sup MTBRIF Ultra Ultra recommended improve childhood pulmonary TB PTB diagnosis USAIDs Alliance Combating TB Bangladesh Activity collaboration National TB Control Programme implementing stoolbased diagnostic approach 51 healthcare facility Bangladesh improve PTB detection Specimens child 15 years presumptive TB tested using stool Ultra routine TB diagnostics Physicians confirmed TB diagnosis provided treatment per national guidelines March 2022 December 2023 16429 specimen tested 871 53 positive 642 737 showed trace detected results Positivity significantly higher among females child presented only cough ≥2 weeks cough ≥2 week  weight loss fever ≥2 weeks weight loss fatigue  contact history Positivity higher among 1014 year old children however trace detected highest among 59 years followed child aged 25 years 02 years Testing stool using Ultra provides effective way diagnosing bacteriologically positive PTB children However positivity varies presenting symptomscriteria highlighting need careful diagnostic evaluation ensure optimum use limited diagnostic resources",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39398435/"
    },
    {
        "pmid": "39374650",
        "title": "Isoniazid resistance pattern among pulmonary tuberculosis patients in Bangladesh: An exploratory study.",
        "abstract": "high tuberculosis TB burden country Bangladesh research policy tend focus rifampicin RIFresistant TB patients leaving RIFsensitive isoniazid INHresistant HrTB patient undiagnosed study aim determine prevalence INH resistance among pulmonary TB patient selected health care facility Bangladesh study conducted across nine TB Screening Treatment Centres situated Bangladesh Sputum sample 1084 Xpertpositive pulmonary TB patient collected April 2021 December 2022 cultured drug susceptibility testing Demographic clinical characteristic HrTB drugsusceptible TB patient compared Among available drug susceptibility testing result 998 culturepositive isolates resistance rate INH regardless RIF susceptibility 64 64998 95 CI 4982 rate significantly higher previously treated 211 1676 95 CI 120342 compared newly diagnosed TB patient 52 48922 95 CI 3869 p  0001 rate HrTB 45 45998 95 CI 3360 also higher among previously treated patient 66 576 95 CI 14135 compared newly diagnosed TB patient 43 40922 95 CI 3159 p 0350 importantly rate HrTB double compared MDRTB 45 45998 vs 19 19998 found current study study reveals high prevalence HrTB surpassing even multidrugresistant TB Bangladesh emphasizes urgent need adopt WHOrecommended molecular tool national level rapid detection INH resistance patient receive timely appropriate treatment",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Male",
            "Female",
            "Tuberculosis, Pulmonary",
            "Isoniazid",
            "Antitubercular Agents",
            "Adult",
            "Mycobacterium tuberculosis",
            "Middle Aged",
            "Microbial Sensitivity Tests",
            "Tuberculosis, Multidrug-Resistant",
            "Young Adult",
            "Prevalence",
            "Sputum",
            "Rifampin",
            "Adolescent",
            "Drug Resistance, Bacterial",
            "Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39374650/"
    },
    {
        "pmid": "39366729",
        "title": "Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021.",
        "abstract": "Smoking leading behavioural risk factor mortality globally accounting 175 million death nearly 4·30 billion year life lost YLLs 1990 2021 pace decline smoking prevalence slowed recent year many countries although strategy recently proposed achieve tobaccofree generations none implemented date Assessing could happen current trend smoking prevalence persist could happen additional smoking prevalence reduction occur important communicating effect potential smoking policies analysis use Institute Health Metrics Evaluations Future Health Scenarios platform forecast effect three smoking prevalence scenario allcause causespecific YLLs life expectancy birth 2050 YLLs computed scenario using Global Burden Disease Study 2021 reference life table forecast causespecific mortality scenario reference scenario forecast could occur past smoking prevalence risk factor trend continue Tobacco Smoking Elimination 2023 Elimination2023 scenario quantifies maximum potential future health benefit assuming zero percent smoking prevalence 2023 onwards whereas Tobacco Smoking Elimination 2050 Elimination2050 scenario provides estimate country considering policy steadily reduce smoking prevalence 5 Together scenario underscore magnitude health benefit could reached 2050 country take decisive action eliminate smoking 95 uncertainty interval UI estimate based 2·5th 97·5th percentile draw carried multistage computational framework Global agestandardised smoking prevalence estimated 28·5 95 UI 27·929·1 among male 5·96 5·766·21 among female 2022 reference scenario smoking prevalence declined 25·9 25·226·6 among males 30·0 26·132·1 among female 2022 2050 scenario forecast cumulative 29·3 billion 95 UI 26·832·4 overall YLLs among male 22·2 billion 20·124·6 YLLs among female period Life expectancy birth scenario would increase 73·6 year 95 UI 72·874·4 2022 78·3 year 75·980·3 2050 Elimination2023 scenario forecast 2·04 billion 95 UI 1·902·21 fewer cumulative YLLs 2050 compared reference scenario life expectancy birth would increase 77·6 year 95 UI 75·179·6 among male 81·0 year 78·583·1 among females Elimination2050 scenario forecast 735 million 675808 141 million 131154 cumulative YLLs would avoided among male females respectively Life expectancy 2050 would increase 77·1 year 95 UI 74·679·0 among male 80·8 year 78·382·9 among females Existing tobacco policy must maintained smoking prevalence continue decline forecast reference scenario addition substantial smokingattributable burden avoided accelerating pace smoking elimination Implementation new tobacco control policy crucial avoiding additional smokingattributable burden coming decade ensure gain past three decade lost Bloomberg Philanthropies Bill  Melinda Gates Foundation",
        "mesh_terms": [
            "Humans",
            "Life Expectancy",
            "Forecasting",
            "Smoking",
            "Prevalence",
            "Female",
            "Male",
            "Global Burden of Disease",
            "Adult",
            "Middle Aged",
            "Global Health",
            "Aged",
            "Young Adult",
            "Adolescent"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39366729/"
    },
    {
        "pmid": "39367477",
        "title": "Effective community-based interventions to prevent and control infectious diseases in urban informal settlements in low- and middle-income countries: a systematic review.",
        "abstract": "impact rapid urbanization taking place across world posing variegated challenges Especially term communicable disease risk concentrated urban poor area basic amenity inadequate systematic review synthesizes evidence effective communitybased intervention CBIs aimed preventing controlling infectious disease among urban poor low middleincome country LMICs systematic review conducted following PRISMA Preferred Reporting Items Systematic Reviews MetaAnalysis guidelines comprehensive search across five major database conducted capture literature CBIs published 2011 2021 Scientific article design reported type CBIs effective preventing controlling infectious disease tuberculosis diarrhea typhoid dengue hepatitis B C influenza COVID19 included Screening selection study done two pair independent researcher using predefined eligibility criteria risk bias included study assessed using modified checklist outlined Cochrane Handbook Systematic Reviews Interventions Effective Public Health Practice Project EPHPP Analysis effective CBIs guided conceptual framework integrated CBIs neglected tropical disease NTDs narrative synthesis carried out Geographical restriction limited LMICs paper published English 18260 identified papers 20 study met eligibility criterion included review Communitybased screening socioeconomic support communitybased vector control behavior change communication capacity building community health worker CHWs health education e mhealth intervention found effective CBIs Diversified CBIs found effective specific diseases including tuberculosis TB diarrhea dengue influenza ARI hepatitis B C Bundling intervention found effective specific diseases However difficult isolate effectiveness individual intervention within bundle sociocultural context considered designing implementing CBIs effectiveness intervention inextricably linked social context stakeholder dimensions broader societal issues System approach recommended emphasizing contextspecific multicomponent intervention address social determinant health Integrating intervention public health strategy community involvement crucial sustainable outcomes finding guide design future intervention better prevention control communicable disease urban poor areas PROSPERO CRD42021278689",
        "mesh_terms": [
            "Humans",
            "Developing Countries",
            "Communicable Disease Control",
            "COVID-19",
            "Community Health Services",
            "Communicable Diseases",
            "Urban Population",
            "SARS-CoV-2"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39367477/"
    },
    {
        "pmid": "39360039",
        "title": "Diagnostic Accuracy of Cancer Antigen 15-3 as a Seromarker Among Recurrent Breast Carcinoma in Bangladesh.",
        "abstract": "diagnosis recurrent breast carcinoma crucial patient treatment present study aimed assess diagnostic accuracy cancer antigen 153 CA 153 seromarker among recurrent breast carcinoma patients prospective observational study evaluated serum CA 153 among woman age ≥18 years recurrent breast carcinoma CA 153 measured enzymelinked immunosorbent assay ELISA concentration stratified using cutoff value 30 UmL receiver operating characteristic ROC curve observed sensitivity specificity CA 153 cutoff value area AUROC curve demonstrate goodnessoffit prediction model total 50 patient recruited mean age 484 ±97years majority n28 560 patient 41 50 year old Further total 42 84 patient high serum level CA 153 mean value 727±95 UmL cutoff level 30 UmL ROC curve demonstrated sensitivity specificity positive predictive value negative predictive value 957 694 841 728 respectively diagnose recurrent breast carcinoma Nonetheless area ROC AUROC curve 0712 indicating satisfactory fit prediction model found CA 153 level ≥30 UmL highly sensitive specific seromarker detecting recurrent breast cancer among Bangladeshi population recommend routinely monitoring breast cancer survivor using CA 153 biomarkers",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39360039/"
    },
    {
        "pmid": "39351745",
        "title": "Clinical and Radiological Presentation of Patients with Smear Positive Pulmonary Tuberculosis.",
        "abstract": "Chest Xray important diagnostic aid frequently used alongside microscopic smear sputum confirmation pulmonary tuberculosis TB However dearth literature investigating clinical radiological pattern sputum positive pulmonary TB among adult Bangladesh current study explored pattern presentation descriptive crosssectional study conducted outpatient department medicine tertiary care hospital total 50 newly diagnosed adult case smear positive pulmonary TB attending Directly Observed Treatment Shortcourse DOTS corner consecutively included Informed written consent taken inclusion Data collected facetoface interview Radiological presentation explored using chest Xray Data analyzed SPSS version 260 average age patient 410±1712 year majority male 780 prevalent respiratory symptom cough 800 followed constitutional symptom like fever 700 weight loss 720 Wasting predominant sign 600 Radiologically lung involved 320 left lung involved 300 case right lung involved 260 cases Twelve percent 120 patient normal chest Xray Upper zone involvement commonly observed studys patient 660 predominant pattern consolidation 460 followed fibrosis 260 nodular opacity 120 collapse 100 cavity 60 pleural effusion 20 bronchiectasis 20 Findings study would help familiarize identify common clinical radiological presentation sputum positive pulmonary TB patient daytoday practice",
        "mesh_terms": [
            "Humans",
            "Tuberculosis, Pulmonary",
            "Male",
            "Female",
            "Adult",
            "Cross-Sectional Studies",
            "Middle Aged",
            "Sputum",
            "Bangladesh",
            "Radiography, Thoracic"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39351745/"
    },
    {
        "pmid": "39351718",
        "title": "Clinicopathological Evaluation of the Patients with Febrile Illness and Altered Consciousness Admitted in a Tertiary Level Hospital.",
        "abstract": "important note altered mental status disease itself rather symptom wide range potential diagnoses structured approach assessing patient symptom frequently lead helpful information rule worstcase scenarios case fever followed change consciousness quick assessment patients level consciousness potential cause decisive focused history physical assessment help differentiate structural medical causes Asymmetrical neurological findings dilated fixed pupil dysconjugated extraocular movement asymmetrical motor findings suggest brainstem dysfunction due structural lesion symmetrical neurological finding usually indicate medical disorder recent study aimed identify feature different etiologies demographic patterns common cause acute prolonged febrile illness patients crosssectional type observational study conducted Department Medicine Mymensingh Medical College Hospital Bangladesh April 2014 October 2015 study period patient admitted satisfying inclusion exclusion criterion study purposively selected nonprobability hospitalized patients Total 100 case febrile illness altered consciousness meeting exclusion inclusion criterion examined investigated find actual etiology 100 patients observed 26260 patient suffering pneumonia 22220 urinary tract infection 18180 meningitis 14140 typhoid fever 880 meningoencephalitis 660 cerebral malaria 440 tuberculosis 220 tuberculoma result revealed large number patient febrile illness altered consciousness suffering pneumonia urinary tract infection",
        "mesh_terms": [
            "Humans",
            "Male",
            "Female",
            "Fever",
            "Consciousness Disorders",
            "Adult",
            "Middle Aged",
            "Cross-Sectional Studies",
            "Tertiary Care Centers",
            "Adolescent",
            "Young Adult",
            "Aged",
            "Child",
            "Bangladesh"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39351718/"
    },
    {
        "pmid": "39343935",
        "title": "Further analysis of tuberculosis in eight high-burden countries based on the Global Burden of Disease Study 2021 data.",
        "abstract": "significant finding Global Tuberculosis TB Report 2023 indicate India Indonesia China Philippines Pakistan Nigeria Bangladesh Democratic Republic Congo DRC collectively contribute approximately twothirds global TB cases study aim provide crucial datadriven insight reference improve TB control measure comprehensive analysis eight highburden countries eight highburden TB country analyzed study include India Indonesia China Philippines Pakistan Nigeria Bangladesh DRC Agestandardized incidence rate ASIR TB derived Global Burden Diseases Study 2021 data Temporal trend analyzed using Joinpoint regression ageperiodcohort model applied examine risk ratio RR TB across diverse age groups periods birth cohorts Bayesian ageperiodcohort framework employed predict ASIR TB 2030 study found Philippines average annual percentage change  31 P  0001 exhibited upward trend 1990 2021 India Philippines Pakistan Bangladesh RR TB incidence exceeded 1 individual reached 25 year old Notably RR shown consistent upward trend since 2001 peaking period 20172021 estimated RR 15 P  0001 Philippines Similarly highest RR observed period 20172021 reaching 11 P  0001 DRC Philippines markedly increasing RR value TB observed among individual born 19972001 Projections suggest ASIR TB expected follow continued upward trajectory estimated rate 3929 per 100000 2030 Philippines India Indonesia projected achieve less 200 target set World Health Organization WHO Among eight highburden countries Philippines India Indonesia diverging goal set WHO risk TB Philippines DRC show trend toward affecting younger populations suggests management strategy TB patient need strengthened",
        "mesh_terms": [
            "Humans",
            "Tuberculosis",
            "Adult",
            "Incidence",
            "Middle Aged",
            "Adolescent",
            "Young Adult",
            "Child, Preschool",
            "Child",
            "Male",
            "Aged",
            "Global Burden of Disease",
            "Female",
            "Infant",
            "Indonesia",
            "Philippines",
            "India",
            "Infant, Newborn",
            "Bayes Theorem",
            "Bangladesh",
            "Pakistan",
            "China",
            "Democratic Republic of the Congo",
            "Aged, 80 and over"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39343935/"
    },
    {
        "pmid": "39304265",
        "title": "Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.",
        "abstract": "Uptodate estimate stroke burden attributable risk trend global regional national level essential evidencebased health care prevention resource allocation planning aimed provide estimate period 19902021 estimated incidence prevalence death disabilityadjusted lifeyear DALY count agestandardised rate per 100 000 people per year overall stroke ischaemic stroke intracerebral haemorrhage subarachnoid haemorrhage 204 country territory 1990 2021 also calculated burden stroke attributable 23 risk factor six risk cluster air pollution tobacco smoking behavioural dietary environmental metabolic risks global regional level 21 GBD region Sociodemographic Index SDI quintiles using standard GBD methodology 95 uncertainty interval UIs individual future estimate derived 2·5th 97·5th percentile distribution generated propagating 500 draw multistage computational pipeline 2021 stroke third common GBD level 3 cause death 7·3 million 95 UI 6·67·8 deaths 10·7 9·811·3 deaths ischaemic heart disease COVID19 fourth common cause DALYs 160·5 million 147·8171·6 DALYs 5·6 5·06·1 DALYs 2021 93·8 million 89·099·3 prevalent 11·9 million 10·713·2 incident strokes found disparity stroke burden risk factor GBD region country territory SDI well stagnation reduction incidence 2015 onwards even increase stroke incidence death prevalence DALY rate southeast Asia east Asia Oceania country lower SDI people younger 70 years Globally ischaemic stroke constituted 65·3 62·467·7 intracerebral haemorrhage constituted 28·8 28·328·8 subarachnoid haemorrhage constituted 5·8 5·76·0 incident strokes substantial increase DALYs attributable high BMI 88·2 53·4117·7 high ambient temperature 72·4 51·1 179·5 high fasting plasma glucose 32·1 26·738·1 diet high sugarsweetened beverage 23·4 12·735·7 low physical activity 11·3 1·834·9 high systolic blood pressure 6·7 2·511·6 lead exposure 6·5 4·511·2 diet low omega6 polyunsaturated fatty acid 5·3 0·510·5 Stroke burden increased 1990 2021 contribution several risk factor also increased Effective accessible affordable measure improve stroke surveillance prevention with emphasis blood pressure lifestyle environmental factors acute care rehabilitation need urgently implemented across country reduce stroke burden Bill  Melinda Gates Foundation",
        "mesh_terms": [
            "Humans",
            "Global Burden of Disease",
            "Risk Factors",
            "Stroke",
            "Global Health",
            "Disability-Adjusted Life Years",
            "Incidence",
            "Prevalence",
            "Quality-Adjusted Life Years",
            "Male",
            "Female"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39304265/"
    },
    {
        "pmid": "39284696",
        "title": "Combination of exhaled breath condensate samples with lipoarabinomannan point of care assay for pulmonary tuberculosis (TB) diagnosis: protocol for a diagnostic accuracy study.",
        "abstract": "estimate gap 30 incident 106 million notified 75 million case tuberculosis TB Combined growing recognition prevalence survey high proportion case identified asymptomatic paucisymptomatic data underscore current symptom screening approach use diagnostic test suboptimal performance sputum miss large number cases Thus development sputumfree biomarkerbased test diagnosis becoming necessary already identified priority new TB diagnosticsThe objective study evaluate combination exhaled breath condensate EBC sample mycobacterial lipoarabinomannan LAM pointofcare POC assay identify TB patients prospective diagnostic accuracy study conducted TB Screening Treatment Centre International Center Diarrhoeal Disease Research Bangladesh cohort adult adolescent 11 year age total 614 individual presumptive pulmonary TB based TB signs symptom radiography recruited 28 August 2023 Spot sputum collected standard reference testing LJ culture GeneXpert MTBRif acidfast Bacilli microscopy finetune categorisation TB disease status participant defined 1 definite TB at least one positive standard reference test 2 probable TB not microbiologically confirmed TB treatment 3 possible TB no TB treatment signs symptom radiography suggestive TB 4 respiratory disease microbiologically confirmed radiography presenting abnormality compatible TB 5 unknown no microbiological evidence normalno TB abnormality radiography Urine EBC specimen subjected LAM POC testing biobanked investigation Statistical analysis include assessment diagnostic accuracy constructing receiver operating curve calculating sensitivity specificity well posttest probabilities study protocol approved Research Review Committee well Ethical Review Committee icddrb recorded protocol reference number PR2301 Results submitted openaccess peerreviewed journals presented academic meetings shared national international policymaking bodies",
        "mesh_terms": [
            "Humans",
            "Lipopolysaccharides",
            "Tuberculosis, Pulmonary",
            "Breath Tests",
            "Prospective Studies",
            "Biomarkers",
            "Bangladesh",
            "Adult",
            "Point-of-Care Testing",
            "Sensitivity and Specificity",
            "Point-of-Care Systems",
            "Male",
            "Female",
            "Adolescent",
            "Mycobacterium tuberculosis",
            "Sputum"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39284696/"
    },
    {
        "pmid": "39280729",
        "title": "Comparative Evaluation of Diagnostic Performance: Standard E TB Feron ELISA vs QuantiFERON-TB Gold Plus for Latent Tuberculosis Infection Detection in Diverse Risk Groups in Bangladesh.",
        "abstract": "Around onequarter global population latent tuberculosis infection LTBI left untreated LTBI 510 lifetime risk developing TB Interferongamma release Assays IGRAs sensitive tuberculin skin test LTBI detection However high cost complexity IGRAs barrier adoption resourceconstrained settings study evaluated diagnostic performance affordable IGRA Standard E TBFeron TBE among different risk group Bangladesh 532 participant age group enrolled TB Screening Treatment Centers Dhaka Hospital icddrb June September 2023 participant categorized four risk groups healthy people healthcare workers attendant TB patients patient microbiologically confirmed TB people history TB diagnostic performance TBE compared QuantiFERONTB Gold Plus QFTPlus groups GeneXpert culture microscopy used confirm TB microbiologically TBE overall agreement 859 95 CI 825 887 positive percent agreement 861 95 CI 806 905 negative percent agreement 857 95 CI 813 894 QFTPlus Among 81 culturepositive patients TBE QFTPlus positive 60 741 62 765 respectively Among healthy people TBE QFT result positive 49 245 59 295 respectively Among health worker contacts TBE QFTPlus positive 79 395 73 355 respectively found substantial agreement Cohens kappa 071 TBE QFTPlus detecting LTBI across different groups suggesting potential costeffective diagnostic tool Implementation TBE routine clinical practice could increase accessibility LTBI diagnosis facilitating timely initiation preventative therapy leading reduction active TB incidence",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39280729/"
    },
    {
        "pmid": "39267928",
        "title": "Multi-drug resistant gene mutation analysis in <i>Mycobacterium tuberculosis</i> by molecular techniques.",
        "abstract": "Rifampicin RIF isoniazid INH two potent antibiotics prescribed cure tuberculosis iMycobacterium tuberculosisi causative agent multidrugresistant tuberculosis MDRTB resistant firstline drugs Here two molecular technique demonstrated PCR sequencingbased GeneXpert assay rapidly identifying MDRTB Pulmonary sample sputum collected 55 MDRTB suspected patient National Tuberculosis Reference Laboratory NTRL Dhaka research work partially accomplished continued department Microbiology University Dhaka Bangladesh strived sequencing technique well GeneXpert assay identify mutation irpoiB ikatiG gene MTB strain sputum directly Culturebased drug susceptibility testing DST performed measure efficacy molecular method employed analyzed irpoiB gene mutation codon 531 5454 526 1454 516 1091 found sequencing 80 samples Nucleotide substitution ikatiG315 AGC→ACC spotted 16 7619 21 samples comparing sequencing result DST sensitivity specificity investigated determine drugresistance rifampicinresistance 98 100 whereas isoniazidresistance 94 100 respectively Additionally point comparison DST 8545 RIF monoresistant TB case accurately evaluated GeneXpert assay research support adoption PCR sequencing approach efficient tool detecting MDRTB counting higher sensitivity specificity well short period produce results",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39267928/"
    },
    {
        "pmid": "39186706",
        "title": "An approach to integrated management of diabetes in tuberculosis patients: Availability and readiness of the health facilities of Bangladesh.",
        "abstract": "Comorbidity diabetes mellitus tuberculosis TB major public health concern low middleincome country including Bangladesh integrated approach required adequate management diabetes mellitus TB objective present study investigate availability readiness TB care center Bangladesh toward diabetic patients management present study conducted based existing data obtained Bangladesh Health Facility Survey BHFS 2017 Data collected total 303 facility providing TB service retrieved outcome variable present study availability readiness TB health facility providing diabetes mellitus service Readiness measured four domains staff guidelines equipment diagnostic facility basic medicine independent variable were facility level management authority location facility Binary multiple logistic regression model constructed outcome variable availability readiness find predictors Services diabetes mellitus available 68 TB facility high readiness present 36 facilities domainspecific readiness index readiness domain staff guidelines equipment diagnostic facility basic medicine reported 46 96 38 25 facility respectively logistic regression model availability diabetes mellitus service better primary level aOR 262 95 CI 178477 secondary level aOR 326 95 CI 182905 facility community facilities Similarly readiness diabetes mellitus care also better facility aOR 255 95 CI 105471 primary aOR 275 95 CI 180432 secondary facilities Besides private TB facility better availability aOR 284 95 CI 175589 readiness aOR 252 95 CI 132429 diabetes mellitus care Availability readiness providing diabetes mellitus service TB care providing facility Bangladesh inadequate",
        "mesh_terms": [
            "Humans",
            "Bangladesh",
            "Diabetes Mellitus",
            "Tuberculosis",
            "Health Facilities",
            "Health Services Accessibility",
            "Delivery of Health Care, Integrated"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39186706/"
    },
    {
        "pmid": "39165781",
        "title": "Systematic review of bovine and zoonotic tuberculosis in the Western Pacific and the Southeast Asia regions of the World Health Organization.",
        "abstract": "Tuberculosis TB remains leading cause mortality worldwide conducted systematic review understand distribution bovine zoonotic tuberculosis World Health Organization WHOs Southeast Asia Region SEAR Western Pacific Region WPR inform understanding risk posed disease twopronged strategy used evaluating data peerreviewed literature official reports systematic search conducted using structured query four database Web Science Scopus Medline PubMed identify report occurrence zoonotic TB language time constraint used search nonEnglish language article later excluded official data sourced World Organization Animal Healths WOAH World Animal Health Information System WAHIS WHOs global TB database retrieved record SEAR WPR ini  113 screened eligibility data disease occurrence extracted tabulated SEAR five study conducted iMycobacteriumi speciation 56 human India reported iMycobacteriumi specie included iM tuberculosisi iM bovisi iM scrofulaciumi iM kansasiii iM phleii iM smegmatisi iM orygisi WPR iMycobacteriumi speciation investigation human conducted Australia 8 China 2 Japan 2 NewZealand 2 Malaysia 1 reported iMycobacteriumi specie included iM bovisi iM africanumi iM tuberculosisi Seven country WHOs SEAR officially reported occurrence iMycobacterium bovisi animals Bangladesh India Indonesia Myanmar Nepal Sri Lanka Thailand WPR WAHIS information system includes report identification iM bovisi 11 country  China Fiji Japan Malaysia Mongolia New Zealand Philippines Republic Korea Singapore Tonga Viet Nam contrast human zoonotic TB case database listed Australia Brunei Darussalam Palau countries available data suggests underreporting zoonotic TB regions Efforts required strengthen zoonotic TB surveillance system animal human health side better understand impact zoonotic TB order take appropriate action achieve goal ending TB epidemic",
        "mesh_terms": [
            "Animals",
            "Cattle",
            "Asia, Southeastern",
            "Humans",
            "Zoonoses",
            "Tuberculosis",
            "Tuberculosis, Bovine",
            "World Health Organization"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39165781/"
    },
    {
        "pmid": "39146948",
        "title": "WHO global research priorities for antimicrobial resistance in human health.",
        "abstract": "research agenda antimicrobial resistance AMR human health identified 40 research priority addressed year 2030 priority focus bacterial fungal pathogen crucial importance addressing AMR including drugresistant pathogen causing tuberculosis research priority encompass entire peoplecentred journey covering prevention diagnosis treatment antimicrobialresistant infections addition addressing overarching knowledge gap AMR epidemiology burden drivers policy regulations awareness education research priority identified multistage process starting comprehensive scoping review knowledge gaps expert input gathered survey open call priority setting involved rigorous modified Child Health Nutrition Research Initiative approach ensuring global representation applicability findings ultimate goal research agenda encourage research investment generation evidence better understand AMR dynamic facilitate policy translation reducing burden consequence AMR",
        "mesh_terms": [
            "Humans",
            "World Health Organization",
            "Global Health",
            "Research",
            "Drug Resistance, Bacterial",
            "Anti-Bacterial Agents",
            "Drug Resistance, Microbial",
            "Bacterial Infections"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39146948/"
    },
    {
        "pmid": "39136526",
        "title": "Targeted next-generation sequencing of <i>Mycobacterium tuberculosis</i> from patient samples: lessons learned from high drug-resistant burden clinical settings in Bangladesh.",
        "abstract": "Lack appropriate early diagnostic tool drugresistant tuberculosis DRTB incomplete drug susceptibility testing DST profiling concerning TB disease control Existing methods phenotypic DST pDST timeconsuming Xpert MTBRIF Xpert line probe assay LPA limited detecting resistance drugs Targeted nextgeneration sequencing tNGS recently approved alternative approach rapid comprehensive DST aimed investigate performance feasibility tNGS detecting DRTB directly clinical sample Bangladesh pDST LPA tNGS performed among 264 sputum samples either rifampicinresistant RR rifampicinsensitive RS TB case confirmed Xpert assay Resistotypes tNGS compared pDST LPA composite reference standard CRS resistant either pDST LPA showed resistant result tNGS result revealed higher sensitivity rifampicin RIF 993 isoniazid INH 963 fluoroquinolones FQs 944 aminoglycosides AMGs 100 comparatively lower ethambutol 766 streptomycin 687 ethionamide 560 pyrazinamide 507 compared pDST sensitivity tNGS INH RIF FQs AMGs 930 966 909 100 respectively specificity ranged 913 100 compared CRS proof concept study conducted highburden setting demonstrated tNGS valuable tool identifying DRTB directly clinical specimens feasibility laboratory suggests potential implementation moving tNGS research setting clinical settings",
        "mesh_terms": [
            "Humans",
            "Mycobacterium tuberculosis",
            "Bangladesh",
            "High-Throughput Nucleotide Sequencing",
            "Tuberculosis, Multidrug-Resistant",
            "Antitubercular Agents",
            "Microbial Sensitivity Tests",
            "Sputum",
            "Rifampin",
            "Male",
            "Female",
            "Adult",
            "Sensitivity and Specificity",
            "Middle Aged",
            "Drug Resistance, Multiple, Bacterial"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39136526/"
    },
    {
        "pmid": "39132840",
        "title": "Gene content, phage cycle regulation model and prophage inactivation disclosed by prophage genomics in the <i>Helicobacter pylori</i> Genome Project.",
        "abstract": "Prophages major clinical implication ability change pathogenic bacterial traits limited understanding prophage role ecological evolutionary adaptive process pathogenicity iHelicobacter pylorii widespread bacterium causally associated gastric cancer Inferring exact prophage genomic location completeness requires complete genomes international iHelicobacter pylorii Genome Project iHpiGP dataset comprises 1011 iH pylorii complete clinical genome enriched epigenetic data thoroughly evaluated iH pylorii prophage genomic content iHpiGP dataset investigated population evolutionary dynamic phylogenetic pangenome analyses Additionally identified genome rearrangement assessed impact prophage presence bacterial gene disruption methylome found 295 298 iHpiGP genome contain prophages 322 96 complete minimizing burden prophage carriage prevalence iH pylorii prophage sequence variable geography ancestry disease status human host Prophage insertion occasionally result gene disruption change global bacterial epigenome Gene function prediction allowed development first model lysogeniclytic cycle regulation iH pylorii disclosed new prophage inactivation mechanism appear occur genome rearrangement merger mobile elements pseudogene accumulation analysis provides comprehensive framework iH pylorii prophage biological genomics offering insight lysogeny regulation bacterial adaptation prophages",
        "mesh_terms": [
            "Helicobacter pylori",
            "Prophages",
            "Genome, Bacterial",
            "Humans",
            "Phylogeny",
            "Genomics",
            "Helicobacter Infections"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39132840/"
    },
    {
        "pmid": "39100507",
        "title": "Expanding molecular diagnostic coverage for tuberculosis by combining computer-aided chest radiography and sputum specimen pooling: a modeling study from four high-burden countries.",
        "abstract": "2022 fewer half person tuberculosis TB access molecular diagnostic test TB due high costs Studies found use artificial intelligence AI software chest Xray CXR interpretation sputum specimen pooling reduce cost testing modeled combination strategy estimate potential saving consumables could used expand access molecular diagnostics obtained Xpert testing positivity data segmented decile AI probability score TB community healthcare facilitybased active case finding conducted Bangladesh Nigeria Viet Nam Zambia AI score model based CAD4TB version 7 Zambia qXR all countries modeled four ordinal screening testing approach involving AIaided CXR interpretation indicate individual pooled testing Setting false negative rate 5 approach calculated additional cumulative saving baseline universal Xpert testing well theoretical expansion diagnostic coverage country optimal screening testing approach use AI rule testing decile low AI score guide pooled v individual testing person moderate high AI scores respectively approach yielded cumulative saving Xpert test baseline ranging 508 Zambia 575 Nigeria 615 Bangladesh Viet Nam Using savings diagnostic coverage theoretically could expanded 34 160 across different approach countries Using AI software data generated CXR interpretation inform differentiated pooled testing strategy may optimize TB diagnostic test use could extend molecular test people need them optimal AI threshold pooled testing strategy varied across countries suggests bespoke screening testing approach may needed differing population settings online version contains supplementary material available 101186s44263024000812",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39100507/"
    },
    {
        "pmid": "39076506",
        "title": "Disseminated histoplasmosis: Long journey of a febrile young man.",
        "abstract": "19yearold nondiabetic nonHIV male presented eighteen month fever weight loss skin rash lymphadenopathy treated antitubercular medication twelve month multiple institution based repeated biopsy report lymph node showing granuloma suggestive tuberculosis diagnosed Bangabandhu Sheikh Mujib Medical University BSMMU disseminated histoplasmosis eighteen month disease already lost twenty kg weight developed multiple small joint pain back pain cough along previously mentioned symptoms Extensive investigation BSMMU revealed biopsy material multiple site showed noncaseating granuloma Periodic acidSchiff PAS stain positive budding oval yeast cells fungal culture revealed growth dimorphic fungus suggestive Histoplasma three weeks treatment intravenous liposomal amphotericin B continuous itraconazole patients fever completely subsided wellbeing improved joint pain reduced started gain weight skin lesion started heal case serf significant reminder imperative consider alternative diagnosis patient fail show improvement conventional antitubercular treatment",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39076506/"
    },
    {
        "pmid": "39024368",
        "title": "In-silico discovery of common molecular signatures for which SARS-CoV-2 infections and lung diseases stimulate each other, and drug repurposing.",
        "abstract": "COVID19 caused SARSCoV2 global health issue yet severe risk factor patients also suffering one chronic disease including different lung diseases study explored common molecular signature SARSCoV2 infection different lung disease stimulate other associated candidate drug molecules identified SARSCoV2 infection different lung disease Asthma Tuberculosis Cystic Fibrosis Pneumonia Emphysema Bronchitis IPF ILD COPD causing topranked 11 shared gene STAT1 TLR4 CXCL10 CCL2 JUN DDX58 IRF7 ICAM1 MX2 IRF9 ISG15 hub shared differentially expressed gene hubsDEGs gene ontology GO pathway enrichment analysis hubsDEGs revealed crucial common pathogenetic process SARSCoV2 infection different lung diseases regulatory network analysis hubsDEGs detected topranked 6 TFs protein 6 micro RNAs key transcriptional posttranscriptional regulatory factor hubsDEGs respectively proposed hubsDEGs guided topranked three repurposable drug molecule Entrectinib Imatinib Nilotinib treatment COVID19 different lung diseases recommendation based result obtained molecular docking analysis using AutoDock Vina GLIDE module Schrödinger selected drug molecule optimized density functional theory DFT observing good chemical stability Finally explored binding stability highestranked receptor protein RELA topordered three drug Entrectinib Imatinib Nilotinib 100 n molecular dynamic MD simulation YASARA Desmond module Schrödinger observed consistent performance Therefore finding study might useful resource diagnosis therapy COVID19 patient also suffering one lung diseases",
        "mesh_terms": [
            "Humans",
            "Drug Repositioning",
            "SARS-CoV-2",
            "COVID-19",
            "COVID-19 Drug Treatment",
            "Lung Diseases",
            "Molecular Docking Simulation",
            "Antiviral Agents",
            "Computer Simulation",
            "Gene Regulatory Networks"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/39024368/"
    },
    {
        "pmid": "38992660",
        "title": "The spectrum of health conditions in community-based cross-sectional surveys in Southeast Asia 2010-21: a scoping review.",
        "abstract": "Southeast Asia undergoing epidemiological transition noncommunicable illness becoming increasingly important yet infectious disease tuberculosis HIV hepatitis B malaria remain widely prevalent populations emerging zoonotic disease threaten also limited populationlevel estimate many important heath conditions restricts evidencebased decisionmaking disease control prevention priorities Crosssectional survey efficient epidemiological tool measure prevalence wide range diseases systematic assessment coverage different health condition produced region conducted systematic search Medline Embase Global Health CINAHL Scopus Web Science Core Collection Global Index Medicus additionally Google Scholar inclusion criterion crosssectional survey conducted communitybased recruitment Bangladesh Cambodia Laos Myanmar Thailand published January 1 2010 January 27 2021 reporting prevalence health condition 542 publication 337 survey included Noncommunicable condition n  205 reported survey infectious condition n  124 Disability n  49 selfreport history disease symptom n  35 selfperceived health status n  34 reflect holistic picture health studied many fewer surveys addition 45 survey studied symptomatic condition overlap noncommunicable infectious conditions surveyed condition undernutrition obesity hypertension diabetes intestinal parasites malaria anemia diarrhea fever acute respiratory infections condition overlap important cause death disability Global Burden Disease study However highburden condition eg hearing loss headache disorder low back pain chronic liver kidney diseases cancers rarely studied relatively recent survey estimate representative prevalence trend health condition beyond known high burden Expanding spectrum health condition crosssectional survey could improve understanding evolving disease pattern region",
        "mesh_terms": [
            "Humans",
            "Asia, Southeastern",
            "Communicable Diseases",
            "Cross-Sectional Studies",
            "Health Status",
            "Health Surveys",
            "Noncommunicable Diseases",
            "Prevalence"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38992660/"
    },
    {
        "pmid": "38971567",
        "title": "Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence-Assisted ARIA Care Pathways (ARIA 2024).",
        "abstract": "traditional healthcare model focused disease medicine natural science acknowledge patients resource ability expert life based lived experiences Improving healthcare safety quality coordination well quality life important aim care patient chronic conditions Personcentered care need ensure peoples value preference guide clinical decisions paper review current knowledge develop 1 digital care pathway rhinitis asthma multimorbidity 2 digitally enabled personcentered caresup1sup combine relevant research evidence including socalled realworld evidence ultimate goal develop digitally enabled patientcentered care paper includes 1 Allergic Rhinitis Impact Asthma ARIA 2decade journey 2 Grading Recommendations Assessment Development Evaluation GRADE evidencebased model guideline airway diseases 3 mHealth impact airway diseases 4 guideline digital care pathways 5 Embedding Planetary Health 6 Novel classification rhinitis asthma 7 Embedding reallife data populationbased studies 8 ARIAEAACI European Academy Allergy Clinical Immunology strategy management airway disease using digital biomarkers 9 Artificial intelligence 10 development digitally enabled ARIA personcentered care 11 political agenda ultimate goal propose ARIA 2024 guideline centered around patient make applicable sustainable",
        "mesh_terms": [
            "Humans",
            "Patient-Centered Care",
            "Asthma",
            "Artificial Intelligence",
            "Rhinitis, Allergic",
            "Telemedicine",
            "Critical Pathways",
            "Practice Guidelines as Topic"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38971567/"
    },
    {
        "pmid": "38962464",
        "title": "Pulmonary tuberculosis masquerading as a mass cancer lesion: A rare case report and review of literature.",
        "abstract": "Despite generally treatable preventative pulmonary tuberculosis PTB one common infectious agent cause death Misdiagnosis TB frequently lead unwarranted diagnostic procedure postpones start treatment Pulmonary tuberculosis PTB present various unusual radiological clinical characteristics Misdiagnosis TB frequently lead unwarranted diagnostic procedure postpones start treatment Here describe 50yearold man presented canceroustype lesion radiological finding atypical symptom led initial diagnosis lung cancer However histopathology biopsy lung lesion revealed chronic granulomatous inflammation caseous necrosis confirming PTB true cause indication malignancy",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38962464/"
    },
    {
        "pmid": "38951780",
        "title": "What is the state of the art on traditional medicine interventions for zoonotic diseases in the Indian subcontinent? A scoping review of the peer-reviewed evidence base.",
        "abstract": "Traditional medicine TM intervention plausible therapeutic alternative conventional medical intervention emerging endemic zoonotic diseases particularly lowand middleincome country may lack resource infrastructure Despite growing popularity usage TM interventions clinical safety effectiveness still contested within conventional healthcare many countries conducted scoping review peerreviewed literature synthesis map evidence TM intervention treatment prevention zoonosis Indian subcontinent region global hotspot biodiversity emerging infections characterised high prevalence TM use Based scientific literature mostly case study research nl06 studies review 1 map scope literature 2 synthesis evidence application TM intervention zoonoses 3 critically reflects state TM identifies area future research focus evidence synthesis confirmed widespread usage TM intervention zoonosis subcontinent majority research reported India n99 studies 934 followed Pakistan n3 studies 28 Bangladesh n2 studies 19 Sri Lanka n1 09 reviewed study reported ethnomedicinal us plant species primarily treating dengue n20 studies tuberculosis n18 studies Escherichia coli infection n16 studies lymphatic filariasis cholera n9 apiece However evidence safety effectiveness reported TM intervention limited indicating data rarely collected andor shared within peerreviewed literature review thus highlight that whilst TMs already used could offer widely accessible intervention emerging endemic zoonosis ectoparasites urgent need rigorous clinical testing validation safety effectiveness interventions",
        "mesh_terms": [
            "Humans",
            "Zoonoses",
            "Medicine, Traditional",
            "Animals",
            "India",
            "Peer Review"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38951780/"
    },
    {
        "pmid": "38947352",
        "title": "Epidemiology and antimicrobial resistance of <i>Mycobacterium</i> spp. in the United Arab Emirates: a retrospective analysis of 12 years of national antimicrobial resistance surveillance data.",
        "abstract": "Eastern Mediterranean Regional Office EMRO region account almost 8 global iMycobacterium tuberculosisi TB cases TB incidence rate ranging 1 per 100000 per year United Arab Emirates UAE 204 per 100000 Djibouti national surveillance data Middle East North Africa MENA region epidemiology antimicrobial resistance trend TB including MDRTB remains scarce retrospective 12year analysis iNi  8086 nonduplicate diagnostic iMycobacterium tuberculosisi complex MTB complex isolates UAE conducted Data generated routine patient care 20102021 years collected trained personnel reported participating surveillance site UAE National Antimicrobial Resistance AMR Surveillance program Data analysis conducted WHONET windowsbased microbiology laboratory database management software developed World Health Organization Collaborating Center Surveillance Antimicrobial Resistance Boston United States httpswhonetorg total 8086 MTBcomplex isolates analyzed MTBcomplex primarily isolated respiratory sample sputum 801 bronchoalveolar lavage 46 pleural fluid 41 Inpatients accounted 632 including 13 ICU Nationality known 843 patients including 38 Emiratis UAE nonnationals 805 110 countries Asian countries India accounted 208 Pakistan 136 Philippines 127 Bangladesh 78 Rifampicinresistant MTBcomplex isolates RRTB found 28 isolates resistance isoniazid streptomycin pyrazinamide ethambutol 89 69 34 04 respectively slightly increasing trend resistance among MTBcomplex observed rifampicin 25 2010 28 2021 Infections due MTBcomplex relatively uncommon United Arab Emirates compared country MENA region TB patient UAE Asian origin mainly country high prevalence TB Resistance first line antituberculous drug generally low however increasing trend MDRTB mainly rifampicin linked resistance major concern MDRTB associated higher mortality admission ICU increased length hospitalization compared nonMDRTB",
        "mesh_terms": [
            "United Arab Emirates",
            "Humans",
            "Retrospective Studies",
            "Tuberculosis, Multidrug-Resistant",
            "Male",
            "Mycobacterium tuberculosis",
            "Female",
            "Adult",
            "Antitubercular Agents",
            "Middle Aged",
            "Drug Resistance, Bacterial",
            "Adolescent",
            "Microbial Sensitivity Tests",
            "Young Adult",
            "Population Surveillance"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38947352/"
    },
    {
        "pmid": "38944719",
        "title": "Needle Biopsy of Pleura in the Aetiological Diagnosis of Pleural Effusion.",
        "abstract": "Exudative pleural effusion appears manifestation underlying specific disease process pleural biopsy usually enough find underlying causative disease aim study find efficacy needle biopsy pleura aetiological diagnosis pleural effusion crosssectional study conducted period one year January 2008 December 2008 Department Medicine Shaheed Ziaur Rahman Medical College Hospital Bogura Bangladesh enrolling 50 subject exudative pleural effusion case transudative pleural effusion included Needle biopsy done cases Histopathological report pleural biopsy specimen correlated data analyzed detect cause effusion Major incidence malignant effusion occurred 41 70 year age malignant effusion found 30 year age Incidence tuberculous malignant pleural effusion much common male females Sensitivity specificity combined pleural biopsy pleural fluid analysis diagnosis pleural effusion 9706 100 tuberculosis 8182 1000 malignancy present study reveals pleural biopsy effective method diagnosis cause pleural effusion",
        "mesh_terms": [
            "Humans",
            "Male",
            "Female",
            "Middle Aged",
            "Aged",
            "Pleural Effusion",
            "Adult",
            "Cross-Sectional Studies",
            "Biopsy, Needle",
            "Pleura",
            "Pleural Effusion, Malignant",
            "Sensitivity and Specificity",
            "Adolescent"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38944719/"
    },
    {
        "pmid": "38904027",
        "title": "Polyphenols as Therapeutics in Respiratory Diseases: Moving from Preclinical Evidence to Potential Clinical Applications.",
        "abstract": "Respiratory disease common severe health complication leading cause death worldwide Despite breakthrough diagnosis treatment safe effective therapeutic reported Phytochemicals gaining popularity due beneficial effect low toxicity Polyphenols secondary metabolite high molecular weight found high level natural food source fruits vegetables grains citrus seeds recent decades polyphenols beneficial effect human health subject intense research notable success preventing major chronic noncommunicable diseases Many respiratory syndrome treated effectively polyphenolic supplements including acute lung damage pulmonary fibrosis asthma pulmonary hypertension lung cancer review summarizes role polyphenols respiratory condition sufficient experimental data highlight polyphenols beneficial effect each identifies therapeutic potential underlying mechanisms Moreover clinical study future research opportunity area discussed",
        "mesh_terms": [
            "Polyphenols",
            "Humans",
            "Animals",
            "Respiratory Tract Diseases"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38904027/"
    },
    {
        "pmid": "38899002",
        "title": "Spatio-temporal pattern and associate meteorological factors of airborne diseases in Bangladesh using geospatial mapping and spatial regression model.",
        "abstract": "Airborne disease due climate change pose significant public health challenge Bangladesh Little known spatiotemporal pattern airborne disease district level country Therefore study aimed investigate spatiotemporal pattern associated meteorological factor airborne disease Bangladesh using exploratory analysis spatial regression models study used districtlevel reported case airborne disease meningococcal measles mumps influenza tuberculosis encephalitis meteorological data temperature relative humidity wind speed precipitation 2017 2020 Geospatial mapping spatial error regression model utilized analyze data 2017 2020 total 315 meningococcal 5159 measles 1341 mumps 346 influenza 4664 tuberculosis 229 encephalitis case reported Bangladesh Among airborne diseases measles demonstrated highest prevalence featuring higher incidence rate coastal Bangladeshi district Lakshmipur Patuakhali Coxs Bazar well Maulvibazar Bandarban district 2017 2020 contrast tuberculosis TB emerged second prevalent disease higher incidence rate observed district Khagrachhari Rajshahi Tangail Bogra Sherpur spatial error regression model revealed among climate variables mean iβi  956 standard error SE 348 maximum temperature iβi  119 SE 040 significant risk factor airborne disease Bangladesh Maximum temperature positively influenced measles iβi  274 SE 139 whereas mean temperature positively influenced meningococcal iβi  557 SE 250 mumps iβi  1199 SE 313 diseases finding study provide insight planning early warning prevention control strategy combat airborne disease Bangladesh similar endemic countries Preventive measure enhanced monitoring taken highrisk district airborne disease country",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38899002/"
    },
    {
        "pmid": "38848797",
        "title": "Inhalable solid lipid nanoparticles of levofloxacin for potential tuberculosis treatment.",
        "abstract": "Delivering novel antimycobacterial agent pulmonary route using nanoparticlebased system show promise treating disease like tuberculosis However creating dry powder inhaler DPI suitable aerodynamic characteristic preserving nanostructure integrity maintaining bioactivity active ingredient travel deeply lung difficult challenge developed DPI formulation containing levofloxacinloaded solid lipid nanoparticles SLNs via spraydrying technique tailored aerosolization characteristic effective inhalation therapy range biophysical techniques including transmission electron microscopy confocal microscopy scanning electron microscopy used measure morphology size spraydried microparticles explored geometric aerodynamic properties Spray drying substantially reduced particle size SLNs preserving nanostructural integrity enhancing aerosol dispersion efficient mucus penetration Despite slower uptake rate compared plain SLNs polyethylene glycol modified formulation exhibited enhanced cellular uptake A549 NR8383 cell lines percent viability Mycobacterium bovis dropped nearly 0  day 5 type SLNs Interestingly levofloxacinloaded SLNs demonstrated lower minimum bactericidal concentration 025 µgmL compared pure levofloxacin 1 µgmL indicated formulation potential effective treatment tuberculosis",
        "mesh_terms": [
            "Levofloxacin",
            "Nanoparticles",
            "Administration, Inhalation",
            "Humans",
            "Dry Powder Inhalers",
            "Antitubercular Agents",
            "Tuberculosis",
            "Particle Size",
            "Lipids",
            "Mycobacterium bovis",
            "Cell Line",
            "Aerosols",
            "A549 Cells",
            "Animals",
            "Spray Drying",
            "Microbial Sensitivity Tests",
            "Drug Carriers",
            "Polyethylene Glycols",
            "Anti-Bacterial Agents",
            "Liposomes"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38848797/"
    },
    {
        "pmid": "38770156",
        "title": "Effects of diabetes mellitus on retreatment of Tuberculosis: A multi-centered case-control study from Bangladesh.",
        "abstract": "Several study suggested diabetes mellitus DM worsens tuberculosis TB treatment outcome information regarding association DM retreatment TB scarce Bangladesh Present study aimed assess effect DM retreatment TB casecontrol study conducted among 254 patient 127 case 127 controls January 2022  December 2022 Patients recruited purposive sampling 92 center Diabetic Association Bangladesh BADAS Data collected facetoface interview record reviewing help semistructured questionnaire checklist respectively Quality data maintained stage study Data analyzed using IBM SPSS software Informed written consent taken patient prior study Ethical issue maintained strictly Present study matched age sex case controls study revealed majority case 890 control 976 married Among case 780  DM among control 646  DM Among diabetic patients 788  cases 646  controls HbA1C level within normal range study found that number episode previous TB AOR  3088 ρ  0019 presence DM AOR  2817 ρ  0012 uncontrolled HbA1C level AOR  2500 ρ  0028 independently associated retreatment TB study found presence DM uncontrolled HbA1C level multiple episode previous TB risk factor retreatment TB So separate guideline treatment TBDM patient established prevent retreatment cases",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38770156/"
    },
    {
        "pmid": "38766427",
        "title": "Tuberculosis-diabetes comorbidities: Mechanistic insights for clinical considerations and treatment challenges.",
        "abstract": "Tuberculosis TB remains leading cause death among infectious diseases particularly poor countries Viral infections multidrugresistant extensively drugresistant TB strains well coexistence chronic illness diabetes mellitus DM greatly aggravate TB morbidity mortality DM particularly type 2 DM T2DM TB converged making control even challenging Two contemporary global epidemics TBDM behaves like syndemic synergistic confluence two highly prevalent diseases T2DM risk factor developing severe form multidrug resistantTB TB recurrence preventive treatment Since bidirectional relationship exists TB DM necessary concurrently treat both promote recommendation joint management diseases also drugdrug interaction resulting adverse treatment outcome TBDM patient including treatment failure reinfection addition autophagy may play role comorbidities Therefore TBDM comorbidities present several health challenges requiring focus multidisciplinary collaboration integrated strategies effectively deal double burden effectively manage comorbidity screening affected countries suitable drugs better treatment strategy required",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38766427/"
    },
    {
        "pmid": "38724531",
        "title": "Sputum culture reversion in longer treatments with bedaquiline, delamanid, and repurposed drugs for drug-resistant tuberculosis.",
        "abstract": "Sputum culture reversion conversion indicator tuberculosis TB treatment failure analyze data endTB multicountry prospective observational cohort NCT03259269 estimate frequency primary endpoint among individual receiving longer 18to20 month regimen multidrug rifampicinresistant MDRRR TB experienced culture conversion also conduct Cox proportional hazard regression analysis identify factor associated reversion including comorbidities previous treatment cavitary disease conversion low body mass index BMI conversion time conversion number likelyeffective drugs 1286 patients 54 42 experienced reversion median 173 day 97306 conversion Cavitary disease BMI  185 hepatitis C prior treatment secondline drugs longer time initial culture conversion positively associated reversion Reversion uncommon cavitary disease low BMI hepatitis C prior treatment secondline drugs culture conversion delayed may benefit close monitoring following conversion",
        "mesh_terms": [
            "Humans",
            "Antitubercular Agents",
            "Sputum",
            "Tuberculosis, Multidrug-Resistant",
            "Diarylquinolines",
            "Male",
            "Female",
            "Oxazoles",
            "Adult",
            "Nitroimidazoles",
            "Middle Aged",
            "Prospective Studies",
            "Mycobacterium tuberculosis",
            "Drug Repositioning"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/38724531/"
    },
    {
        "pmid": "40824148",
        "title": "Health-related quality of life based on the European Questionnaire 5D-5L utility score in patients with multidrug-resistant tuberculosis.",
        "abstract": "Patients healthrelated quality life HRQOL negatively impacted multidrugresistant tuberculosis MDRTB HRQOL MDRTB patient assessed study using European Questionnaire 5D5L EQ5D5L utility score HRQOLrelated parameters conducted casecontrol study Haji Hospital June December 2024 MDRTB patient drugsensitive DSTB patient divided case control groups respectively HRQOL utility score depression level measured using Indonesian EQ5D5L Patient Health Questionnaire9 PHQ9 respectively study included 84 TB patients 36 48 MDRTB DSTB respectively Patients DRTB significantly higher PHQ9 score 755±597 vs 469±421 p0047 patient DSTB compared control group cases EQ5D5L EQ Visual Analog Scale utility score considerably lower 086±011 6930±1665 p0005 092±007 8070±1553 p0002 respectively EQ5D5L utility score considerably lower DRTB patient depression history TB treatment conclusion HRQOL MDRTB patient low Among MDRTB patients depression TB treatment history associated quality life study provides insight need healthcare practitioner evaluate patients HRQOL particularly risk factors",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824148/"
    },
    {
        "pmid": "40824133",
        "title": "Evaluating hematological and inflammatory biomarkers in tuberculosis management.",
        "abstract": "Tuberculosis TB remains significant public health concern particularly resourcelimited settings Accurate timely diagnosis effective monitoring disease progression treatment response remain challenge research aim evaluate function hematological inflammatory biomarkers including hemoglobin HB serum amyloid SAA Creactive protein CRP erythrocyte sedimentation rate ESR white blood cell WBC count TB patients Overall 80 TB patient analyzed evaluate association biomarkers disease status demographic characteristics finding revealed significant alteration inflammatory markers elevated WBC SAA CRP ESR levels indicating ongoing inflammatory response Additionally decreased HB level observed suggesting presence anemia commonly associated chronic infection TB Pearsons correlation analysis revealed significant negative connection HB inflammatory markers reinforcing link anemia TBassociated inflammation However noteworthy association found biomarker level demographic parameters including age gender residence treatment duration finding emphasize potential utility biomarkers TB diagnosis prognosis treatment monitoring especially region advanced diagnostic tool readily available study suggests routine hematological inflammatory marker serve costeffective adjunctive tool TB administration Additional investigation needed confirm result determine role predicting treatment outcome disease severity",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40824133/"
    },
    {
        "pmid": "40823191",
        "title": "Diagnostic accuracy and predictive value of the QuantiFERON-TB gold plus assay for tuberculosis in immunocompromised individuals: a prospective TBnet study.",
        "abstract": "low tuberculosis TBendemic countries tuberculosis preventive therapy TPT recommended immunocompromised individual positive immunodiagnostic test study aimed assess performance QuantiFERONTB Gold Plus QFT assay predictive power future tuberculosis immunocompromised individuals prospective observational study immunocompromised adult ≥18 year age including people living HIV PLHIV chronic renal failure rheumatoid arthritis solidorgan transplantation stemcell transplantation immunocompetent adult without TBdisease recruited 21 site 11 European country tested QFT assay Individuals without TBdisease followed development tuberculosis TB incidence rate IR calculated stratified QFT result acceptance TPT study registered Clinicaltrialsgov NCT02639936 total 2663 individual 1115 female 1548 male enrolled 03112015 29032019 Persons without tuberculosis followed least two years Among 1758 immunocompromised individual without active tuberculosis 136 positive QFT results Sensitivity specificity TBdisease 700 521833 914 896929 respectively immunocompromised 814 766853 960 925979 respectively immunocompetent individuals 2457 cumulative year followup among 932 individual chronic renal failure rheumatoid arthritis solidorgan transplantation stemcell transplantation including 83 person positive QFT test without TPT noone developed active tuberculosis contrast among 642 PLHIV without TPT one indeterminate QFT 330 individual positive QFT developed active tuberculosis detectable HIVreplication low CD4 Tcell count incidence 41 95 CI 13124 per 100 personyears individual receiving TPT developed active tuberculosis 269 year followup immunocompromised individual low TBendemic countries 2yearrisk active tuberculosis highest among PLHIV detectable HIVreplication low CD4counts study QFT assay strongly predict progression active tuberculosis emphasis need incorporate additional risk factors None",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823191/"
    },
    {
        "pmid": "40823118",
        "title": "Treatment of Tuberculous Meningitis With Contezolid in a Patient With Complex Comorbidities: A Case Report and Literature Review.",
        "abstract": "Central nervous system CNS tuberculosis TB severe manifestation iMycobacterium tuberculosisi MTB infection characterized high mortality Contezolid novel oxazolidinone antibiotic exhibit vitro activity MTB may offer safety advantage linezolid firstgeneration oxazolidinone frequently linked myelosuppression neuropathy Clinical data contezolid CNS tuberculosis remain scarce report middleaged man chronic renal allograft dysfunction receiving longterm hemodialysis subsequently developed severe CNS TB complicated multiple coinfections diabetes mellitus pancytopenia individualized multidrug regimen included contezolid successfully employed suggesting potential utility complex CNS TB report highlight therapeutic consideration similar patient underscore need research role contezolid TB treatment",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40823118/"
    },
    {
        "pmid": "40822692",
        "title": "BCG vaccination: historical role, modern applications, and future perspectives in tuberculosis and beyond.",
        "abstract": "Tuberculosis TB remains fatal disease primarily transmitted airborne droplets child susceptible particularly area poor tuberculosis control BCG vaccine developed Albert Calmette Camille Guérin history spanning century vaccine implemented numerous countries significantly reducing child mortality region heavily affected TB review aim revisit vaccines development rollout also highlighting current attribute successful application Russian Federation 90 newborn receive antituberculosis vaccination Due practice isolated case young child generalized tuberculosis about five seven annually observed Russia Research BCG vaccine ongoing revealing significant genetic alteration BCG strain evolved original variant genetic difference may contribute variation vaccine efficacy making screening important predict effectiveness BCG vaccine initiate localized mucosal immune response offering besides antiTB effect protection infection involving mucous membranes including salmonellosis HIV acute viral respiratory infections essential investigate role BCG various applications however exploration detract main protective benefit tuberculosis TB Future study may provide evidence vaccines safety efficacy support use beyond TB prevention BCG vaccination lower risk infection iMycobacterium tuberculosisi prevent progression severe clinical manifestation such miliary TB tuberculous meningitis caused hematogenous spread iMtuberculosisi challenge protecting HIVinfected child TB remains urgent especially region burdened drugresistant TB highlighting need robust protective measures",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40822692/"
    },
    {
        "pmid": "40822559",
        "title": "Status and outlook of pulmonary tuberculosis coinfection.",
        "abstract": "Coinfections pulmonary tuberculosis TB occur people damaged lung structures chronic malnutrition compromised immunity Moreover common clinical challenge lead poor clinical outcome contributes increased morbidity mortality patient TB Coinfection lung prolong hospital stay increase cost treatment TB patients imposes heavy burden family society Therefore pulmonary TB PTB combined pulmonary infection diagnosed treated promptly review describes trend epidemiology factor influence incidence PTB coinfection Current emerging diagnosis well infection treatment discussed",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40822559/"
    },
    {
        "pmid": "40822456",
        "title": "Synergistic antibacterial photodynamic therapy of lysine-porphyrin conjugate and metal ions combination against <i>Candida albicans</i> and <i>Mycobacterium tuberculosis</i>.",
        "abstract": "previous research antibacterial photodynamic therapy using lysineporphyrin conjugate LDsub4sub effectively inactivated methicillinresistant Staphylococcus aureus Pseudomonas aeruginosa Escherichia coli however exhibited limited activity Candida albicans Mycobacterium tuberculosis address limitation developed synergistic antibacterial strategy combining LDsub4sub Cusup2sup Znsup2sup Synergy confirmed via minimum inhibitory concentration fractional inhibitory concentration index analyses demonstrating 16 64fold enhanced antibacterial efficacy compared LDsub4sub alone Mechanistic study revealed divergent pathway LDsub4sub  Cusup2sup LDsub4sub  Znsup2sup Znsup2sup increased reactive oxygen specie yield promoted LD4 uptake pathogens LDsub4sub  Cusup2sup induced oxidative damage cell wall membrane darkness light exposure exacerbating structural damage Cytotoxicity assessment confirmed low toxicity 90 survival normal cell bactericidal concentrations Fluorescence infrared spectroscopy characterized metalLDsub4sub complexes showing stabilization interaction amino pyrrolic imino group LDsub4sub metal ions promoted nonradiative transition fluorescence quenching combination caused significant bacterial membrane disruption growth suppression Notably cytotoxicity exhibited biphasic doseresponse linked metalLDsub4sub complexationdependent particle size changes study elucidated enhanced antimicrobial mechanism safety LDsub4submetal ion combinations finding resolve limitation LDsub4sub providing theoretical framework developing novel therapy fungal mycobacterial infections",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40822456/"
    },
    {
        "pmid": "40822329",
        "title": "Standardized Infliximab Regimen to Treat Severe Central Nervous System Tuberculosis: A Case Series of 18 Patients.",
        "abstract": "Morbidity associated central nervous system tuberculosis CNS TB remains high due persistent inflammation despite standardofcare SOC treatment including antituberculosis therapy corticosteroids Tumor necrosis factor alpha TNFα key cytokine driving inflammatory response limited number case report suggest TNFα inhibitor may improve outcomes report 1year outcome cohort consecutive patient treated infliximab severe CNS TB Following guidance provided French Tuberculosis Consilium standardized regimen intravenous infliximab 5 mgkg per dose used treat CNS TB unresponsive SOC retrospectively included consecutive patient received least 1 infliximab injection CNS TB 2017 September 2021 Eighteen patient CNS TB 94 tuberculous meningitis included severe disease 82 classified British Medical Research Council grade II III 44 required intensive care unit admission demonstrated clinical radiological worsening despite SOC 89 due paradoxical reaction infliximab initiation symptom remained disabling median modified Rankin scale mRS score 35 interquartile range 34 One month first infusion 38 showed improved mRS scores increasing 78 1 year Oneyear survival 94 1 death occurred 12 month single infliximab dose unrelated TB treatment Infliximab may represent promising adjunctive treatment CNS TB unresponsive SOC including paradoxical reaction Prospective study needed confirm findings",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40822329/"
    },
    {
        "pmid": "40822287",
        "title": "Evaluating the cost-effectiveness of levofloxacin therapy for household contacts of multidrug-resistant tuberculosis in Vietnam.",
        "abstract": "Multidrugresistant tuberculosis TB threatens global TB control account poor treatment outcomes high treatment toxicity costs Recent trial demonstrated effectiveness sixmonths levofloxacin 6Lfx prevent TB disease among highrisk contacts However costeffectiveness strategy previously evaluated VQUIN study doubleblinded randomised control trial Vietnam assessing effectiveness 6Lfx household contact multidrug resistantrifampicin resistant TB MDRRRTB prevent progression TB disease Incorporating intrial cost effectiveness outcome VQUIN trial developed closed cohort decisionanalytic Markov model assess cost effectiveness 6Lfx versus placebo cohort exposed MDRRRTB Vietnam 20year time horizon provision 6Lfx preventative therapy household contact people infected MDRRRTB found gain total 401 QALYs per 1000 population save US23145 per 1000 population indicating strategy cost saving MDRRRTB case averted 20 year 199 per 1000 population treated 6Lfx number death averted 32 per 1000 people treated 6Lfx therapy costsaving strategy reduce incidence active disease household contact MDRRRTB resourcelimited setting National Health Medical Research Council Project Grant 1081443 GJF supported NHMRC Leadership Fellowship Level 1 2007920",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40822287/"
    },
    {
        "pmid": "40821831",
        "title": "MDSC depletion during immunization with heat-killed <i>Mycobacterium tuberculosis</i> increases protection against BCG infection.",
        "abstract": "Tuberculosis TB remains one deadliest infectious disease globally Although approved human BacilleCalmetteGuérin BCG vaccine provide limited protection vaccine based iMycobacterium tuberculosisi Mtb yet approved previous finding demonstrated sc immunization heatkilled Mtb significantly increased number monocytic myeloidderived suppressor cell MMDSC mice Thus hypothesized defense subsequent BCG infection would compromised Mtbimmunized mice Surprisingly mouse vaccinated Mtb protected BCG infection exhibited elevated frequency activation dendritic cell DC mycobacteriaspecific cells despite high frequency suppressor activity MMDSC Genetic ablation CCR2supsup monocytic cell pharmacological intervention alltrans retinoic acid ATRA reduced frequency Mtbinduced MMDSC enhanced frequency activation DC CD4supsup cells resulted decreased bacterial load lung spleen finding provide new insight TB vaccination using heatkilled Mtb despite concurrent unwanted effect vaccineinduced MMDSC MMDSC depletion via ATRA shift balance toward immunity considered adjunct hostdirected therapy alongside TB vaccine humans",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40821831/"
    },
    {
        "pmid": "40821687",
        "title": "Tuberculous endocarditis: a case-based proposal for new diagnostic criteria.",
        "abstract": "Tuberculous endocarditis TBE rare often fatal manifestation iMycobacterium tuberculosisi Although diagnosis possible advanced techniques lack standardized diagnostic criterion complicates timely recognition management 79yearold man history Bentall procedure annuloaortic ectasia presented fever chest pain Imaging revealed infective endocarditis aortic root abscess vegetations Histopathology identified granulation tissue multinucleated giant cells iM tuberculosisi confirmed via PCR culture literature review TBE case performed develop systematic diagnostic criteria diagnosis TBE established histopathology molecular methods Based case prior reports diagnostic criterion TBE developed categorized Definitive Probable Possible criterion incorporate clinical microbiological histological imaging finding aid diagnosis patients treatment included surgical intervention combined antimicrobial therapy aligning strategy designed improve outcomes case underscore importance considering TBE infective endocarditis cases especially atypical features proposed diagnostic criterion aim improve recognition guide management TBE emphasizing multidisciplinary approach better patient outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40821687/"
    },
    {
        "pmid": "40821686",
        "title": "Hepatic safety of pretomanid- and pyrazinamide-containing regimens in TB Alliance clinical trials.",
        "abstract": "STAND SimpliciTB clinical trial drugsusceptible TB regimen containing pretomanid pyrazinamide agent PaZX hepatotoxicity standardofcare regimen isoniazid rifampicin pyrazinamide ethambutol HRZE NixTB ZeNix clinical trial drugresistant TB regimen bedaquiline pretomanid linezolid BPaL demonstrated favorable benefitrisk profile compare hepatic safety HRZE PaZX BPaL respective populations posthoc analysis data six clinical trials rate treatmentemergent elevation alanine transaminase ALT first 8 week treatment estimated KaplanMeier KM analysis compared via logrank testing Cox modeling KMestimated probability treatmentemergent ALT elevation greater 3x upper limit normal 3xULN 536 127 114 HRZE PaZX BPaL respectively significant p  005 difference HRZE versus PaZX probability ALT elevation 8xULN 268 458 105 significant difference PaZX versus BPaL BPaL HRZE similar hepatic safety profile respective populations Pretomanid pyrazinamide coadministered benefit outweighs risk",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40821686/"
    },
    {
        "pmid": "40821685",
        "title": "Analysis of gene expression in patients prior to TB treatment to identify those associated with pyrazinamide-hepatotoxicity.",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40821685/"
    },
    {
        "pmid": "40821684",
        "title": "Using linezolid as a substitute for the injectable in case of ototoxicity is safer and as effective as all-oral treatment for rifampicin-resistant TB.",
        "abstract": "recommends alloral bedaquiline BDQ linezolid LZDcontaining regimen rifampicinresistant TB RRTB Niger high cure rate achieved using adaptive short treatment regimen aSTR secondline injectable drug SLID LZD LZD replaced SLID case ototoxicity detected monthly audiometry 2020 recommended short oral BDQLZD regimen oSTR However success reported oSTR lower aSTR Niger SHOrt ORal Treatment trial therefore compared safety efficacy aSTR oSTR Niger pragmatic clinical trial patient fluoroquinolonesusceptible RRTB assigned alternate month aSTR oSTR Regression model estimated association regimen safety grade 34 adverse event AEs efficacy excluding loss followup 20212022 158 RRTB patient included 80 oSTR 78 aSTR Overall 34 patient experienced 43 grade 34 AEs anaemia 15 neurotoxicity 11 vomiting 8 hepatitis 7 arthralgia 1 QTc prolongation 1 Grade 34 AEs occurred 2680 325  oSTR versus 878 103 aSTR anaemia neurotoxicity arthralgia significantly higher oSTR group Ototoxicity nephrotoxicity appeared frequently aSTR none evolved grade 3 Patients treated oSTR 3fold increase grade 34 AE aHR 30495 CI136680 Endoftreatment success similar oSTR compared aSTR aSTR safer oSTR approach similar treatment efficacy",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40821684/"
    },
    {
        "pmid": "40821683",
        "title": "Acceptability of a clofazimine tablet in children with rifampicin-resistant TB in three high-burden countries.",
        "abstract": "Rifampicinresistant TB RRTB child frequently treated clofazimine CFZ widely available 100mg gel capsule formulation challenging administer poorly acceptable child caregivers Poor acceptability may negatively impact adherence treatment outcomes describe acceptability novel 50mg CFZ tablet formulation among child South Africa India Philippines Mixed method assessment completed moxifloxacin CFZ safety pharmacokinetics trial child RRTB Quantitative data collected 36 participant 4 timepoints subsample 26 childcaregiver dyad participated ∼4 qualitative interviews Descriptive statistic thematic analysis employed median age n36 participant South Africa n20 India n6 Philippines n10 49 years majority 2936 received CFZ gel capsule prior switching tablet formulation 50mg tablet better acceptability score taste p0035 smell p0035 ease swallowing p002 compared gel capsules Participants described tablet formulation easier administertake without lingering smell taste Limited concern noted staining novel 50mg CFZ tablet better acceptability prioritised child wherever possible",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40821683/"
    },
    {
        "pmid": "40821682",
        "title": "Risk of relapse: TB treatment outcome associates with differentially culturable <i>M. tuberculosis</i> counts in sputum samples.",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40821682/"
    },
    {
        "pmid": "40821374",
        "title": "Ischemic stroke due to tuberculosis in an uncommon arterial territory: A case report and literature review.",
        "abstract": "Tuberculous meningitis TBM severe form tuberculosis lead complication stroke occurring 1357 cases report describes 21yearold man prior medical history presented headache fever vomiting followed visual hallucinations impaired alertness speech disturbances Initial CT imaging revealed bilateral hypodense frontal lesion poor contrast enhancement cerebrospinal fluid analysis indicated lymphocytic meningitis MRI demonstrated bilateral parasagittal frontal signal abnormality extending knee corpus callosum leptomeningeal enhancement angiographic sequence showed occlusion left anterior cerebral artery thinning distal right anterior cerebral artery leading diagnosis ischemic stroke secondary TBM Stroke TBM patient may asymptomatic present focal neurological deficits MRI angiographic sequence essential identifying ischemic change vascular involvement suggestive vasculitis Although targeted therapy exists stroke TBM timely diagnosis initiation standard antituberculosis treatment supportive care crucial case highlight need early neuroimaging TBM detect stroke mitigate longterm neurological complications",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40821374/"
    },
    {
        "pmid": "40821343",
        "title": "Indeterminate QuantiFERON Results in Pediatric Kawasaki Disease: Inflammatory Predictors and Diagnostic Implications.",
        "abstract": "Introduction Interferongamma release assay IGRAs QuantiFERON®TB Gold Plus QFT widely used tuberculosis TB screening children However indeterminate QFT result remain diagnostic challenge particularly patient Kawasaki disease KD systemic inflammation may transiently impair Tcell function study aimed identify clinical laboratory factor associated indeterminate QFT result pediatric patients focus KD Methods retrospectively analyzed 147 pediatric QFT test performed tertiary medical center Japan September 2019 May 2025 Clinical characteristic laboratory parameter compared patient indeterminate negative QFT results Subgroup analysis conducted child KD Results Among 147 pediatric cases 30 204 yielded indeterminate QFT results 24 80 involved KD KD subgroup indeterminate group significantly higher Creactive protein level median 565 vs 321 mgdL p0016 lower serum albumin level 275 vs 290 gdL p0013 compared negative group significant difference observed laboratory parameters Conclusion study suggests QFT may yield indeterminate result pediatric KD acute inflammatory phase potentially reflecting transient inflammationinduced Tcell suppression Clinicians consider timing IGRA testing alternative assay TSPOTTB adjunctive diagnostic tool screening TB population",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40821343/"
    },
    {
        "pmid": "40821330",
        "title": "Synchronous Intestinal Tuberculosis and Ulcerative Colitis: A Diagnostic Challenge.",
        "abstract": "Intestinal tuberculosis ITB rare manifestation extrapulmonary tuberculosis often mimic inflammatory bowel diseases particularly ulcerative colitis UC complicating diagnostic process report case 54yearold woman poorly controlled type 2 diabetes presented fivemonth history abdominal pain diarrhea bloating fatigue lowgrade fever Initial imaging suggested feature consistent inflammatory bowel disease IBD colonoscopy revealed mucosal ulcerations Histopathological examination confirmed diagnosis ITB patient started standard antituberculous therapy However clinical improvement remained limited followup colonoscopy six month later demonstrated persistent inflammatory changes raising suspicion coexisting UC Initiation mesalamine therapy resulted significant symptom resolution case underscore diagnostic challenge posed overlapping gastrointestinal pathology ITB UC Timely recognition coexisting condition critical guiding appropriate treatment optimizing patient outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40821330/"
    },
    {
        "pmid": "40821300",
        "title": "Metastatic Lung Adenocarcinoma in a Lifetime Nonsmoker With an Atypical Radiological and Clinical Presentation.",
        "abstract": "Lung cancer remains leading cause cancerrelated death globally smokingrelated lung cancer still account case cause approximately 100000 death annually USA smoking rate declining decades Lung cancer neversmokers LCINS tends affect woman Asian populations fifth common cause cancerrelated death worldwide 2023 20000 lung cancer death USA projected occur neversmokers making LCINS eighth leading cause cancerrelated mortality country number LCINS case rises becomes increasingly important explore unique cause characteristic disease call tailored diagnostic approach personalized treatment plans Lung adenocarcinoma LUAD present atypical imaging feature often resemble benign conditions including pneumonia lung abscesses postinfectious scarring atelectasis mediastinal masses emphysema granulomatous disease variability presentation hinder accurate diagnosis potentially delay timely treatment lung cancer uncommon younger individuals 56 new case occurring 54 year old clinician maintain high index suspicion early detection essential atypical case easily missed Here present complex case involving unusual radiologic manifestation lung mass tuberculosis initially considered primary differential diagnosis",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40821300/"
    },
    {
        "pmid": "40821222",
        "title": "Neutrophil-Predominant Peritoneal Tuberculosis With Salpingitis Mimicking Ovarian Cancer: A Case Report.",
        "abstract": "Tuberculosis TB caused iMycobacterium tuberculosisi multisystem infection common manifestation pulmonary TB leading cause death among infectious diseases Abdominal TB form extrapulmonary TB EPTB often present nonspecifically result genitourinary hematogenous spread present case 20yearold Bangladeshi woman presented twomonth history fever night sweat accompanied vomiting tachycardia tachypnea Laboratory investigation revealed elevated inflammatory markers lactate dehydrogenase cancer antigen 125 QuantiFERONTB QIAGEN NV Venlo Netherlands positive abdominal ultrasound showed free fluid throughout abdomen CT scan abdomen revealed thickening enhancement peritoneum omental caking bilateral bulky ovary measuring 85 x 54 cm right side raising suspicion malignancy However MRI showed pelvic mass were fact bilateral hydrosalpinx Peritoneal analysis indicated serum ascites albumin gradient SAAG less 11 suggesting peritonitis neutrophil predominance Acidfast bacillus AFB culture peritoneal fluid grew iM tuberculosisi Abdominal TB ovarian cancer overlap clinical presentation especially young female patients Imaging may misleading seen case Imaging modality may assist diagnosis exploration particularly diagnostic laparoscopy biopsy required suspected ovarian cancer EPTB",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40821222/"
    },
    {
        "pmid": "40821206",
        "title": "Primary Testicular Tuberculosis Presenting as a Scrotal Emergency: A Report of a Rare Case.",
        "abstract": "Tuberculosis TB continues pose major health challenge worldwide particularly region disease endemic India Although lung commonly affected TB also involve organs including genitourinary system Testicular involvement extremely uncommon clinically resemble frequent scrotal condition like pyocele epididymoorchitis present case 50yearold male developed unilateral scrotal pain swelling initially suggestive acute infection Emergency scrotal exploration uncovered abscess necrotic testicular tissue Histopathological examination confirmed testicular tuberculosis patient responded well antituberculous treatment emphasizing need include TB differential diagnosis atypical scrotal swellings especially endemic areas",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40821206/"
    },
    {
        "pmid": "40821205",
        "title": "Miliary Lung Lesions Mimicking Tuberculosis: A Case of Metastatic Lung Adenocarcinoma.",
        "abstract": "Miliary pattern chest imaging frequently prompt urgent consideration disseminated infectious disease tuberculosis TB particularly patient endemic regions However noninfectious aetiology like metastatic malignancy must also considered report case 39yearold previously healthy male miliary pulmonary lesion initially treated empirically disseminated TB Despite therapy condition deteriorated biopsy result confirmed metastatic lung adenocarcinoma case highlight diagnostic challenge TBendemic region underscore importance early tissue diagnosis",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40821205/"
    },
    {
        "pmid": "40821159",
        "title": "Secondhand Smoke and Biomass Fuel Exposure as Risk Factors for Pulmonary Tuberculosis: A Matched Case-Control Study From Southern Haryana.",
        "abstract": "Introduction Secondhand smoke SHS exposure biomass cooking fuel utilization represent persistent growing health threat region tuberculosis TB pose major public health risks comprehensive study conducted Nuh district Haryana India investigated association environmental exposures including SHS biomass cooking fuel use pulmonary TB development Methodology matched casecontrol study included 218 newly diagnosed pulmonary TB case matched 218 nonTB control recruited healthcare facility Cases comprised nonsmoking adult men woman presenting incident pulmonary TB patient diagnosed Tuberculosis Detection Center TDC standard guidelines Data collected structured questionnaire Bivariate logistic regression assessed association dependent independent variables Adjusted odds ratio calculated significant associations Results Kitchen facility analysis showed 192436 44 home without separate cooking area 215436 493 lacking exhaust ventilation Cooking fuel analysis revealed 73218 335 case used biomass fuel compared 42218 193 controls Results demonstrated significant association TB environmental risk factors SHS exposure adjusted odds ratio OR 283 95 confidence interval CI 139575 biomass fuel use adjusted 185 95 CI 113303 overcrowding adjusted 285 95 CI 169478 inadequate ventilation adjusted 165 95 CI 108252 Conclusions finding provide compelling evidence role indoor air pollution environmental tobacco smoke exposure TB pathogenesis among vulnerable population resourcelimited settings SHS exposure biomass cooking fuel use emerged independent risk factor substantial effect sizes supporting biological mechanism linking indoor air pollution TB susceptibility Additional environmental factors including overcrowding dampness inadequate ventilation demonstrated strong association disease occurrence",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40821159/"
    },
    {
        "pmid": "40820821",
        "title": "Rifampin-induced bullous pemphigoid in tuberculosis treatment: A strategic rechallenge approach.",
        "abstract": "purpose case report highlight unusual presentation rifampininduced bullous pemphigoid 37yearold female undergoing tuberculosis treatment report aim explore challenge managing druginduced bullous pemphigoid maintaining effective treatment tuberculosis emphasizing necessity strategic approach drug management disease control 37yearold female tuberculosis developed atypical form bullous pemphigoid rifampin therapy patient presented painful pruritic vesicular lesion directly manifested bullous lesion without typical prodromal phase without mucosal involvement Histopathological examination confirmed diagnosis subepidermal blister eosinophilic infiltration Management case involved carefully balancing tuberculosis treatment bullous pemphigoid control required modified rechallenge protocol dose titration rifampin combination systemic corticosteroids immunomodulators supportive care case underscore complexity managing druginduced bullous pemphigoid patient undergoing treatment tuberculosis successful outcome achieved cautious approach including rechallenge protocol careful drug dose adjustments case offer valuable insight clinician managing similar complex presentation druginduced bullous pemphigoid demonstrating that tailored treatment strategy condition effectively controlled",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40820821/"
    },
    {
        "pmid": "40820626",
        "title": "Comparison Between the Efficacy of Oblique Lumbar Debridement Using an Expandable Channel Combined With Posterior Percutaneous Internal Fixation and Traditional Anterior-Posterior Surgery for Single-Segment Lumbar Tuberculosis.",
        "abstract": "Lumbar tuberculosis cause spinal instability neurological deficits often requiring surgery Traditional anteriorposterior surgery effective highly invasive leading greater trauma longer recovery Minimally invasive techniques oblique lumbar debridement posterior percutaneous fixation may reduce surgical damage improve recovery However efficacy remains unclear study compare minimally invasive approach conventional surgery assess feasibility alternative treatment retrospective analysis conducted 156 patient diagnosed singlesegment lumbar tuberculosis July 2016 October 2019 Patients divided minimally invasive group Min group n  76 treated oblique lumbar approach combined Posterior Percutaneous Pedicle Screw Fixation PPPSF conventional Open group n  80 patient received standard antituberculosis therapy isoniazid rifampicin pyrazinamide ethambutol least two week preoperatively continued 1012 month postoperatively adjusted based drug sensitivity testing Nutritional support bracing three month postsurgery also provided Surgical postoperative metric evaluated including operative time intraoperative blood loss length abdominal incision postoperative drainage volume postoperative hospital stay Functional outcome assessed using visual analogue scale VAS oswestry disability index ODI serology marker erythrocyte sedimentation rate ESR Creactive protein CRP creatine phosphokinase CPK level measured Radiographic parameters including Cobb angle sagittal vertical axis SVA also evaluated Postoperative complication also documented Min group demonstrated significantly shorter operation time smaller incisions reduced blood loss shorter hospital stays lower postoperative drainage CPK level compared conventional Open group ipi  005 significant difference VAS ODI ESR CRP level two group different time surgery ipi  005 Radiographic assessment revealed significant difference Cobb angle SVA postoperative time point ipi  005 However Min group exhibited significantly higher rate Grade 1 spinal fusion 59 vs 38 cases ipi  005 Although postoperative complication lower Min group 145 vs 188 difference statistically significant ipi  0474 Oblique lumbar debridement PPPSF represents viable alternative traditional anteriorposterior surgery singlesegment lumbar tuberculosis offering reduced surgical trauma accelerated postoperative recovery",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40820626/"
    },
    {
        "pmid": "40820206",
        "title": "Heterologous expression of the M. abscessus CBASS system confers phage TM4 resistance in M. smegmatis.",
        "abstract": "Phage therapy multidrugresistant Mycobacterium abscessus constrained narrow lytic spectrum phage due unknown antiphage mechanisms Bacteria deploy various defense strategy prevent phage infection comprehensively characterized mycobacteria Mycobacteriophage TM4 successfully delivers DNA M abscessus fails establish infection Bioinformatic analysis predicted three candidate phage defense system multiple individual putative defense protein M abscessus Among them Mab2091 Mab2092 Mab2093 designated CmaABC component cyclic oligonucleotidebased antiphage signaling system CBASS preventing TM4 infection However inability TM4 form plaque even CBASSdeficient M abscessus implies involvement additional resistance mechanisms finding underscore challenge faced mycobacteriophages infecting M abscessus highlight complex interaction pathogen viral adversaries",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40820206/"
    },
    {
        "pmid": "40820129",
        "title": "A multilevel analysis on spatiotemporal and individual-level determinants of tuberculosis treatment failure in China.",
        "abstract": "exploring factor influence treatment failure tuberculosis study aimed provide reference treatment management tuberculosis study data derived National Tuberculosis Specialized Reporting System Univariate analysis used test individual characteristic variable related tuberculosis treatment failure threelevel model conducted estimate risk tuberculosis treatment failure temporal spatial levels well individual level Analysis revealed demographic characteristics older age 50 year above male sex independent risk factor tuberculosis treatment failure Among diagnostic treatment factors type tuberculosis diagnosis contributed treatment failure followed positive result Mycobacterium tuberculosis detection history previous drug therapy treatment delay one month excluding effect individual factors also spatiotemporal effect treatment failure Besides effect individual factors macro factor socioeconomic development level quality tuberculosis management might also play important role treatment failure study spatiotemporal effect provided reference objectively evaluating quality work different regions",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40820129/"
    },
    {
        "pmid": "40819079",
        "title": "Impact of an optimized care model for advanced HIV disease: a non-randomized cluster study in Malawi.",
        "abstract": "Despite significant advance HIV diagnosis access ART many patient still present advanced HIV disease AHD assessed effect optimized AHD care package screening diagnosis opportunistic disease among client enrolled AHD care nonrandomized cluster design conducted using hubandspoke model Twentytwo health facilities including hub facility eight hub sites associated spoke facility 14 spoke sites purposively selected intervention site IS across three district Malawi optimized AHD package implemented included enhanced CD4 testing tuberculosis TB cryptococcal antigen CrAg screening appropriate treatment opportunistic disease delivered hubandspoke model Thirteen nonintervention site NIS five hub eight spoke sites chosen four district implement intervention matched based ruralurban setting health facility types abstracted individuallevel data routine clinical record client meeting World Health Organizations definition AHD June December 2021 963 patient AHD 574 seen IS 426 NIS showed higher proportion AHD client identified 443 vs 368 p  0020 increased screening child five year old 71 vs 27 p  0004 Additionally diagnosed case stage 3 4 disease 476 vs 405 P  0029 Patients seen significantly likely receive TB symptom screening Adjusted Relative Risk ARR 113 95 Confidence Interval CI 106121 urine lateral flow lipoarabinomannan test administration ARR 194 95 CI 118320 TB diagnosis ARR 264 95 CI 147475 Screening neurological sign also improved ARR 107 95 CI 102113 diagnosis cryptococcal meningitis ARR 428 95 CI 1581170 compared NIS difference retention mortality care patient twelve month followup NIS study underscore vital role improving screening diagnostic effort advanced HIV disease AHD notably targeting AHDrelated opportunistic infections including TB Cryptococcal diseases Word count 4832 words excluding references",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40819079/"
    },
    {
        "pmid": "40817574",
        "title": "Successful Treatment of Multidrug-Resistant Tuberculous Meningitis in a Young Chinese Woman: A Case Study From Japan.",
        "abstract": "BACKGROUND Multidrugresistant tuberculosis MDRTB continues pose serious public health challenge especially associated tuberculous meningitis TBM complicates treatment due need central nervous system CNS penetration nonoral administration routes case report describes 24yearold woman MDR pulmonary tuberculosis tuberculous meningitis TBM successfully treated combination pyrazinamide levofloxacin cycloserine linezolid CASE REPORT previously healthy 24yearold woman Jilin Province China presented fever headache impaired consciousness Chest computed tomography CT showed centrilobular nodule treeinbud appearances magnetic resonance imaging MRI revealed basal meningeal enhancement tuberculomas Acidfast bacillus AFB detected smear microscopy cerebrospinal fluid CSF culture confirmed Mycobacterium tuberculosis Drug susceptibility testing confirmed MDRTB Due impaired consciousness treatment regimen selected based CNS penetration enteral administration compatibility combination pyrazinamide levofloxacin cycloserine linezolid administered 18 months Bedaquiline pretomanid used due insufficient CNS penetration data time limited availability Japan patient required prolonged mechanical ventilation discharged minimally conscious state 541 days CONCLUSIONS case highlight importance individualized drug selection MDRTB CNS involvement managing tuberculosis especially lowincidence countries epidemiological background patients country origin also considered Early diagnosis appropriate drug selection critical patients survival despite severe neurological sequelae",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40817574/"
    },
    {
        "pmid": "40817073",
        "title": "ACTG A5409 (RAD-TB): Study protocol for a phase 2 randomized, adaptive, dose-ranging, open-label trial of novel regimens for the treatment of pulmonary tuberculosis.",
        "abstract": "standard care SOC treatment drugsusceptible pulmonary tuberculosis DSTB consists isoniazid rifampicin pyrazinamide ethambutol HRZE New treatment regimen option DSTB needed HRZE long duration 6 months associated frequent adverse events unforgiving adherence lapses complicated rifamycinbased drugdrug interactions recent resurgence TB drug development particularly context drugresistant TB offer promise additional regimen person DSTB provided sufficiently effective welltolerated spotlight wave 1 RADTB platform trial ACTG A5409 NCT06192160 investigate new chemical entity treatment DSTB wave 1 RADTB platform adult participant initiating treatment DSTB randomized SOC HRZE Arm 1 one five experimental arm 8week intensive phase experimental treatment arm consist bedaquiline pretomanid backbone BPa combination one three oxazolidinones Arm 2 study linezolid BPaL dose 600 mg daily Arms 3A 3B study TBI223 1200 mg 2400 mg daily respectively Arms 4A 4B study sutezolid 800 mg 1600 mg daily respectively primary efficacy objective compare sputum culture time positivity TTP slope first 6 week treatment experimental treatment arm SOC primary safety objective compare new Grade 3 higher adverse event first 8 week treatment experimental treatment arm SOC intensive phase participant receive standard isoniazid rifampicin HR continuation phase 18 weeks Participants followed 52 week TB treatment initiation assess longterm outcomes Wave 1 RADTB platform aim identify optimal oxazolidinones regard efficacy safety combine BPa backbone treatment DSTB Subsequent wave platform trial may add fourth drug regimen study new diarylquinolines substitute bedaquiline study novel agent TB drug classes ClinicalTrialsgov NCT06192160  Registered January 5 2024",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40817073/"
    },
    {
        "pmid": "40816540",
        "title": "Characteristics and in-hospital outcomes of clinically diagnosed tuberculosis patients in a high-burden setting: A five-year retrospective analysis.",
        "abstract": "2016 National TB Prevalence Survey revealed TB prevalence 25 time higher routine surveillance indicated half patient receiving treatment missing national registry Clinically diagnosed tuberculosis CDTB duly recognized national TB guideline microbiological confirmation unattainable remains understudied despite relevance TB diagnostic surveillance program retrospective study analyzed 1187 hospitalized CDTB patient 20152019 Philippine tertiary hospital Statistical analysis identified mortality predictor via binary logistic regression p  005 significant Patients mean age 472 ± 173 years 70  male faced significant resource constraints 73  received GeneXpert testing 527  extrapulmonary TB case lacked required imaging Advancing age reduced improvement likelihood OR  09889year 95  CI 0981509963 p  0003 Pulmonary TB decreased improvement odds 60  OR  040 95  CI 023068 p  0001 Respiratory failure depicts disease severity patient supplemental oxygen OR  060 95  CI 040089 p  0011 mechanical ventilation OR  014 95  CI 008025 p  0001 reduced improvement 40  86  respectively Conversely incentive spirometry OR  359 95  CI 1191086 p  0024 surgical intervention OR  310 95  CI 184523 p  0001 tripled improvement odds Age pulmonary TB respiratory failure predict mortality hospitalized CDTB patients Incentive spirometry surgery significantly improve outcomes Findings provide input Philippine Acceleration Action Plan TB PAAPTB 20232035 scale pulmonary rehabilitation surgical pathways address diagnostic gap imaging GeneXpert integrate screening povertyalleviation program DSWD4Ps",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40816540/"
    },
    {
        "pmid": "40815535",
        "title": "Undetectable HIV-1 viral load among virally suppressed people living with HIV: implications for Undetectable equals Untransmittable (U=U) in resource-limited settings using dried spot testing.",
        "abstract": "UndetectableUntransmittable UU campaign grounded strong scientific evidence affirms people living HIV PLHIV undetectable viral load VL defined ≤50 copy per milliliter cmL 200 cmL HIV RNA transmit HIV sexual partners resourcelimited settings VL commonly measured using dried blood spot DBS testing higher limit detection 5501000 cmL report proportion PLHIV VL 1000 cmL also VL 200 cmL ≤50 cmL inform interpretation DBS VL result UU analyzed data 13 crosssectional nationally representative survey 20152019 including PLHIV aged 1559 year receiving antiretroviral therapy ART valid plasma VL results estimated proportion participant VL 200 cmL ≤50 cmL among VL 1000 cmL overall among ART ≥12 month using survey weights Among 16533 PLHIV across 13 countries 873 VL 1000 cmL PLHIV VL 1000 cmL 954 VL 200 cmL 849 VL ≤50 cmL Among ART ≥12 months 966 VL 200 cmL 874 VL ≤50 cml PLHIV VL 1000 cmL VL 200 cmL ≤50 cmL indicating risk sexual HIV transmission finding provide evidence setting relying DBS VL testing PLHIV VL 1000 cmL likely fall 200 cmL undetectable based assays lower limit detection",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40815535/"
    },
    {
        "pmid": "40814737",
        "title": "Silver-loaded hollow copper sulfide particles for antibacterial therapy.",
        "abstract": "misuse antibiotic accelerated spread antibiotic resistance AR making major global health threat Drugresistant bacteria iMycobacterium tuberculosisi iM tbi iStaphylococcus aureusi iS aureusi iEscherichia colii iE colii iPseudomonas aeruginosai iP aeruginosai continue cause severe infection worldwide underscore need alternative antibacterial strategies Photothermal therapy PTT appealing antibacterial approach excellent biocompatibility ability overcome AR however effectiveness often limited heat resistance bacteria study stepwise preparation method employed hollow copper sulfide CuS structure first synthesized using templating method followed reduction silver nanoparticles Ag NPs surface obtain CuSAg hybrid nanostructure iIn vitroi iBacillus CalmetteGuérini BCG selected model iM tbi antibacterial activity testing Briefly BCG treated 002 mg mLsup1sup CuSAg followed exposure 808 nm laser irradiation 6 minutes incubated 37 °C 24 hours achieving antibacterial rate 948 Additionally iE colii iS aureusi subjected condition incubated 37 °C 1 hour achieving antibacterial rate 335 494 respectively high 102 mg mLsup1sup concentration CuSAg exhibited 100 antibacterial efficacy BCG iE colii iS aureusi iP aeruginosai Overall result demonstrate CuSAg effectively combine controllable photothermal therapeutic property CuS antibacterial activity Ag nanoparticles resulting potent antimycobacterial broadspectrum antibacterial effects",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814737/"
    },
    {
        "pmid": "40814508",
        "title": "Comparative analysis of tuberculosis drug consumption data in public and private sectors across selected districts of Madhya Pradesh.",
        "abstract": "study aimed compare drug consumption rate public private healthcare sector 2018 2022 Tikamgarh Datia Niwari district Madhya Pradesh communitybased survey methodology employed alongside analysis program data evaluation antiTB drug sale utilization healthcare sectors Data collected district hospital public private sectors Hospital record pharmacy log reviewed assess antiTB medication consumption rate 2018 2022 Sputum sample patient chest symptom history antiTB treatment tested using XpertRifTrueNat analysis compared drug consumption rate based hospital record calculated according pharmacy sale data mean patient month public sector 10354 months SD  8780 significantly exceeded private sector 4820 months SD  9519 Public sector drug sale varied Tikamgarh declining sharply 38304 patient month 2018 8810 2019 Datia remained stable private sector particularly Datia peaked 30238 patient month 2020 Oneway ANOVA showed significant difference sector patient month iFi  274 iPi  109 Linear regression identified patient month significant predictor calculated patient estimate  016529 iPi  001 Aligning drug consumption pattern across healthcare sector vital effective tuberculosis management Addressing disparity drug consumption rate crucial accurate TB incidence estimates",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814508/"
    },
    {
        "pmid": "40814469",
        "title": "Rare cause of extrapulmonary tuberculosis in an immunocompetent elderly patient.",
        "abstract": "Tubercular hepatic abscess geriatric population rare often misdiagnosed frequently leading delayed presumptive treatment based tissue biopsy findings Early accurate diagnosis using advanced diagnostic tool crucial improving prognosis present case 65yearold immunocompetent male reported threemonth history fever one month right hypochondrial pain Diagnosis tubercular hepatic abscess confirmed using cartridgebased nucleic acid amplification test CBNAAT isolated iMycobacterium tuberculosisi sensitive rifampicin patient treated successfully standard antitubercular regimen Although case tubercular liver abscess documented using CBNAAT direct identification pu sample rare Misidentification abscess bacterial neoplastic often result inappropriate treatment increasing risk mortality case highlight importance early diagnosis prompt initiation appropriate therapy improve outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814469/"
    },
    {
        "pmid": "40814457",
        "title": "Estimate of TB incidence and a critical analysis of programmatic data of TB score from Sub national Certification survey of district Niwari, M.P., India.",
        "abstract": "India accounted 26 global tuberculosis TB burden 2023 27 lakh case reported 89 treatment coverage Madhya Pradesh highburden state reported 28299 case 2023 Government India aim eliminate TB 2025 Strategic National Campaign SNC emphasizing surveillance early diagnosis comprehensive care study evaluates TB management trend Niwari district Madhya Pradesh tribal region 2018 2022 estimate TB incidence validate claim TBfree status SNC surveys analyze TB score trend Niwari district retrospective crosssectional study utilized data National Tuberculosis Elimination Programme NTEP including record District Tuberculosis Officer DTO treatment cards laboratory registers Nikshay portal Seven TB score parameter analyzed notification HIV screening UDST treatment success TB incidence calculated per 100000 population five year 20182022 Ethical clearance obtained TB notification improved 596 833 97 HIV screening 2022 UDST peaked 1125 2020 Treatment success rate ranged 806 876 However Nikshay Poshan Yojana beneficiary payment declined 875 2021 494 2022 TB incidence fluctuated 129 per lakh 2018 143 per lakh 2022 reflecting improved detection postCOVID19 Verified data closely matched reported data 2022 Niwari district made significant progress TB management particularly notification HIV screening challenge persist sustaining financial support addressing operational inefficiencies Continued community engagement advocacy SNC round crucial achieving TB elimination 2025",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814457/"
    },
    {
        "pmid": "40814267",
        "title": "Discovery of Rigid Linker-Based IRAK4 PROTACs with Improved Metabolic Stability for the Treatment of Inflammatory Diseases.",
        "abstract": "Interleukin1 receptorassociated kinase 4 IRAK4 promising therapeutic target inflammatory diseases However solely inhibiting IRAK4 kinase activity fails fully block inflammatory signaling resulting limited efficacy Herein describe design synthesis novel IRAK4 degrader based proteolysistargeting chimera PROTAC strategy preferred compound bFIP22b effectively degraded cellular IRAK4 DCsub50sub 32 nM 115fold higher lead compound bDE5b Mechanistically bFIP22b induces ubiquitinproteasome system forming IRAK4bFIP22bCRBN ternary complex thereby potently blocking IRAK4mediated NFκB MAPK signaling pathways Concurrently bFIP22b demonstrated favorable safety profile excellent metabolic stability eg 180fold longer halflife lead compound bDE5b Furthermore bFIP22b exhibited significant therapeutic efficacy 24dinitrochlorobenzeneinduced atopic dermatitis mouse model summary bFIP22b represents candidate IRAK4 degrader alternative targeting strategy advanced drug development",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814267/"
    },
    {
        "pmid": "40814110",
        "title": "Mid- to short-term efficacy of Uniportal Video-Assisted Thoracoscopic Surgery in the treatment of thoracic spinal tuberculosis.",
        "abstract": "Surgical treatment thoracic spine tuberculosis using traditional procedure often challenged high trauma slow recovery study aimed investigate short mediumterm efficacy safety Uniportal VideoAssisted Thoracoscopic Surgery minimally invasive singleport thoracoscopy combined posterior internal fixation treatment thoracic spinal tuberculosis Nineteen patient thoracic spinal tuberculosis 15 men four women mean age 52 years retrospectively included patient underwent singleport thoracoscopic lesion removal intervertebral implant fusion combined posterior internal fixation Surgical time intraoperative bleeding volume hospitalization time complication recorded rate bone fusion correction kyphosis angle assessed using imaging followup period 612 months patient achieved postoperative bone fusion without serious complications average operative time 14958 min 75212 min average intraoperative bleeding volume 21053 mL 50600 mL average hospital stay 1558 229 d mean thoracic kyphosis angle improved 2333° preoperatively 1900° final followup Singleport thoracoscopic technique combined posterior internal fixation effectively remove thoracic tuberculosis focus correct kyphosis deformity Moreover advantage less trauma quicker recovery significant short mediumterm efficacy making feasible minimally invasive surgical procedure treating thoracic spinal tuberculosis However optimizing instrumentation design expanding sample size future necessary validate longterm effects",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40814110/"
    },
    {
        "pmid": "40812722",
        "title": "Association between Allergic Bronchopulmonary Aspergillosis or Aspergillus sensitization and Tuberculosis: A Systematic Review of 607 cases.",
        "abstract": "Although allergic bronchopulmonary aspergillosis ABPA classically described asthma cystic fibrosis pulmonary tuberculosis PTB posttubercular lung disease PTLD reported likely predisposing factor  however reviewed systematically aimed achieve current systematic review screened available literature PubMed Embase SCOPUS Web Science database study reporting association ABPA PTB beginning time June 30 2023 collated data association ABPA tuberculosis 1176 article identified initial search 60 article 27 original article 33 case reports included final analysis  Four pattern described ABPA patient previous TB 151 249 coexistent ABPA TB 16 26  Aspergillus sensitization patient prior current TB 91 ∼15 ABPA misdiagnosed TB 349 575 significant heterogeneity diagnostic criterion used ABPA andpulmonary TB limited individual data could extractedobservations were 1 Central bronchiectasis 248 cavity 196 fungal ball 109 mucus plughigh attenuation mucus HAM 76 centrilobular nodule 65 common radiographic abnormalities 2 964 received steroids11 received antifungal mostly relapse inadequate response 3 Adequate treatment response noted limited cohort reported ABPA commonly misdiagnosed TB Aspergillus sensitization ABPA develop patient prior TB However significant heterogeneity diagnostic criterion limit generalizability Future welldesigned study required confirm associations",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40812722/"
    },
    {
        "pmid": "40812685",
        "title": "Revolutionizing non-tuberculous mycobacteria research: Advances in molecular diagnostics, phylogenetics, and clinical management.",
        "abstract": "Nontuberculous mycobacteria NTM emerged one significant opportunistic pathogens presenting challenge diagnosis treatment due diverse species intrinsic drug resistance rising global incidence Advanced molecular techniques including nextgeneration sequencing NGS polymerase chain reaction PCR matrixassisted laser desorption ionizationtime flight mass spectrometry MALDITOF MS significantly improved accuracy speed specie identification enabling precise timely diagnosis Phylogenetic study utilizing wholegenome sequencing WGS deepened understanding NTM evolution genetic diversity pathogenicity refining specie classification epidemiological tracking Despite advancements key challenge remain including lack standardized diagnostic criteria prolonged treatment durations emerging antimicrobial resistance Integrating multiomic technologies artificial intelligencedriven diagnostics innovative therapeutic strategy hold great promise overcoming barriers Future research must focus translating molecular discovery clinical application enhance NTM diagnosis treatment surveillance leveraging advancements medical community improve patient outcomes reduce global burden NTM infections advance precision medicine fight challenging pathogens review highlight recent molecular diagnostics phylogenetics clinical management breakthrough transforming NTM research patient care",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40812685/"
    },
    {
        "pmid": "40812596",
        "title": "Pulmonary drug delivery of clofazimine: A route of administration and pharmacokinetics guided repositioning strategy against drug resistant tuberculosis informed by use for other disease indications.",
        "abstract": "Current oral therapeutic regime Clofazimine CFZ tuberculosis treatment limited poor pharmacokinetics long tsub12sub especially exposurerelated systemic toxicity review critically evaluates pulmonary administration targeted delivery approach reduce dose improve therapeutic efficacy primarily antileprotic indication CFZ evolved treatment multidrugresistant tuberculosis MDRTB nontuberculous mycobacterial NTM diseases smallcell lung cancer programmed cell death protein 1 PD1 cytotoxic Tlymphocyteassociated antigen 4 CTLA4 cancer patients Despite broadspectrum activity clinical effectiveness constrained poor physicochemical pharmacokinetic properties Due high lipophilicity orally administered CFZ high volume distribution 1470 L tends accumulate fatty tissues resulting long time reach steady state concentrations subtherapeutic drug level infection site increased risk systemic toxicity triggering drug resistance time Although novel delivery system administered oral route also explored extensively inadequate address concern sustained systemic exposure Pulmonary delivery enables direct deposition diseased site provides higher local concentration reduces offtarget effects Poor solubility high lipophilicity principal biopharmaceutical disadvantage CFZ oral formulation development However property advantageous pulmonary delivery facilitating prolonged lung retention reduced dosing frequency review evaluates current advantage challenge CFZ inhalation versus oral formulations discusses pharmacokinetic profiles explores pulmonary macrophage uptake strategy optimize tuberculosis treatment outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40812596/"
    },
    {
        "pmid": "40811999",
        "title": "Mechanisms of bacterial heme uptake and degradation: Diverse strategies for ring opening.",
        "abstract": "Iron acquisition bacterial pathogen critical survival virulence within host Heme represents viable source iron pathogen overcome limited iron availability establish infection past decade several new paradigm bacterial heme degradation identified Herein briefly discus mechanism bacterial pathogen acquire utilize heme particular focus three major class hemedegrading enzymes canonical heme oxygenase HO noncanonical HOs class C radical SAM methyl transferases canonical HO enzyme typified gramnegative pathogen Pseudomonas aeruginosa Neisseriae meningitidis shown structurally mechanistically similar eukaryotic HO enzymes contrast noncanonical HOs grampositive pathogen Staphylococcus aureus Mycobacterium tuberculosis distinct ferredoxinlike structural fold extreme heme ruffling give rise alternate heme metabolites Enteric pathogen E coli O157H7 Vibrio cholera encode hemedependent radical SAM methyl transferase open porphyrin ring oxygenindependent manner essential anoxic environment gut three class hemedegrading enzyme provide advantage survival within host also yielding metabolite play role bacterial adaptation virulence Therefore complete understanding distinct mechanism heme degradation role unique heme metabolite provide platform development antibacterial strategy targeting heme catabolism",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40811999/"
    },
    {
        "pmid": "40809674",
        "title": "Improving tuberculosis infection treatment completion among pregnant and postpartum women.",
        "abstract": "",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40809674/"
    },
    {
        "pmid": "40809215",
        "title": "Synchronous percutaneous microwave ablation combined with percutaneous biopsy for highly suspected malignant pulmonary nodules: a retrospective study.",
        "abstract": "still lack study optimal sequence treatment microwave ablation MWA combined percutaneous biopsy PB treatment highly suspected malignant pulmonary nodule PNs study aimed investigate feasibility safety efficacy computed tomography CTguided simultaneous MWA combined PB treatment highly suspected malignant PNs discus influence sequential order MWA PB treatment outcome January 2021 December 2024 91 patient single highly suspected malignant PNs underwent synchronous MWA combined PB total 56 patient group underwent synchronous MWA followed PB MWAfirst group 35 case group B underwent synchronous PB followed MWA PBfirst group technical success pathologically positive diagnosis rate complications efficacy two group compared difference technical success rate 100 ivsi 971 positive pathologic diagnosis rate 804 ivsi 886 group group B statistically significant P005 common complication included pneumothorax intrapulmonary hemorrhage hemoptysis pleural effusion incidence intrapulmonary hemorrhage significantly lower group group B 196 ivsi 428 P005 median followup time 180 months local control rate 988 complete ablation CA rate 566 Synchronous MWA combined PB safe effective strategy MWA followed PB could reduce impact intrapulmonary hemorrhage ablation outcome alternative treatment highly suspected malignant PN",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40809215/"
    },
    {
        "pmid": "40808947",
        "title": "BCG and beyond: unlocking new frontiers in TB vaccine development.",
        "abstract": "Please confirm Frontiers AI generated AltText accurate visual description Figures Figure Alttext proposal replace figure caption visible article wish make changes kindly provide exact revised AltText would like use ensuring wordcount remains approximately 100 word best accessibility results information AltText found hereWith 10 million new case 16 million death annually tuberculosis TB continues significant worldwide healthburden assist curbing spread TB centuryold BCG liveattenuated vaccine licensed TB vaccine used humans However BCGs limited efficacy poor antigenicity adult evoked need design new vaccine TB limited parameter availability potent antigens consequence imperative study iMycobacterium tuberculosisi iMtbispecific antigen provide stronger immune response included vaccine candidates review aim concentrate progress current vaccinecandidates undergoing preclinical clinicalstudies Moreover pathogen genetics host play essential role finetuning immuneresponse susceptibility TB past 50 years systematic approach treating TB patient overlooked factor like pharmacokinetics immuneresponse treatment duration Henceforth review highlight precision medicineguided approach considering geneticmakeup host immunity could influence clinical management choices consolidated review shed light advancement vaccinecandidates harnessed prophylactic development TB",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40808947/"
    },
    {
        "pmid": "40808944",
        "title": "Experimental validation of cuproptosis-associated molecular signatures and their immunological implications in pulmonary tuberculosis.",
        "abstract": "pathogenic mechanism underlying iMycobacterium tuberculosisi MTB remains elusive posing challenge diagnosis treatment Cuproptosis newly identified mechanism cell death study explores role cuproptosisrelated gene CRGs pulmonary tuberculosis PTB uncover potential diagnostic biomarkers therapeutic targets Differentially expressed gene DEG analysis weighted gene coexpression network analysis WGCNA carried using GSE83456 dataset PTBassociated DEGs intersected CRGs identify PTBrelated CRGs Subsequent analysis included functional enrichment gene interaction proteinprotein interaction PPI network construction Hub CRGs screened via least absolute shrinkage selection operator LASSO regression random forest RF algorithms Diagnostic model subsequently constructed validated association immune cell infiltration pathway identified hub gene evaluated singlesample gene set enrichment analysis ssGSEA CIBERSORT Hub gene expression validated GSE42834 GSE89403 datasets well RTqPCR Western blot WB PTB extrapulmonary tuberculosis EPTB patients GSE89403 dataset gene expression profiling leveraged analyze differential expression hub gene dynamic change treatment Seven PTBrelated CRGs significantly upregulated significantly upregulated among ASPHD2 GK GCH1 identified hub genes gene exhibited high expression level patient PTB EPTB marked reduction observed following treatment Notable alteration immune cell infiltration immune function PTB patient closely related hub genes suggesting activation innate immune response suppression adaptive immune function cuproptosis hub gene ASPHD2 GK GCH1 influence pathogenesis PTB possibly serve novel diagnostic biomarkers therapeutic targets",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40808944/"
    },
    {
        "pmid": "40808635",
        "title": "Studying intrapulmonary pharmacokinetics for tuberculosis treatment: a systematic review of methodology.",
        "abstract": "Drug concentration site disease pulmonary tuberculosis TB remain limitedly available adequate exposure antiTB drug lung required sterilization lesions Intrapulmonary concentration data could benefit TB treatment optimization conducted systematic review identify method used sampling quantifying describing predicting intrapulmonary pharmacokinetics antiTB drug humans Two systematic search strategy conducted database Embase PubMed last searched 18 July 2024 total 253 study identified applied method classified three different categories i sampling techniques ii quantitative analysis iii modelling methods type pulmonary disease included search Sputum sampling reported sampling method nine studies tissue biopsy 51 bronchoalveolar lavage 115 bronchoscopic microsampling eight bronchoabsorption one microdialysis 12 studies LCMSMS gold standard drug quantification biological samples used 67 studies quantification method included positron emission tomography reported 12 study matrixassisted laser desorption ionization mass spectrometry lung tissue three studies prediction description preclinical intrapulmonary concentration data population pharmacokinetic modelling reported 32 study physiologically based pharmacokinetic modelling 35 studies Many identified method associated considerable limitation including invasiveness complexity cost lack standardization importantly method choice must provide adequate representation site disease pharmacokinetics Determining best approach studying intrapulmonary pharmacokinetics involves careful consideration factors",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40808635/"
    },
    {
        "pmid": "40808616",
        "title": "Ti<sub>3</sub>C<sub>2</sub>O<sub>2</sub> MXene as a dual-action modulator of inflammatory and tuberculosis signaling: structural and <i>in vitro</i> insights.",
        "abstract": "growing threat antimicrobial resistance tuberculosis TB necessitates innovative therapeutic capable modulating infection host immune responses study report dual antitubercular antiinflammatory activity oxygenfunctionalized Tisub3subCsub2subOsub2sub MXene twodimensional nanomaterial synthesized iviai selective HF etching Tisub3subAlCsub2sub followed ethanolassisted delamination Structural characterization XRD Raman spectroscopy confirmed successful conversion MXene phase increased interlayer spacing 987 Å SEM TEM analysis revealed uniform sheetlike morphology AFM confirmed fewlayer thickness ∼15 nm Biological assay using lipopolysaccharide LPSstimulated murine macrophage cell line RAW 2647 macrophage demonstrated significant downregulation proinflammatory mediators inducible nitric oxide synthase iNOS Tumor necrosis factor TNFα Interleukin6 IL6with ICsub50sub value 232 261 216 μg mLsup1sup respectively Western blot analysis validated suppression inflammatory pathway protein level parallel Tisub3subCsub2subOsub2sub exhibited robust antitubercular activity iMycobacterium tuberculosisi H37Rv achieving complete inhibition 40 μg mLsup1sup Computational study revealed strong specific interaction Tisub3subCsub2subOsub2sub TB inflammatory target protein PDB ID 5V3Y forming stable hydrogen bond His185 Gln186 Asp219 Molecular dynamic simulation 3000 n confirmed highly stable proteinMXene complex RMSD 241 Å ΔiGisubbindsub 7854 kcal molsup1sup Comparative simulation streptomycin revealed weaker binding greater structural fluctuation ADMET prediction suggested favorable pharmacokinetic properties including high volume distribution low toxicity absence major cytochrome P450 cardiotoxic liabilities finding establish Tisub3subCsub2subOsub2sub MXene promising nanoplatform dualfunction immunomodulation antimicrobial therapy offering mechanistic structural insight bioactivity",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40808616/"
    },
    {
        "pmid": "40807063",
        "title": "The Role of Obstructive Sleep Apnea in Pulmonary Hypertension Associated with Lung Diseases (Group 3 Pulmonary Hypertension): A Narrative Review.",
        "abstract": "Obstructive sleep apnea OSA could increase pulmonary artery pressure However clinical consequence vary mainly depending comorbidities Patients pulmonary hypertension associated lung disease World Health Organization WHO Group 3 pulmonary hypertension particularly vulnerable increase pulmonary artery pressure Managing pulmonary hypertension specific patient population present considerable challenge positive airway pressure therapy OSA shown promise improving pulmonary hemodynamics patient obesity hypoventilation syndrome chronic obstructive pulmonary disease evidence lacking similar improvement pulmonary disease hypoventilation disorders Furthermore pulmonaryarteryspecific therapy may carry risk clinical worsening group Weight management new pharmacotherapy together emerged crucial intervention demonstrating benefit OSA pulmonary hemodynamics reviewed key study provide insight influence OSA Group 3 pulmonary hypertension clinical management conditions",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40807063/"
    },
    {
        "pmid": "40806949",
        "title": "Elevated Serum TNF-α/IL-1β Levels and Under-Nutrition Predict Early Mortality and Hospital Stay Burden in Pulmonary Tuberculosis.",
        "abstract": "bBackgroundObjectivesb Romania remains tuberculosis TB hotspot European Union yet hostderived factor poor outcome poorly characterised quantified circulating proinflammatory cytokine examined interplay behavioural risk factors nutritional status clinical course adult hospitalised pulmonary TB analysed 80 adult microbiologically confirmed pulmonary TB 40 respiratory symptom controls four TB patient 5 died hospitalisation within 10 day admission bMethodsb retrospective analytical casecontrol study conducted Constanța regional TB referral centre October 2020October 2023 Patients smear cultureconfirmed TB frequencymatched sex 10year age band BMI class culturenegative respiratory control 21 ratio patients serum interferonγ IFNγ interleukin1α IL1α interleukin1β IL1β tumournecrosisfactorα TNFα quantified within 24 h admission neutrophillymphocyte ratio NLR extracted full blood counts Independent predictor inhospital mortality identified multivariable logistic regression factor associated length stay LOS modelled quasiPoisson regression bResultsb median TNFα 241 pg mLsup1sup vs 162 pg mLsup1sup ipi  0009 IL1β 534 pg mLsup1sup vs 367 pg mLsup1sup ipi  0008 significantly higher TB case controls TNFα strongly correlated IL1β ρ  080 ipi  0001 NLR showed weak concordance multiplex cytokine patterns Among patient TB four early death 5 exhibited tripling TNFα 714 pg mLsup1sup doubling NLR 78 compared survivors 10 pg mLsup1sup rise TNFα independently increased odds inhospital death 18fold 95 CI 1130 ipi  002 LOS median 29 days unrelated smoking alcohol comorbidity load varied across BMI strata underweight 27 days normal weight 30 days overweight 23 day KruskalWallis ipi  003 multivariable analysis undernutrition BMI  185 kg msup2sup prolonged LOS 19 IRR 119 95 CI 105134 ipi  0004 independently disease severity bConclusionsb hyperTNFαIL1β systemic signature correlate early mortality Romanian pulmonary TB undernutrition dominant modifiable determinant prolonged hospitalisation Admission algorithm pair rapid TNFα testing systematic nutritional assessment could enable targeted hostdirected therapy trial optimise bed utilisation highburden settings",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40806949/"
    },
    {
        "pmid": "40806905",
        "title": "Willingness to Become a Living Kidney Donor to a Stranger Among Polish Health Care Professionals Employed in a Dialysis Center: A National Cross-Sectional Study.",
        "abstract": "bBackgroundb Kidney transplantation living donor considered beneficial form treatment endstage renal failure which addition providing patient better treatment results significantly improves quality life Understanding factor influence willingness donate kidney stranger critical promoting expanding living donor pool considering decision become altruistic kidney donor individual must evaluate multiple factors including identity recipient perceived level safety study aimed assess willingness dialysis center employee act living kidney donor stranger bMethodsb conducted crosssectional study February 2023 June 2024 among dialysis specialist across Poland study involved 1093 people doctors nurses study used survey questionnaire standardized tools bResultsb Nurses vs physicians advocated regulation unspecified living kidney donation Poland believe risk organ trafficking would donate kidney husbandwife friend accept kidney transplantation husbandwife likely donate kidney stranger Furthermore respondent accepted loved ones decision donate kidney stranger significantly willing donate kidney person themselves Perceived selfefficacy positively associated willingness donate kidney stranger bConclusionsb Less half healthcare professional supported unspecific living organ donation Poland nurse willing donate physicians factor supporting decision generally included knowledge organ donation transplantation lack fear organ trafficking attitude towards donation",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40806905/"
    },
    {
        "pmid": "40806803",
        "title": "Evaluating Secukinumab as Treatment for Axial Spondyloarthritis and Psoriatic Arthritis in Patients with Comorbidities: Multicenter Real-Life Experience.",
        "abstract": "bBackgroundb Secukinumab fully human monoclonal antibody target interleukin IL17A used treat axial spondyloarthritis axSpA psoriatic arthritis PsA Treating axSpA PsA challenging patient comorbidities multicenter retrospective study aimed evaluate efficacy safety secukinumab treatment patient axSpA PsA history tuberculosis multiple sclerosis MS congestive heart failure CHF bMethodsb study included 44 patient diagnosis axSpA PsA history tuberculosis MS CHF received secukinumab treatment 13 center country Erythrocyte sedimentation rate Creactive protein CRP Bath Ankylosing Spondylitis Disease Activity Index Ankylosing Spondylitis Disease Activity Score CRP visual analog scale Disease Activity Score28 CRP marker month 0 3 12 secukinumab treatment analyzed Alongside this tuberculosis MS CHF evaluated followup using clinical assessment imaging method chest radiographs brain magnetic resonance echocardiography bResultsb statistically significant improvement inflammatory marker disease activity score observed patient treated secukinumab reactivation patient history tuberculosis MS patients disease stable clinical radiological improvement observed one patient worsening CHF stage observed patient history CHF bConclusionsb regular clinical monitoring secukinumab may effective safe treatment option axSpA PsA patient history tuberculosis MS CHF",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40806803/"
    },
    {
        "pmid": "40805879",
        "title": "A Systematic Review of Tuberculosis Stigma Reduction Interventions.",
        "abstract": "Stigma associated tuberculosis TB continues undermine patient wellbeing treatment adherence public health goal objectives study aim systematically review literature identify synthesize TB stigma reduction intervention published 2015 2025 Following PRISMA guidelines conducted comprehensive literature search across PubMed Scopus Science Direct ProQuest Google Scholar Eligible study included qualitative quantitative mixedmethods design focused intervention related TBrelated stigma categorized study three groups 1 intervention development studies 2 TB treatment program stigma reduction outcomes 3 stigmaspecific interventions Data extraction quality appraisal conducted independently two reviewer using Mixed Methods Appraisal Tool MMAT total 15 study met inclusion criteria Five study focused codeveloping stigma interventions incorporated multilevel multicomponent strategy targeting internalized enacted anticipated intersectional stigma Two study assessed TB treatmentrelated intervention eg homebased care digital adherence tools incidental stigma reduction effects remaining seven study implemented stigmatargeted interventions including educational programs videobased therapy peerled support antiselfstigma toolkits Interventions addressed stigma across individual interpersonal institutional community policy levels review highlight evolution diversification TB stigma intervention past decade earlier intervention emphasized education support recent strategy increasingly integrate peer leadership digital platforms socioecological frameworks finding underscore need comprehensive contextually grounded intervention reflect lived experience people affected TB",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40805879/"
    },
    {
        "pmid": "40805128",
        "title": "Incidence and Clinical Features of Pseudoprogression in Brain Metastases After Immune-Checkpoint Inhibitor Therapy: A Retrospective Study.",
        "abstract": "bBackgroundb Pseudoprogression known occur immunecheckpoint inhibitor ICI therapy brain metastasis complicate clinical decisionmaking Still incidence timing clinical presentation remain unclear retrospective cohort study melanoma nonsmall cell lung cancer brain metastasis patient conducted address this bMaterials Methodsb Brain metastasis patient showing progression MRI according response assessment neurooncology brain metastasis criterion starting ICI therapy included irrespective prior irradiation Lesions classified tumour progression TP pseudoprogression based threemonth radiological followup histopathology TP assigned progression shown three months Pseudoprogression assigned lesion showed stability partial complete response three months Nonclassified lesion new changed treatment followup bResultsb cohort 98 patient 233 lesion included 13year period 170 lesion considered nonclassified 41 22 lesion classified TP pseudoprogression respectively resulted lesion patientspecific incidence pseudoprogression 94 173 respectively Due large number lesion could classified case clinical practice reported incidence study likely underestimation seen minimum incidence rate Ten pseudoprogression 455 13 317 TP lesion previously irradiated Pseudoprogression occurred median 27 month starting ICI therapy clinical feature distinguishing patient TP pseudoprogression TP patient likely need dexamethasone neurological symptoms bConclusionsb Pseudoprogression lesionspecific incidence rate least 94 occurs median 27 month starting ICI therapy Severe neurological symptom requiring dexamethasone may clinical feature typical TP",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40805128/"
    },
    {
        "pmid": "40803739",
        "title": "ThiPhiSA: new pathways to TB prevention from community screening - a household-randomised controlled trial in KwaZulu-Natal, South Africa.",
        "abstract": "Tuberculosis TB remains leading cause infectious disease deaths particularly among people living HIV PWH Despite preventable TB preventive therapy TPT uptake low highburden region like South Africa new guideline expanded TPT eligibility introduced shorter effective regimen like 3 month weekly rifapentine isoniazid 3HP differentiated service delivery model HIV care proven effective increasing recognition decentralising TPT delivery may improve coverage completion study explores whether communitybased TPT delivery strategy enhance uptake completion TPT compared traditional clinicbased services conduct householdrandomised nonblinded controlled trial Persons eligible TPT recruited TB TRIAGETrial study communitybased household TB screening study Households containing least one person eligible TPT randomised 11 either communitybased TPT standardofcare clinic referral TPT enrolment participant provided 2week supply TPT community Participants randomised community arm receive entire course TPT single dispense 12 week 3HP 6 month isoniazid 3HP contraindicated Clinicarm participant referred local clinic remainder course TPT collect TPT refill clinicdetermined schedule primary outcome proportion participant complete course TPT Secondary outcome include overall adherence TPT predictor adherence TPT participant satisfaction assigned TPT delivery method adverse events study tool approved Human Sciences Research Councils Research Ethics Committee approval number 2251023 based Pretoria Gauteng South Africa well University Washington Institutional Review Board Study 00018448 Study finding shared community advisory group local stakeholder meetings relevant international local meetingsconferences peerreviewed publications NCT06214910 Date version 30 30 July 2024",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40803739/"
    },
    {
        "pmid": "40803725",
        "title": "Patient-cost studies on self-administered treatment (SAT) for drug-sensitive tuberculosis compared to facility-based directly observed treatment, short-course (DOTS): a protocol for a systematic review.",
        "abstract": "Many patient tuberculosis TB suffer huge economic burden even though TB service often provided free charge point care Costs create significant barriers hindering patients access TB treatment cost include direct medical cost such consultation fees direct nonmedical cost such transportation costs indirect cost such wage foregone systematic review aim synthesise best available evidence economic evaluation patientcost study selfadministered treatment SAT drugsensitive TB compared facilitybased directly observed treatment shortcourse FB DOTS globally conduct systematic review following Preferred Reporting Items Systematic Review MetaAnalysis Protocols guideline search PubMed Academic Search Complete Scopus CINAHL Plus EBSCO Google Scholar article published 2025 without date restrictions Eligible study must full partial cost analysis without effectiveness data economic evaluation conducted globally comparing SAT FB DOTS regarding TB patient costs Grey literature included Exclusion criterion include study reporting patient cost SAT FB DOTS noneconomic evaluation nonoriginal research Two independent reviewer conduct screening data extraction quality assessment quality assessment performed using Consolidated Health Economic Evaluation Reporting Standards statement Consensus Health Economic Criteria checklist ROBINSI tool Ethics approval required systematic review use individual patient data Instead use publicly available economic evaluation research studies Findings presented international national conference published openaccess peerreviewed journals CRD42024591221",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40803725/"
    },
    {
        "pmid": "40803711",
        "title": "Effects of Communication Strategies on Treatment Adherence and Success in Tuberculosis: A Systematic Review and Meta-Analysis.",
        "abstract": "Tuberculosis although curable present challenge related treatment adherence compromise treatment effectiveness Individual social structural barrier interfere patients ability properly follow therapeutic regimen thereby impacting treatment outcomes Given limitation conventional healthcare model relies primarily inperson consultation standard treatment protocol without additional adherence support technologies new approach explored improve patient outcomes study seek identify effective communication approach context identify effective communication strategy optimise treatment adherence improve therapeutic success patient diagnosed tuberculosis systematic review metaanalysis conducted included study available MEDLINE via PubMed EMBASE SCOPUS databases publication date January 2005 December 2024 primary outcome adherence success tuberculosis treatment systematic review included 17 study tuberculosis treatment adherence these 12 included metaanalysis adherence 8 treatment success effective strategy adherence community education 2 studies RR 025 95 CI 011056 video observed therapy VDOT 2 studies RR 029 95 CI 021040 combination electronic device SMS also showed positive result 3 studies RR 053 95 CI 037077 SMS alone 5 studies electronic device alone 3 studies effective treatment success combination electronic device SMS RR 031 95 CI 017055 community education RR 051 95 CI 040064 effective combination electronic device SMS community education effective strategy improving adherence therapeutic success tuberculosis treatment Isolated intervention SMS electronic technology show significant results Adapting approach local reality crucial optimising outcomes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40803711/"
    },
    {
        "pmid": "40803230",
        "title": "The repurposed STAT3 inhibitor pyrimethamine controls mycobacterial infection-induced vascular permeability and mycobacterial burden.",
        "abstract": "Infectioninduced vascular pathology side effect immune response contact range pathogens Mycobacteria including Mycobacterium tuberculosis particularly adept coopting vascular leakiness survival mechanism shape host immune response impede delivery antibiotic site infection using zebrafishMycobacterium marinum infection model confirm critical role Signal transducer activator transcription 3 STAT3 mediating infectioninduced vascular permeability demonstrate ability FDAapproved drug atovaquone Mepron pyrimethamine Daraprim restore vascular barrier function without compromising innate immune control mycobacterial infection find additional antibiotic effect pyrimethamine M marinum M tuberculosis Together finding suggest pyrimethamine could used adjunctive therapy mycobacterial infection explain protective effect Daraprim prophylaxis tuberculosis diagnosis HIV positive populations",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40803230/"
    },
    {
        "pmid": "40803204",
        "title": "Ultra-sensitive urinary lipoarabinomannan (LAM) immunoassay for tuberculosis detection: a performance evaluation.",
        "abstract": "development rapid nonsputum test remains global priority accelerate Tuberculosis TB diagnosis treatment initiation WHOrecommended rapid diagnostic test RDT Alere Determine TB Lipoarabinomannan Ag AlereLAM suboptimal sensitivity laboratorybased electrochemiluminescence LAM assay EclLAM current sensitivity benchmark RDT development gold standard urinary LAM detection assessed diagnostic accuracy ultrasensitive Plasmonic Fluorlinked Immunosorbent LAM assay PFLISALAM compared Sputum Xpert MTBRIF sputum culture urine EclLAM developed evaluated assay performance PFLISALAM Two substudies conducted using banked urine samples 1 Preclinical study using 337 wellcharacterised urine sample cutoff determination initial evaluation performance PFLISALAM compared sputum Xpert MTBRIF culture 2 Diagnostic accuracy assessment study using 77 blinded sample evaluate performance PFLISALAM compared EclLAM versus microbiological reference standard MRS Xpert positive andor culture positive PFLISALAM limit detection LOD 084 ± 09 pgmL detecting purified LAM spiked urine preclinical study optimal assay cutoff determined 17 pgmL sensitivity PFLISALAM sputum Xpert MTBRIF compared culture 51 95 confidence interval CI 4359 62 95 CI 5370 specificity PFLISALAM Xpert MTBRIF 99 95 CI 96100 100 95 CI 100100 Combining PFLISALAM Xpert MTBRIF test data improved sensitivity 76 95 CI 6983 achieved diagnostic study sensitivity EclLAM PFLISALAM assay 42 95 CI 2759 73 95 CI 5685 specificity EclLAM PFLISALAM 95 95 CI 8599 98 95 CI 88100 better analytical diagnostic sensitivity compared EclLAM PFLISALAM better detect urinary LAM TBpositive cases PFLISALAM assay also demonstrated capability increase diagnostic value detecting urinary LAM complementing molecular tests achieving improved diagnostic outcome report external financial support conducting study",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40803204/"
    },
    {
        "pmid": "40802343",
        "title": "Trends and clusters of tuberculosis treatment interruption among people experiencing homelessness in Brazil: influence of individual, social and programmatic factors.",
        "abstract": "analyze temporal trend statelevel cluster tuberculosis treatment interruption indicator among homeless population Brazil ecological study treatment interruption among homeless people tuberculosis assessed 2015 2023 Joinpoint regression used trend analysis stratified sociodemographic epidemiological variables State cluster identified kmeans clustering analysis based socioeconomic programmatic indicators Tuberculosis treatment interruption increased among men average quarterly percent change  AQPC015 95 confidence interval  95CI 004029 individual aged 4059 year AQPC038 95CI 025053 tobacco user AQPC072 95CI 061082 beneficiary social program AQPC459 95CI 369602 without directly observed treatment AQPC049 95CI 039063 without HIV coinfection AQPC038 95CI 030051 North AQPC151 95CI 096221 Midwest AQPC083 95CI 017159 regions According cluster analysis cluster lowest treatment interruption rate low AIDS incidence better programmatic indicators Cluster B high poverty low level education income strong primary health care performance Cluster C stood higher human development better social indicators lower inequality Cluster concentrated worst outcomes higher treatment interruption greater inequality higher AIDS incidence weaker primary health care Socioeconomic programmatic inequality evident access attachment tuberculosis treatment among people experiencing homelessness Brazil",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40802343/"
    },
    {
        "pmid": "40801004",
        "title": "Molecular identification and antifungal susceptibility testing of <i>Aspergillus</i> species among patients with chronic pulmonary aspergillosis in Nigeria.",
        "abstract": "Triazole resistance iAspergillusi spp therapeutic implication managing chronic pulmonary aspergillosis CPA worldwide However antifungal susceptibility testing AFST routinely performed Nigeria country high CPA burden study aimed confirm identity iAspergillusi spp isolated patient CPA using molecular methods determine antifungal susceptibility profile ascertain phylogenetic relatedness study examined 47 iAspergillusi isolates sputum sample obtained prospective longitudinal study CPA prevalence among 141 consenting symptomatic tuberculosis patient Lagos Nigeria June 2021 May 2022 preliminary phenotypically identified iAspergillusi spp identified amplifying calmodulin gene performing AFST seven antifungal agent using Clinical Laboratory Standard Institute CLSI microdilution method well determining phylogenetic relatedness 51 patient met diagnostic criterion CPA included 30 590 male 21 410 female patient age range 1768 years Thirtysix 710 positive iAspergillusi cultures isolate initially identified phenotypically iA fumigatusi reidentified iA pseudonomiaei Phylogenetic analysis iA fumigatusi iA flavusi isolates suggested absence clonal transmission isolates susceptible tested antifungals Clinical iAspergillusi isolates azolenaïve patient CPA demonstrate triazole resistance Nonetheless AFST required patient longterm azole therapy systematic surveillance clinical environmental isolates recommended detect emergence azoleresistant phenotypes study underscore importance routine surveillance antifungal resistance detect occurrence resistance strain early clinical settings therapeutic implication patient harbouring resistant phenotypes",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40801004/"
    },
    {
        "pmid": "40800027",
        "title": "Geospatial Distribution of Tuberculosis Incidence and Determinants of Tuberculosis Treatment Outcomes in Nzema East Municipality, Ghana.",
        "abstract": "Ghana seen notable rise tuberculosis TB case mired treatment outcomes However evidence suggests disparity incidence TB treatment outcome across country Nzema East Municipality specifically reported 6234 increase TB incidence 2023 compared 2022 study therefore aim determine geospatial distribution TB incidence predictor TB treatment outcome Nzema East Municipality study used retrospective cohort quantitative approach utilising health record 545 TB case 2018 2023 Nzema East Data processed Microsoft Excel analysed using ArcGIS Pro version 332 Joinpoint Regression Programme 520 STATA MP version 17 Morans index 003 ipi  0001 subdistricts least one settlement 226 TB case per square kilometre Significant TB hotspot identified populationdense community mining communities Overall successful TB treatment outcome 7670 significant decline successful TB treatment outcome 2018 end 2020 2023 ipi  003 ipi  0001 respectively least one followup lab aRR  043 95 CI  032 058 treatment supporter aRR  056 95 CI  040 079 lessens risk unsuccessful TB treatment outcome started TB treatment 2020 increase chance unsuccessful outcome aRR  197 95 CI  113 343 TB incidence Nzema East spatially dependent statistically significant higher incidence highly populated mining communities overall successful treatment outcome suboptimal demand targeted intervention mitigate menaces",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40800027/"
    },
    {
        "pmid": "40799963",
        "title": "Sociodemographic and health-related factors associated with viral load non-suppression and body mass index in adults with depression symptoms receiving antiretroviral therapy in South African primary care: secondary analysis of randomised trial data.",
        "abstract": "Unsuppressed viral load antiretroviral therapy ART associated health decline HIV transmission overweight obese increase risk noncommunicable diseases increasing risk multimorbidity people living HIV ART effectiveness obesity shown affected socioeconomic psychological health related factors interrelationship South Africans living HIV well known secondary analysis data randomised controlled trial depression management 2002 adult receiving ART investigated effect sociodemographic characteristics comorbidities depression symptom Patient Health Questionnaire9 PHQ9 functional disability WHODAS20 AIDSrelated stigma ART adherence viral load nonsuppression viral load ≥1000 copiesml body mass index BMI baseline baseline change 12 month later using longitudinal mixed effect logistic linear regression models Potentially confounding covariates selected adjusted using least absolute shrinkage selection operator LASSO inference People viral load nonsuppression baseline likely male younger earn lower income Health characteristic associated viral load nonsuppression baseline previous tuberculosis ART less 6 month 10 years selfreported nonadherence ART Higher disability score ART duration 6 month 10 year baseline associated increasing likelihood viral load nonsuppression 12 month later Higher BMI baseline associated female married earning higher income hypertension history tuberculosis viral load nonsuppression BMI increased baseline followup younger age associated greater increase BMI 12 month later Depression symptom score stigma score associated viral load nonsuppression BMI Viral load nonsuppression associated lower BMI likely due effect HIVrelated illness Viral load nonsuppression BMI associated variety sociodemographic factors viral load nonsuppression also associated disability ART nonadherence finding together indicate subgroup people HIV need improved ART access adherence support Neither outcome associated severity depression symptom selfreported stigma ClinicalTrialsgov  NCT02407691  Pan African Clinical Trials Registry 201504001078347 South African National Clinical Trials Register SANCTR DOH2705155048 NHREC 4048",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40799963/"
    },
    {
        "pmid": "40799900",
        "title": "Laryngeal Tuberculosis Mimicking Laryngeal Carcinoma: A Case Report.",
        "abstract": "Laryngeal tuberculosis LTB rare form extrapulmonary tuberculosis clinically radiologically resemble laryngeal carcinoma leading potential misdiagnosis report case 53yearold man history chronic smoking known tuberculosis BCG vaccination presented progressive dyspnea dysphonia significant weight loss Laryngoscopy revealed ulcerative lesion involving anterior commissure right ventricular strip arytenoid fold epiglottis CT imaging suggested malignancy biopsy confirmed LTB pulmonary involvement patient responded favorably antituberculous therapy nearcomplete resolution two months case highlight diagnostic challenge differentiating LTB malignancy Awareness rare presentation essential especially tuberculosis TBendemic regions avoid unnecessary surgical intervention ensure prompt medical treatment",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40799900/"
    },
    {
        "pmid": "40799783",
        "title": "Stool-Based Molecular Tuberculosis Treatment Monitoring: A Faster Means for Detecting Persistent Mycobacteria Compared to Phenotypic Culture.",
        "abstract": "Tuberculosis TB treatment monitoring hindered lack rapidly measured biomarker accurately predicts clinically relevant outcomes Symptom screening poorly correlate bacillary burden Although culture direct measure viable bacillary burden long turnaround time make clinically irrelevant TB treatment monitoring potential stoolbased quantitative polymerase chain reaction qPCR prospectively assessed among 231 participant age Eswatini Tanzania Mozambique microbiologically confirmed TB Stool qPCR result compared sputum culture persistent symptoms drug resistance World Health Organization TB outcomes Quantitative bacillary burden measured stool qPCR strongly correlated sputum culture baseline Spearman correlation iri subssub  079 iPi  001 Stool successfully collected 90 timepoints sputum collection decreased 50 end therapy Participants isoniazid rifampin resistance demonstrated decreased bacillary clearance sputum culture stool qPCR first 2 week treatment Participants remained culture positive 2 month slower decrease bacillary burden measured stool qPCR compared culture negative 2 months odds participant culture positive 2 month associated lower initial qPCR cycle threshold odds ratio OR 0792 iPi  004 smaller absolute difference qPCR cycle threshold measured 2 week baseline OR 072 iPi  0006 Neither sputum culture sputum Xpert Ultra stool qPCR associated resolution symptom intreatment death Stoolbased TB treatment monitoring correlate sputum culture provides result faster leverage accessible specimen identifies patient TB risk drug resistance persistent 2month culture positivity None quantitative test bacillary burden singularly could predict symptom resolution death",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40799783/"
    },
    {
        "pmid": "40799590",
        "title": "Minimal immune cell subset differences in a cohort of close contacts of tuberculosis index cases.",
        "abstract": "Understanding perturbation immune response across spectrum TB infection still unclear study followed cohort close contact pulmonary TB patient serial QFT testing 0 3 6 12 months stratified six subgroups QFTincreasing lowhigh QFT converter QFT QFT QFT stable QFT individuals Despite distinct QFT trajectories observed minimal difference immune cell frequencies activation profiles helper subset distribution among QFT subgroups suggesting limited immunological stratification based QFT dynamic alone Ex vivo immune phenotyping including analysis CD4 CD8 NKT cell frequencies memory cell subsets activated cell HLADR⁺CD38⁺ failed distinguish QFT subgroups Antigenspecific CD4 cell response assessed activationinduced marker AIM assay elevated QFT compared QFT individuals finding suggest bloodbased immune profiling may capture subtle immunological transition among QFT converter individual increasing QFT responses contrast individual active TB ATB showed clear immune perturbations ATB patient diagnosis exhibited significantly elevated frequency antigenspecific CD4 cells increased activated cells higher frequency intermediate monocyte NK cell compared QFTQFT contacts Many immune feature declined treatment indicating therapyassociated immune resolution Additionally shift helper subset effector memory population observed course treatment result suggest ex vivo immune profiling robustly distinguish active TB nondiseased states lack resolution differentiate QFT subgroup based QFT dynamic alone could reflect either immunological similarity among close contact regardless QFT status limitation bloodbased phenotyping detecting early subclinical immune shifts study highlight challenge immunologically distinguishing QFTdefined subgroup within close contact using conventional ex vivo profiling approaches",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40799590/"
    },
    {
        "pmid": "40799565",
        "title": "Sterilizing activity of spectinamide MBX-4888A when replacing linezolid in the Nix- TB regimen in the relapsing BALB/c mouse model of tuberculosis.",
        "abstract": "Spectinamides garnered interest experimental tuberculosis therapeutic owing safety profile efficacy partner agent used conjunction established regimen mice NixTB regimen bedaquiline pretomanid linezolid represents short effective regimen recommended treatment preextensively drugresistant tuberculosis However linezolid administration associated severe adverse event limit use present preclinical data spectinamide MBX4888A replace linezolid NixTB",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40799565/"
    },
    {
        "pmid": "40799379",
        "title": "Overview of antimicrobial resistance mitigation efforts in Benin 2024.",
        "abstract": "Antimicrobial resistance AMR significant global public health threat undermines sustainable development Benin high AMR rate common antibiotics including lastresort treatments exacerbate infection outcome healthcare costs Inappropriate antibiotic use worsens challenge address issues Benin implemented National Multisectoral AMR Action Plan 20192024 study aim assess implementation Benins National AMR Action Plan 20192024 identify critical gap future updates evaluation covered six Benins 12 departments engaging stakeholder human animal environmental health sectors retrospective crosssectional evaluation performed 05 August 2024 30 September 2024 Data collected documentary review standardised questionnaires semistructured interview group discussions executed scoring grid Strengths Weaknesses Opportunities Threats analysis used 224 planned activities 4018 initiated 3125 started 1964 partially executed 536 nearly completed 357 fully implemented Critical gap included lack fully operational multisectoral coordination group limited financial resources inadequate surveillance systems insufficient communication education initiative absence infection prevention control IPC programmes Despite progress regulatory frameworks gap coordination resources surveillance IPC hinder effective AMR control Benin Strengthening governance communication addressing identified gap critical future success evaluation provides evidencebased recommendation update Benins AMR strategy within One Health framework",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40799379/"
    },
    {
        "pmid": "40799345",
        "title": "Mechanism of the dual action self-potentiating antitubercular drug morphazinamide.",
        "abstract": "Pyrazinamide PZA cornerstone firstline antitubercular drug therapy unique ability kill nongrowing population iMycobacterium tuberculosisi disruption coenzyme CoA metabolism Unlike drugs PZA action conditional requires potentiation hostrelevant environmental stressors low pH nutrient limitation Despite pivotal role tuberculosis therapy durability crucial drug challenged emergent spread drug resistance advance drug discovery efforts characterized activity potent PZA analog morphazinamide MZA Here demonstrate like PZA MZA act part impairment CoA metabolism Unexpectedly find that contrast PZA MZA require potentiation maintains bactericidal activity PZAresistant strain due additional mechanism involving aldehyde release Further find principal mechanism resistance aldehyde component promoter mutation increase expression mycothiol oxidoreductase MscR finding reveal dualaction synergistic mechanism MZA result faster kill rate higher barrier resistance observation provide new insight discovery improved therapeutic approach addressing growing problem drugresistant tuberculosis",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40799345/"
    },
    {
        "pmid": "40797354",
        "title": "Adverse effects of linezolid in the treatment of drug-resistant tuberculosis combined with diabetic peripheral neuropathy.",
        "abstract": "aimed observe adverse effect linezolid nerve conduction velocity patient drugresistant tuberculosis combined diabetic peripheral neuropathy Patients hospitalized hospital March 2018 March 2022 divided drugresistant tuberculosis DRTB group type 2 diabetes peripheral neuropathy DPN group type 2 diabetic peripheral neuropathy combined drugresistant tuberculosis DMDRTB group drugresistant TB treatment regimen used linezolid antituberculous drugs Neurophysiological examination performed patient 2 month treatment conduction velocity superficial peroneal nerve peroneal nerve lower limb three group recorded conduction velocity deep peroneal nerve superficial peroneal nerve common peroneal nerve tibial nerve femoral nerve lower limb motor nerve three group compared statistically analyzed 2 month linezolid treatment sensory nerve conduction velocity superficial peroneal nerve sural nerve lower limb DRTB group DMDRTB group significantly decreased difference statistically significant p  005 significant decrease motor nerve conduction velocity deep peroneal nerve superficial peroneal nerve common peroneal nerve tibial nerve femoral nerve lower limb DRTB DMDRTB groups difference statistically significant p  005 Linezolid slow lower limb sensory nerve conduction velocity patient DRTB DMDRTB however effect lower limb motor nerve significant",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40797354/"
    },
    {
        "pmid": "40797252",
        "title": "Impact of detection rate and preventive treatment of latent tuberculosis infection on the future burden of tuberculosis among students in shanghai: a predictive study using Markov modeling.",
        "abstract": "Students represent key demographic tuberculosis TB control China study utilizes dynamic Markov model forecast epidemiological trend active tuberculosis ATB among student Shanghai 2035 evaluate effectiveness different control strategies Markov model incorporating six distinct state TB transmission utilized simulate disease dynamic within hypothetical cohort 100000 individuals model assessed prevalence latent tuberculosis infection LTBI ATB categorizing case based whether received recommended treatment regimen current measure without additional interventions model projected marginal decline ATB prevalence Specifically ATB prevalence predicted decrease 1480 per 100000 2035 increase tuberculosis preventive treatment TPT coverage 20 50 80 reduction ATB prevalence modest detection rate LTBI fixed 12 combined TPT coverage level 20 50 80 reduction ATB prevalence 1701 3656 5068 respectively Increasing detection rate LTBI 35 alongside TPT coverage 20 50 80 led pronounced decline ATB prevalence 4095 6936 8046 respectively current TB control measures prevalence ATB among student would result marginal decline trajectory 2035 falling substantially short achieving strategic goal ending TB Enhanced strategy simultaneously increase detection rate coverage TPT likely significantly reduce ATB prevalence population online version contains supplementary material available 101186s12889025237509",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40797252/"
    },
    {
        "pmid": "40797224",
        "title": "Ecological drivers of malaria vector habitat and transmission over 1 year of long-lasting insecticidal net intervention in Côte d'Ivoire.",
        "abstract": "Malaria mosquitoborne parasitic disease cause significant morbidity mortality atrisk populations especially child subSaharan Africa Despite reduction malaria burden owing scaleup effective interventions concern longlasting insecticidal net LLIN effect may sustained owing widespread insecticide resistance differential impact LLIN vector species study aimed test effect different LLIN product environmental factor ecological niche three mosquito vector specie using stateoftheart ecological niche modelling approaches study used data cluster randomized control trial took place Tiébissou Central Côte dIvoire Anopheles mosquito density Plasmodium falciparum vector infection data available across 33 clusters used satellite remote sensing related land cover climate topography population density across study area alongside vector specie occurrence data construct ecological niche model An coluzzi An gambiae ss An funestus ss P falciparuminfected vectors baseline 1year postLLIN intervention compared projected habitat habitat determinant species assessed respective contribution intervention arm environmental factor probability specie occurrence Minimal considerable overall reduction suitable habitat across study area observed three mosquito vector specie less 1 60 considerable overall reduction observed P falciparuminfected vector more 50 detect effect intervention arm probability occurrence vector species found strong significant effect combination land cover climate topography andor population density variable three mosquito vector specie malariainfected vectors result suggest environmental factor may facilitated restricted change probability occurrence vector specie infected vector context vector control interventions study highlight wide ecological difference across malaria vector specie support need consider malaria vector specie composition deploying malaria vector control intervention endemic settings",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40797224/"
    },
    {
        "pmid": "40797008",
        "title": "Pyrazolopyridine pyrimidone hybrids as potential DprE1 inhibitors, design, synthesis and biological evaluation as antitubercular agents.",
        "abstract": "Tuberculosis TB remains major global health challenge study present design synthesis evaluation novel pyrazolo34bpyridinepyrimidone derivative targeting Mycobacterium tuberculosis Mtb compound assessed antitubercular activity using Microplate Alamar Blue Assay MABA Mtb H37Rv strain Key derivative 8 14 showed significant activity minimum inhibitory concentration MIC value 312 µgmL 125 µgmL respectively comparable standard drug nontoxic effective concentration antiTB agents Molecular docking study demonstrated strong binding interaction DprE1 MtbDHFR enzymes suggesting inhibition critical proteins computational analyses including density functional theory DFT molecular dynamic simulations confirmed binding stability compound target proteins Overall pyrazolo34bpyridinepyrimidone derivative potential lead development future therapeutic treating drugresistant TB",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40797008/"
    },
    {
        "pmid": "40796011",
        "title": "Systematic investigation of baseline nosocomial transmission of tuberculosis in the Kyrgyz Republic, Central Asia.",
        "abstract": "Controlling tuberculosis TB transmission paramount importance combating TB pandemic Although TB hospital considered hotspot transmission systematic longitudinal study examining underlying incidence possible risk factor nosocomial TB transmission lacking objective study detect nosocomial transmission event 20 month period using whole genome sequencing WGS Mycobacterium tuberculosis complex MTBC isolates collected 563 patient pulmonary TB hospitalized Kyrgyz Republic Whole genome sequencing WGS performed 698 Mycobacterium tuberculosis complex MTBC isolates including 563 first isolates recovered participant within four week hospitalization 135 followup isolates treatment control sample collected least four week apart participants roommate recorded whole study period cohort represented 95 TB patient hospitalized study site followup period 53372 hospitalization days Genomebased cluster analysis revealed 173 563 307 first isolates fell 56 cluster 5 SNPs Two nosocomial TB transmission index case roommate proven addition five potential transmission observed patient shared time room hospital index case identified transmitted strain resistant previous one Withincommunity transmission MTBC highly active Kyrgyzstan 137 per 1000 patient year 95CI 16495 observed markedly higher rate nosocomial transmission reported previous WGSbased studies",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40796011/"
    },
    {
        "pmid": "40796001",
        "title": "Model-based evaluation of the interaction between ritonavir-boosted atazanavir and rifampicin in Ugandan adults with HIV.",
        "abstract": "Concomitant treatment tuberculosis TB human immunodeficiency virus HIV complicated drugdrug interaction DDI analysis aimed characterize DDI ritonavirboosted atazanavir ATVr rifampicin plasma peripheral blood mononuclear cell PBMC DERIVE study NCT04121195 recruited Ugandan adult HIV not TB ATVrbased secondline antiretroviral therapy collected intensive plasma PBMC pharmacokinetic sample four visits i standarddose ATVr 300100 mg QD ii ATVr regimen adding rifampicin 600 mg QD iii doubling ATVr BID rifampicin 600 mg QD iv ATVr 300100 mg BID rifampicin increased 1200 mg QD ATVr plasma PBMC concentration analysed population pharmacokinetic modelling NONMEM Twentysix participant 23 female enrolled median age weight 44 year 67 kg respectively twocompartment model effectcompartment effectively described atazanavir concentration plasma PBMC Rifampicin increased atazanavir clearance threefold decreasing bioavailability absorption rate Doubling dosing frequency ATVr largely mitigated interaction rifampicin restoring proportion simulated participant achieving targeted trough atazanavir concentration 0014 mgL 99 Rifampicin affect ratio atazanavir concentration PBMCs plasma Metabolic induction rifampicin account decrease plasma exposure ATVr Doubling ATVr dosing frequency BID effectively mitigated interaction plasma exposure ATVr mirrored PBMCs suggesting drugs plasma concentration provide reliable reflection siteofaction exposures",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40796001/"
    },
    {
        "pmid": "40795373",
        "title": "Single-cell profiling of blood and cerebrospinal fluid in tuberculous meningitis.",
        "abstract": "Tuberculous meningitis TBM severe form tuberculosis fatality rate 20 50 treated individuals Although corticosteroid therapy increase survival HIVnegative people TBM better antimicrobial hostdirected therapy required improve outcome is therefore need better understand local immunopathologic pathways Despite power identifying diseasespecific cellular profiles singlecell RNA sequencing scRNAseq underutilized cerebral sample brain infection employed scRNAseq analyze fresh pretreatment cerebrospinal fluid CSF 4 TBM patients along paired PBMCs 29 cell subtypes present tissues relative abundance varied significantly particular CSF enriched highly inflammatory microglialike macrophages GZMKCD8 effectormemory TEM cells CD56bright NK cells latter 2 subset exhibited reduced cytotoxicity compared bloodenriched counterparts namely cytotoxic GNLYCD8 TEM CD56dim NK cells respectively Across multiple cell types inflammatory signaling pathway increased oxidative phosphorylation decreased CSF compared PBMCs study highlight value scRNAseq exploring CSF immunopathogenesis TBM patient offer resource future study investigating pathophysiology TBM brain infections including potentially targetable cell population linked immunemediated pathology",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40795373/"
    },
    {
        "pmid": "40795178",
        "title": "Preventing multidrug resistant tuberculosis: the dawn of a new era.",
        "abstract": "Multidrug resistant tuberculosis MDRTB remains global health threat account quarter death due antimicrobial resistance Individuals infected MDRTB risk progressing TB disease Treatment drugresistant TB infection prevent progression disease avert associated morbidity mortality global priority Randomised evidence inform TB preventive treatment guideline lacking Two recently completed trial provide first randomized evidence treatment household contact exposed patient MDRTB daily levofloxacin six month safe efficacious preventing TB Based results World Health Organization updated TB preventive treatment guideline make strong recommendation use levofloxacin six month MDRTB exposed contacts Novel shorter regimen development usher new era treatment MDRTB infection shown safe efficacious",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40795178/"
    },
    {
        "pmid": "40794705",
        "title": "Deriving Dosages for Levofloxacin Tuberculosis Preventive Treatment for Young People Exposed to Rifampicin-Resistant Tuberculosis.",
        "abstract": "Tuberculosis TB leading single bacterial cause death worldwide 2023 approximately 400 000 people developed multidrug rifampicinresistant TB MDRRRTB complicates treatment TB preventive treatment TPT critical strategy prevent progression TB infection TB disease among risk February 2024 based data 2 randomized controlled trials levofloxacin strongly recommended World Health Organization WHO TPT option people age exposed MDRRRTB uncertainty optimal dosing levofloxacin child adolescent using dispersible solid formulations used pharmacokinetic modeling simulation determine best dosing strategy people aged 19 year formulation levofloxacin previously developed population pharmacokinetic model levofloxacin child 02168 years used applied new harmonized weight bands Simulations conducted using demographic data country highest incidence RR MDRTB Two currently available levofloxacin formulation 100 mg pediatric dispersible tablet 250 mg solid tablets considered dosing regimen weight band developed levofloxacin used TPT people aged 019 year exposed MDRRRTB Doses correspond 833 mgkg 100 mg dispersible tablet 1042 mgkg 250 mg solid tablets dos achieve adequate adult target exposure levels Pragmatic weightband dosing strategy help simplify administration MDRRRTB TPT included guidance",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40794705/"
    },
    {
        "pmid": "40794594",
        "title": "Macrophage Response to Avirulent and Virulent Mycobacterium tuberculosis and Anti-TB Effects of Exosome Treatment.",
        "abstract": "Tuberculosis TB returned leading cause death single infectious agent 2023 Humanmacrophages secreted exosomes play important role combating invading Mycobacterium tuberculosis Mtb However panoramic analysis underlying immune mechanism infected macrophages package mechanism antiTB effect Mtb treated exosomes remain understood conducted comprehensive analysis macrophage infected avirulent virulent Mtb H37Ra  H37Rv exosomes omics phenotypic analyses result showed H37Ra stimulated strong immune response apoptosis macrophage eliminate invading Mtb H37Rv induced severe necrosis immune escape survival Interestingly result suggest macrophage kill Mtb interferongamma IFNγ independent simulative way highlighting central role IFN signaling pathway antiTB response Moreover observed selective transport host Mtb RNAs macrophage exosomes Notably H37Ratreated exosomes displayed higher antiTB effect H37Rvtreated exosomes due enriched proinflammation immune escape related Mtb protein two exosomes respectively Conclusively finding shed new light immune mechanism macrophage response Mtb infection offering new TB treatment strategy promising vaccine candidates",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40794594/"
    },
    {
        "pmid": "40794122",
        "title": "Mycobacterium tuberculosis curli pili facilitates pathogenicity by modulating central carbon metabolism.",
        "abstract": "Strategies specifically targeting initial hostpathogen interactions hold great promise identification accurate biomarkers tuberculosis TB prevention interventions Mycobacterium tuberculosis Mtb curli pili MTP encoded mtpRv3312A surface adhesin utilised pathogen interact host receptor cells reported suitable target TB diagnostic therapeutic strategies Previous omics study highlighted role MTP potentially play Mtb central carbon metabolism CCM However precise contribution metabolism remains unknown study aimed examine role MTP bioenergetic metabolism Mtb using bedaquiline BDQ inhibit ATP production oxidative phosphorylation OXPHOS extracellular flux analysis Mtb wildtype WT ∆mtp deletion mutant mtpcomplemented strains role MTP regulation CCM assessed using sup13supCsub6submetabolic flux analysis MTP associated increased bacterial respiration decreased carbon catabolism via glycolysis response inhibition ATP synthase BDQ dependence Mtb Δmtp OXPHOS energy production demonstrated greater WT mtpcomplemented strains addition metabolic flux profile revealed Δmtp mutant CCM dysregulated decreasing flux glycolysis tricarboxylic acid cycle glyoxylate dicarboxylate metabolism pentose phosphate pathway comparison WT novel finding show MTP associated regulation bioenergetics metabolism pathway substantiate MTP potential biomarker TB diagnosticstherapeutics novel target vaccinedrug development",
        "mesh_terms": [
            "Mycobacterium tuberculosis",
            "Carbon",
            "Fimbriae, Bacterial",
            "Oxidative Phosphorylation",
            "Diarylquinolines",
            "Energy Metabolism",
            "Bacterial Proteins",
            "Glycolysis",
            "Adenosine Triphosphate",
            "Tuberculosis"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40794122/"
    },
    {
        "pmid": "40793863",
        "title": "Genetic determinants of <i>Mycobacterium tuberculosis</i> adaptation and drug efficacy during stationary phase growth.",
        "abstract": "adaptation iMycobacterium tuberculosisi Mtb slowly growing nongrowing state growthlimited condition play crucial role drug tolerance Although mechanism Mtb adaptation growthlimited condition extensively studied remains unclear extent cellular process necessary sustain nongrowing state affect drug efficacy investigate this performed genomewide transposon mutant screen allowed parallel identification gene influence bacterial fitness drug efficacy stationary phase analysis revealed gene encoding SOS response membrane phospholipid biosynthesis proteasomal protein degradation cell wall remodeling critically determine Mtb fitness stationaryphase condition antibiotic exposure Surprisingly found many mutant compromise stationaryphase adaptation result increased fitness antibiotic treatment including recently identified genetic marker associated poor clinical outcomes Furthermore gene involved cell envelope biosynthesis remodeling antibiotic efflux phosphate transport significantly enriched mutant sensitized antibiotics indicating reduced drug entry critical factor limit antibiotic efficacy nonreplicating Mtb demonstrated mutant deficient utilization lipids primary carbon source Mtb infection became tolerant killing rifampicin provided genetic metabolic evidence activity lipid metabolism associated rifampicin efficacy finding provide detailed assessment Mtb gene necessary adaptation stationary phase drug treatment new insight mechanism antibiotic tolerance nongrowing MtbIMPORTANCEIt long known antibiotic efficacy generally proportional bacterial growth rate Yet remains unclear extent growth arrestinduced physiological metabolic change affect drug efficacy Using genomewide transposon mutant screen identified mutant influence iMycobacterium tuberculosisi adaptation drug efficacy stationary phase growth revealed positive negative correlation stationary phase adaptation drug sensitivity identified many mutant compromise stationary phase adaptation result increased fitness antibiotic treatment including identified genetic marker associated poor clinical outcomes result provide new insight mechanism antibiotic tolerance nongrowing Mtb suggest potential target drug development",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40793863/"
    },
    {
        "pmid": "40792312",
        "title": "Empirical Tuberculosis Treatment in Human Immunodeficiency Virus (HIV)-Associated Fever of Unknown Origin: A Case-Based Rationale.",
        "abstract": "Fever unknown origin FUO people living human immunodeficiency virus PLHIV clinically defined recurrent fever lasting four week outpatient setting three day hospitalization despite thorough diagnostic evaluation evaluation typically includes comprehensive medical history physical examination imaging study such chest radiography extensive range laboratory tests including complete blood counts blood urine cultures metabolic panels Among many possible causes tuberculosis TB stand leading concern given disproportionate burden PLHIV However whether initiate empirical antitubercular therapy HIVpositive patient presenting FUO remains matter clinical debate variability regional TB prevalence resource availability make universal recommendation difficult apply context review available evidence supporting use empirical TB treatment PLHIV FUO aiming guide clinical decisionmaking setting diagnostic certainty elusive",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40792312/"
    },
    {
        "pmid": "40791918",
        "title": "Risk factors, molecular analysis and treatment outcomes of amikacin-resistant <i>Mycobacterium avium</i> complex pulmonary disease.",
        "abstract": "Although incidence amikacin AMKresistant iMycobacterium aviumi complex MAC pulmonary disease PD suspected increased limited data available AMKresistant MACPD study evaluated risk factor associated AMK resistance molecular characteristic AMKresistant isolates treatment outcome patient AMKresistant MACPD retrospective casecontrol study included 73 patient severe refractory MACPD history aminoglycoside drug use Patients initial repeat AMK minimum inhibitory concentration MIC ≥64 μg·mLsup1sup classified AMKresistant clarify clinical outcome prognosis observational study conducted 21 patient AMK resistance AMKresistant 52 control AMKsusceptible analysed case AMK resistance previous isolates available AMK MICs elevated compared level prior aminoglycoside administration multivariate analysis risk factors clarithromycin resistance OR 631 95 CI 168237 12 month total duration aminoglycoside use OR 469 95 CI 109202 identified independent risk factor AMK resistance 12 57 21 AMKresistant isolates found mutation irrsi region significant difference AMKresistant AMKsusceptible group term worsening outcomes including introduction home oxygen therapy 38 iversusi 12 p001 3year mortality 33 iversusi 10 p002 Better management strategy patient severe refractory MACPD crucial includes placing strong emphasis preventing AMK resistance",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40791918/"
    },
    {
        "pmid": "40791718",
        "title": "Pharmacokinetics of dexamethasone in tuberculosis meningitis.",
        "abstract": "Dexamethasone recommended adjunctive therapy tuberculosis meningitis TBM Coadministration rifampicin expected reduce dexamethasone exposure TBM effect may pronounced higher rifampicin dos currently evaluated clinical trials pharmacokinetic study nested randomised controlled trial comparing safety highdose rifampicin oral 35 mgkg intravenous 20 mgkg plus linezolid without aspirin v standarddose rifampicin 10 mgkg adult HIVassociated TBM participant received adjunctive oral dexamethasone every 12 hour starting dose 04 mgkgday Dexamethasone concentration measured intensively sampled plasma day 3 study enrolment analysed using nonlinear mixedeffects modelling total 261 dexamethasone concentration 43 participant available model development Eight 18 participant efavirenzbased ART five 11 lopinavirritonavirbased regimen median duration rifampicin therapy time pharmacokinetic sampling 4 day range 07 Dexamethasone pharmacokinetics best described onecompartment disposition model firstorder absorption elimination Typical oral clearance CLF 131 Lh reduced 115 Lh concomitant lopinavirritonavir Highdose rifampicin significant additional effect dexamethasone pharmacokinetic parameter compared standarddose adult HIVassociated TBM high dexamethasone clearance likely related drugdrug interaction rifampicin Highdose rifampicin additional effect dexamethasone exposure pharmacokinetic analysis dexamethasone adult HIVassociated tuberculosis meningitis found high oral clearance 131 Lh likely due drugdrug interaction rifampicin Highdose rifampicin additional effect dexamethasone exposure compared standard dose",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40791718/"
    },
    {
        "pmid": "40791701",
        "title": "High treatment success among individuals with rifampicin-resistant tuberculosis in Botswana: A retrospective cohort study.",
        "abstract": "study report tuberculosis TB treatment outcome among individual diagnosed rifampicinresistant TB RRTB assesses predictor associated treatment outcomes conducted retrospective study analyse treatment outcome 162 individual RRTB 2016 2023 Treatment outcome proportion estimated using binomial exact method 95 confidence interval CI Predictors treatment outcome assessed using logistic regression models 162 individuals 102 627 male median age 39 interquartile range IQR 2950 individuals 78 481 Greater Gaborone health district 88 543 people living HIV PLWH Among individuals 137 846 95 CI 782 897 successfully treated Males higher odds unfavourable treatment outcome compared female OR  170 95 CI 073 398 Among cured slightly higher proportion observed among PLWH 718 95 CI 621 803 compared people living HIV PNLWH 692 95 CI 587 785 However mortality rate higher PLWH 107 95 CI 55 183 compared PNLWH 66 95 CI 25 138 history TB treatment 103 odds unfavourable treatment outcome 95 CI 040 273 however association statistically significant study show high success rate treatment among individual RR TB significant difference based sex TB treatment history HIV status Higher mortality among PLWH highlight need targeted intervention among highrisk groups",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40791701/"
    },
    {
        "pmid": "40791694",
        "title": "Diagnostic accuracy of tongue swab testing in persons with sputum Xpert Ultra Trace results.",
        "abstract": "Molecular amplification tongue swab sample nonsputumbased investigational approach diagnose pulmonary tuberculosis pTB improved manual qPCR method tongue swab recently achieved 90 sensitivity overall diagnosing TB compared sputum microbiologic reference standard Performance characteristic person lowpositive result sputum molecular test unknown Adults South Africa Uganda sputum Xpert MTBRIF Ultra Trace TR result recruited confirmatory evaluation followup underwent symptom evaluation examination chest Xray sputum testing repeat Xpert Ultra two solid liquid mycobacterial cultures two tongue swabs Tongue swab tested using qPCR amplification IS6110 gene single copy detected 1 swab considered TBpositive TR person diagnosed TB baseline reevaluated 1 3 months determined sensitivity specificity tongue swab TB culture alone microbiologic reference standard MRS positive result Xpert Ultra TB culture composite reference standard CRS clinical recommendation TB treatment positive culture baseline 225 enrolled TR participant 115 51 women median age 38 IQR 3047 130 58 people living HIV PWH provided least 1 tongue swab baseline culture reference standard 45 20 positive TB baseline testing 58 26 positive TB MRS 83 37 CRS Sensitivity specificity tongue swab culture 25 95 CI 1340 94 9097 vs MRS 25 95 CI 1438 96 9198 vs CRS 16 926 94 8998 Tongue swab low sensitivity moderately high specificity TB person Trace Xpert Ultra result Tongue swab limited value diagnosing people lowpositive molecular test result uncertain clinical significance",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40791694/"
    },
    {
        "pmid": "40791690",
        "title": "Cumulative TB disease burden following sputum Xpert Ultra 'Trace' results in clinical settings: Results from a multi-site observational clinical study.",
        "abstract": "Highly sensitive molecular tests like Xpert Ultra reshaping TB diagnosisdetecting paucibacillary TB sometimes creating uncertainty detect DNA extremely low quantity may signal disease ambiguity also complicates evaluation novel diagnostic strategies sought monitor adult Trace result Xpert Ultra test estimate risk tuberculosis disease 24 month later conducted multisite clinical observational study South Africa Uganda enrolled ambulatory participant aged 15 year sputum Xpert Ultra Trace result yet initiated TB treatment participant underwent comprehensive clinical evaluation repeated standard sputum TB testing Clinicians deferred treatment recommendation TB status remained uncertain evaluation Untreated participant followed regularly TB diagnosis andor treatment initiation estimated cumulative incidence TB disease defined three reference standards 311 participant Trace result 50 male 57 PLHIV 37 treated TB within last 5 years 24 positive TB within 12 month culture 37 sputum Xpert culture 54 culture clinical diagnosis excluding diagnosed TB baseline patient identified baseline recent TB history abnormal chest xray positive tongue swab higher risk TB diagnosis hazard ratios 26 24 45 respectively followup hazard highest first three month negative baseline evaluation 022 95 CI 019026 per personmonth decreased 001 95 CI 0002 per personmonth 36 612month intervals Approximately half adult adolescent sputum Trace result diagnosed TB disease within twelve months Although TB diagnosis made within 3 months risk remained higher estimated population incidence rate followup period Individuals sputum Trace result receive close clinical monitoring despite initial clinical treatment decision Xpert Ultra Trace result detect low quantity TB DNA creating diagnostic uncertainty complicates clinical decision diagnostics evaluation clinical observational cohort study followed untreated patient Trace result twelve months using survival analysis estimate actual tuberculosis disease risk identify risk factors",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40791690/"
    },
    {
        "pmid": "40791516",
        "title": "Increased proportion of growth-arrested bacilli in acidic pH adaptation promotes <i>Mycobacterium tuberculosis</i> treatment survival.",
        "abstract": "ability iMycobacterium tuberculosisi Mtb adapt growth behavior response host environment promotes survival immune drug stressors However behavior shift singlecell level remains poorly understood Here show Mtb adapts acidic condition increasing proportion bacteria growtharrested state rather uniformly slowing growth rate entire population nongrowing subpopulation exhibit greater tolerance ethambutol Clinical strain displayed higher proportion growtharrested cell neutral acidic conditions suggesting growth arrest serf bethedging strategy infection Though PhoPR twocomponent system contributes regulating nongrowing state show partial regulator nongrowing bacterial subpopulation additional transcriptional regulator involved study demonstrates nongrowing subpopulation Mtb provide fitness benefit active adaptation environmental cue passive consequence stressors",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40791516/"
    },
    {
        "pmid": "40791357",
        "title": "An activator of a two-component system controls cell separation and intrinsic drug resistance in <i>Mycobacterium tuberculosis</i>.",
        "abstract": "Unlike commonly studied rodshaped bacteria mycobacteria grow poles requiring precise coordination division initiation new pole growth mechanism mediate transition largely unknown likely represent rich source drug target treatment mycobacterial infections including tuberculosis Here identify TapA MSMEG3748Rv1697 key regulator transition TapA interacts sensor kinase MtrB septum initiate signaling cascade ultimately result expression essential peptidoglycan hydrolases RipAB amongst others end division Loss TapA disrupts division dysregulates pole formation sensitizes iMycobacterium tuberculosisi mycobacteria several first secondline TB antibiotics establishing TapA potential therapeutic target defining new link cell cycle progression envelope remodeling intrinsic antibiotic resistance mycobacteria",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40791357/"
    },
    {
        "pmid": "40790778",
        "title": "Analysis of the clinical value and influencing factors of combined detection of tuberculosis-specific cytokines IFN-γ and IL-2 in the diagnosis of active tuberculosis in children and adolescents.",
        "abstract": "study aimed conduct combined detection Mycobacterium tuberculosis MTB infection using tuberculosis TBspecific cytokine interferonγ IFNγ interleukin2 IL2 release assay hospitalized child adolescent TB evaluate clinical value technique diagnosis active TB child adolescents analyze related influencing factors retrospective study conducted collect data suspected pediatric adolescent TB patient hospitalized Chengdu Public Health Clinical Medical Center April 2022 December 2024 combined detection MTB infection using IFNγ IL2 release assay referred dualfactor detection TB infection carried out Microbiological molecular biological test result MTB also obtained total 904 patient diagnosed TB 176 nonTB patient included analysis effectiveness dualfactor TB infection testing related influencing factors combined detection IFNγ andor IL2 demonstrated improved diagnostic performance active tuberculosis ATB sensitivity 9104 specificity 6534 AUC  0782 95 CI 07450818 IFNγ IL2 level showed significant difference MTBpositive MTBnegative subgroup within TB cohort IFNγ 36552 vs 38211 pgml IL2 24156 vs 21312 pgml cytokine markedly elevated TB group compared nonTB control IFNγ 681 pgml IL2 4168 pgml Agerelated variation observed IFNγ P  005 IL2 concentrations Untreated patient exhibited higher median level IFNγ 3979 vs 3060 pgml IL2 2392 vs 1733 pgml treated individuals Among 904 ATB cases 896 81904 falsenegative cytokines Multivariate analysis identified advanced age retreatment TB pleural effusion TST positivity independent risk factor dualnegative result all P  005 pediatric adolescent patients combined detection IFNγ IL2 exhibit high sensitivity specificity diagnosing ATB test convenient stable highly accurate making great significance early diagnosis TB evaluation treatment effects Age positive TST result retreatment TB presence pleural effusion may influence result IFNγ andor IL2",
        "mesh_terms": [
            "Humans",
            "Interleukin-2",
            "Child",
            "Adolescent",
            "Interferon-gamma",
            "Male",
            "Female",
            "Retrospective Studies",
            "Tuberculosis",
            "Child, Preschool",
            "Mycobacterium tuberculosis",
            "Infant",
            "Sensitivity and Specificity"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40790778/"
    },
    {
        "pmid": "40790736",
        "title": "Risk factors for tuberculosis treatment outcomes: a statistical learning-based exploration using the SINAN database with incomplete observations.",
        "abstract": "Understanding early predictor treatment outcome allows better outcome prediction resource allocation efficient tuberculosis TB management study aimed predict treatment outcome TB patient realworld populationwide health record dataset significant rate incomplete observations addition potential risk factor associated death TB treatment investigated exploited upweighting approach multiple imputation analysis MIA address extreme imbalance response missing data Three algorithm employed TB treatment outcome prediction including logistic regression LOGIT random forest stochastic gradient boosting three model exhibited similar performance predicting treatment outcomes Moreover interpretation LOGIT conducted adjusted odds ratio aORs computed interpretation result compared MIA complete case analysis CCA MIA appropriate method coping missing data addition compared CCA interpretation result MIAderived LOGIT showed statistically significant covariates associated TB treatment outcomes MIA factor TB clinical form involving pulmonary TB extrapulmonary TB aOR  3077 95 confidence interval CI  29943163 retreatment abandonment aOR  2272 95 CI  22092338 absence isoniazid aOR  2072 95 CI  18922269 rifampicin aOR  1968 95 CI  17462218 treatment regimen associated increased odds death conclusion result shed light potential risk factor death TB treatment suggest use simple yet interpretable LOGIT prediction TB treatment outcomes",
        "mesh_terms": [
            "Humans",
            "Risk Factors",
            "Female",
            "Male",
            "Tuberculosis",
            "Middle Aged",
            "Adult",
            "Databases, Factual",
            "Antitubercular Agents",
            "Treatment Outcome",
            "Machine Learning",
            "Outcome Assessment, Health Care",
            "Aged",
            "Young Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40790736/"
    },
    {
        "pmid": "40790601",
        "title": "Community and Universal Testing for TB among close contacts of microbiologically confirmed pulmonary TB patients in two high TB burden countries: a protocol for a pragmatic cluster-randomised control trial.",
        "abstract": "Tuberculosis TB symptom screening testing using either smear microscopy GeneXpert MTBRIF Ultra Xpert Ultra mainstay diagnosing TB disease case finding Reliance symptombased TB screening result missed TB cases universal TB testing approach might suitable find missing TB case highrisk populations Universal TB testing involves testing TB disease regardless TB symptom risk TB However limited evidence exists support adoption including costeffectiveness study evaluate effectiveness universal TB testing detection TB uptake TB preventive therapy TPT among eligible household community contact high TB setting per country guidelines pragmatic clusterrandomised trial conducted Lesotho Tanzania Drugsensitive TB DSTB index patient aged ≥ 18 years least one contact enrolled microbiologically confirmed TB within ≤ 6 week diagnosis time recruitment study team health facility selected district regions TB index patient contacts randomised either universal TB testing standard TB screening arms Household community contact listed TB index case enumerated invited participate study providing informed consent assent household visits study four substudies including health economics modelling paediatrics microbiology sociobehavioural preparatory crosssectional study conducted delivery pragmatic clusterrandomised trial determine prevalence TB infection TBI TPT eligibility household contact HHCs compare performance QuantiFERONTBGoldPlus QFTPlus QIAreach diagnosing TBI among HHCs TB index patients Clusterrandomised trial community contact tracing conducted phase II trial provide evidence intensive approach hypothesised increase costeffectiveness TB case finding addition provide evidence high TB burden country inherently different cost structure compared intermediate low burden setting previous costeffectiveness analysis undertaken BMC Trial Registry ISRCTN10003903 Registered December 22 2020 Protocol version number date Version 12 dated 15 January 2023 Date recruitment began 1 March 2022 Estimated date recruitment completion 31 July 2025",
        "mesh_terms": [
            "Humans",
            "Contact Tracing",
            "Cost-Benefit Analysis",
            "Mass Screening",
            "Multicenter Studies as Topic",
            "Mycobacterium tuberculosis",
            "Pragmatic Clinical Trials as Topic",
            "Predictive Value of Tests",
            "Tanzania",
            "Tuberculosis, Pulmonary",
            "Randomized Controlled Trials as Topic"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40790601/"
    },
    {
        "pmid": "40790500",
        "title": "Incidental diagnosis of Bardet-Biedl syndrome in a case of abdominal tuberculosis: a case report.",
        "abstract": "BardetBiedl syndrome rare autosomal recessive disease occurring due ciliopathic genetic defect caused mutation gene encoding protein vital BBSome complex complex essential ciliary function cellular signaling multisystem involvement present variety phenotypes 30yearold adult male patient Indian ethnicity presented 2week history ascites dyspnea ascitic fluid analysis confirmed abdominal tuberculosis However patient showed symptom sign syndromic nature patient entirely blind since age 9 years confirmed retinitis pigmentosa complaint progressive weight gain cognitive impairment Examination showed central obesity almondshaped eyes moonshaped face hexadactyly left lower limb Liver functional tests renal function tests lipid profile ultrasonography abdomen abnormal Beales diagnostic criterion confirmed BardetBiedl syndrome patient treated abdominal tuberculosis psychosocial support nutritional counseling provided Effective treatment BardetBiedl syndrome requires genetic counseling personalized care plan includes multidisciplinary team regular monitoring supportive service neuropsychological psychiatric care family support case also increase clinicians awareness presentation BardetBiedl syndrome diagnosis setting without advanced diagnostic modalities",
        "mesh_terms": [
            "Humans",
            "Male",
            "Bardet-Biedl Syndrome",
            "Adult",
            "Incidental Findings",
            "Tuberculosis, Gastrointestinal",
            "Ascites"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40790500/"
    },
    {
        "pmid": "40790469",
        "title": "Dysbiosis associated with enhanced microbial mobility across the respiratory tract in pulmonary tuberculosis patients.",
        "abstract": "microbiota actively engaged interaction network host among constituent members However comprehensive study examining microbiome profile across various respiratory site pulmonary tuberculosis PTB lacking Here explored diversity microbiome PTB patient across multiple respiratory site investigated potential interaction microbiomes sites total 130 respiratory tract sample collected multiple site 22 patient PTB 14 healthy individuals including oral cavity trachea healthy affected side lungs sample subjected metagenomic sequencing analyze characteristic diversity respiratory microbiome found respiratory tract PTB patient higher microbial diversity seen healthy individual 8182 v 6465 Among them iRothiai iPrevotellai iActinomycesi exhibited higher proportion PTB characteristic high diversity feature oral site prominent PTB especially notable difference iRothia mucilaginosai Additionally iStreptococcusi iNeisseriai iPrevotellai iFusobacteriumi strong interaction specie present various site PTB patients well frequent communication specie migration upper lower respiratory tract diversity translocation microbiota across respiratory tract PTB patient associated increased susceptibility microbiome predominance iRothiai iPrevotellai iActinomycesi may represent progressionassociated microbial signatures warranting mechanistic study pathogenic potential hostmicrobe interaction guide therapeutic targeting online version contains supplementary material available 101186s1286602504206x",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40790469/"
    },
    {
        "pmid": "40790221",
        "title": "Gut microbiota profile in newly diagnosed pulmonary tuberculosis patients: an exploratory pilot study in southern India.",
        "abstract": "Emerging evidence suggests link pulmonary tuberculosis PTB gut microbiota dysbiosis first study southern Indian population characterized gut microbiota PTB patient using 16 amplicon sequencing analysis revealed significant reduction gut microbial diversity among PTB patients particularly lower alpha diversity Chao1 index p ≤ 00001 healthy control HC depleted antitubercular therapy ATT Beta diversity indicated distinct clustering group p  005 Subgroup analysis showed supplementation probiotic ATT improved microbial richness diversity However broader shift composition observed genus level specific taxon upregulated downregulated PTB patient compared HC Functional analysis showed depletion biosynthesis pathway PTB patients Shortterm probiotic supplementation partial effect microbial recovery fully restore gut microbial diversity finding highlight persistent dysbiosis PTB patients even ATT Largescale study needed evaluate role microbiometargeted therapy address dysbiosis",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40790221/"
    },
    {
        "pmid": "40790202",
        "title": "Nano delivery of MiR-146a and its effect study on genes involved in apoptosis and autophagy pathways in lung cancer and tuberculosis.",
        "abstract": "Tuberculosis TB lung cancer LC among leading cause death worldwide present serious challenge diagnosis treatment Therefore developing new strategy treatment crucial MicroRNAs miRNAs biological molecule play critical role regulating essential processes apoptosis autophagy TB LC targeting specific genes Recently carbon nanotube functionalized Polyethyleneimine CNTPEI deliver miRNAs target cell investigated enhance therapeutic effects study miR146a transfected LC A549 macrophage infected TB THP1 healthy lung cell MRC5 using CNTPEI Then expression miR146a target gene TNF receptorassociated factor6 TRAF6 gene involved apoptosis autophagy pathway including BCL2 IL6 tumor necrosis factoralpha TNFα measured using RealTime PCR Finally effect overexpression miR146a gene investigated three cell lines result showed successful transfection miR146a using CNTPEI nano delivery system LC TB cell models Then increased expression miR146 increased apoptosis autophagy targeting TRAF6 gene affecting gene BCL2 IL6 TNFα NFkB signaling pathway finding suggest important role miR146a TB LC regulates inflammatory response treat diseases However study needed using CNTPEI vivo well balance local antiinflammatory noninflammatory factors",
        "mesh_terms": [
            "MicroRNAs",
            "Humans",
            "Autophagy",
            "Apoptosis",
            "Lung Neoplasms",
            "Nanotubes, Carbon",
            "Tuberculosis",
            "Polyethyleneimine",
            "TNF Receptor-Associated Factor 6",
            "A549 Cells",
            "Transfection",
            "Intracellular Signaling Peptides and Proteins"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40790202/"
    },
    {
        "pmid": "40789978",
        "title": "Exploratory investigation of urinary alkanes and other volatile organic compounds in paediatric patients with tuberculous meningitis.",
        "abstract": "Tuberculous meningitis TBM disease caused Mycobacterium tuberculosis M tb infection brain Alkanes volatile organic compound VOCs biologically important metabolite used infectious mycobacteria specie growth survival strategies study investigated altered alkane VOCs urine paediatric case TBM used untargeted gas chromatography coupled timeofflight mass spectrometry GCTOFMS analyse compare volatile underivatised compound present urine 27 confirmed case paediatric TBM treatment period six months well control group n  13 Four elevated alkane pentadecane 57dimethylundecane 47dimethylundecane 26dimethylundecane three alkene decreased 25dimethyl2hexene 44dimethyl1pentene increased 3methoxy1pentene three VOCs biological interest decreased 2butenoic acid methyl ester 3heptanone increased 2pyrrolidinone identified statistically significant volatile compound remained perturbed TBM treatment study discovered new systemic metabolic information M tb host role alkane VOCs potential persistence M tb demonstrate value targeting alkane VOCs future metabolomics study M tb",
        "mesh_terms": [
            "Humans",
            "Alkanes",
            "Volatile Organic Compounds",
            "Child",
            "Female",
            "Male",
            "Gas Chromatography-Mass Spectrometry",
            "Tuberculosis, Meningeal",
            "Child, Preschool",
            "Adolescent",
            "Mycobacterium tuberculosis"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40789978/"
    },
    {
        "pmid": "40788892",
        "title": "Barriers to leprosy elimination in Bolivia: Exploring perspectives and experiences of medical professionals and leprosy patients-A phenomenological study.",
        "abstract": "Leprosy elimination recently reentered global health sphere World Health Organisations WHO Towards zero leprosy strategy 20212030 Previously elimination defined prevalence less 1 case per 10000 achieved global scale 2000 leading large withdrawal resource leprosy control neglect global national scales Despite this leprosy continued spread affect hundred thousand people annually study explores barrier leprosy elimination Bolivia using phenomenological approach discover perception experience leprosy patient medical professional regarding leprosy Bolivia also explores role active case finding ACF leprosy elimination Bolivia Indepth semistructured interview conducted Spanish mainly Jorochito Dermatological Hospital national referral centre leprosy Bolivia Barriers leprosy elimination Bolivia present provider patient governmental societal community levels include poor health financing untrained workforce poor treatment adherence centralised organisation leprosy diagnosis treatment health illiteracy barrier leprosy elimination Bolivia complex interconnected embedded Bolivian society Leprosy elimination must given priority global national scale increase funding importance continue ACF activities promote national solution sustainable leprosy control",
        "mesh_terms": [
            "Humans",
            "Bolivia",
            "Leprosy",
            "Male",
            "Female",
            "Disease Eradication",
            "Health Personnel",
            "Adult",
            "Middle Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40788892/"
    },
    {
        "pmid": "40788398",
        "title": "Bactericidal activity of gallic acid against multidrug-resistant Mycobacterium tuberculosis.",
        "abstract": "persistent rise multidrugresistant MDR bacteria represents significant public health challenge necessitating exploration alternative therapeutic options slow pace approval new antituberculosis TB medication underscore urgent need identify potential alternative agents Gallic acid GA possesses numerous biological properties including antibacterial antiseptic effects study standard MDR strain M tuberculosis utilized assess antibacterial efficacy GA related mechanisms GA achieved minimum inhibitory minimum bactericidal concentration comparable examined antibiotic significantly lower cytotoxicity THLE3 cell line pvalue  005 Furthermore GA displayed bactericidal properties enhanced effectiveness moxifloxacin levofloxacin MDR M tuberculosis modulated expression efflux pump genes specifically Rv1410c Rv1258c pvalue  0001 result contribute deeper understanding GAs antibacterial potential suggest novel alternative approach managing MDR bacterial infections",
        "mesh_terms": [
            "Gallic Acid",
            "Mycobacterium tuberculosis",
            "Microbial Sensitivity Tests",
            "Antitubercular Agents",
            "Drug Resistance, Multiple, Bacterial",
            "Humans",
            "Tuberculosis, Multidrug-Resistant",
            "Cell Line",
            "Levofloxacin",
            "Moxifloxacin",
            "Bacterial Proteins"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40788398/"
    }
]